2025/04/30 更新

写真a

カワサキ ナナ
川崎 ナナ
Nana Kawasaki
所属
生命医科学研究科 生命医科学専攻 教授
理学部 理学科
職名
教授
プロフィール
研究テーマ:細胞・組織等の糖タンパク質の構造・機能解析とバイオ関連製品開発への応用
外部リンク

学位

  • 薬学博士 ( 北海道大学 )

研究キーワード

  • バイオ医薬品

  • 抗体医薬品

  • LC/MS

  • グライコミクス

  • プロテオミクス

  • iPS細胞

  • 分子マーカ―

  • 糖タンパク質

研究分野

  • ライフサイエンス / 構造生物化学

  • ライフサイエンス / 医療薬学

  • ライフサイエンス / 薬系分析、物理化学

経歴

  • 横浜市立大学生命医科学研究科   教授

    2015年4月 - 現在

      詳細を見る

  • 北海道大学生命科学院   客員教授

    2011年4月 - 現在

      詳細を見る

  • 厚生労働省 国立医薬品食品衛生研究所 生物薬品部   部長

    2010年4月 - 2015年3月

      詳細を見る

所属学協会

▼全件表示

委員歴

  • 日本質量分析学会   理事  

    2017年5月 - 現在   

      詳細を見る

    団体区分:学協会

    researchmap

  • 厚生労働省   薬事・食品衛生審議会臨時委員  

    2011年1月 - 2020年12月   

      詳細を見る

    団体区分:政府

    researchmap

  • 独立行政法人医薬品医療機器総合機構   専門委員  

      詳細を見る

    団体区分:政府

    researchmap

  • 世界保健機関WHO   バイオアドバイザー  

      詳細を見る

    団体区分:政府

    researchmap

論文

  • Comparative Analysis of Site-Specific N-glycosylation of LAMP1 from Breast Cancer Tissues. 国際誌

    Shoko Ohashi, Daisuke Takakura, Noritoshi Kobayashi, Motohiko Tokuhisa, Yasushi Ichikawa, Nana Kawasaki

    Journal of biochemistry   2024年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Glycosylation changes in cancer proteins have been associated with malignant transformation. However, techniques for analyzing site-specific glycosylation changes in target proteins obtained from clinical tissue samples are insufficient. To overcome these problems, we developed a targeted N-glycoproteomic approach consisting of immunoprecipitation, glycopeptide enrichment, LC/MS/MS, and structural assignment using commercially available analytical software followed by manual confirmation. This approach was applied to the comparative site-specific glycosylation analysis of lysosome-associated membrane glycoprotein 1 (LAMP1) between breast cancer (BC) tumors and normal tissues adjacent to tumors. Extensive determination of glycan heterogeneity from four N-glycosylation sites (Asn84/103/249/261) in LAMP1 identified 262 glycoforms, and revealed remarkable diversity in tumor glycan structures. A significant increase in N-glycoforms with multiple fucoses and sialic acids at Asn84/249 and high-mannose-type glycans at Asn103/261 were observed in the tumor. Principal component analysis revealed that tumors of different subtypes have independent distributions. This approach enables site-specific glycopeptide analysis of target glycoprotein in breast cancer tissue and become a powerful tool for characterizing tumors with different pathological features by their glycan profiles.

    DOI: 10.1093/jb/mvae001

    PubMed

    researchmap

  • O-GalNAc glycosylation determines intracellular trafficking of APP and Aβ production. 国際誌

    Yuriko Tachida, Junko Iijima, Kazuto Takahashi, Hideaki Suzuki, Yasuhiko Kizuka, Yoshiki Yamaguchi, Katsunori Tanaka, Miyako Nakano, Daisuke Takakura, Nana Kawasaki, Yuko Saito, Hiroshi Manya, Tamao Endo, Shinobu Kitazume

    The Journal of biological chemistry   299 ( 7 )   104905 - 104905   2023年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    A primary pathology of Alzheimer's disease (AD) is Aβ deposition in brain parenchyma and blood vessels, the latter being called cerebral amyloid angiopathy (CAA). Parenchymal amyloid plaques presumably originate from neuronal Aβ precursor protein (APP). Although vascular amyloid deposits' origins remain unclear, endothelial APP expression in APP-knock-in mice was recently shown to expand CAA pathology, highlighting endothelial APP's importance. Furthermore, two types of endothelial APP-highly O-glycosylated APP and hypo-O-glycosylated APP-have been biochemically identified, but only the former is cleaved for Aβ production, indicating the critical relationship between APP O-glycosylation and processing. Here, we analyzed APP glycosylation and its intracellular trafficking in neurons and endothelial cells. Although protein glycosylation is generally believed to precede cell surface trafficking, which was true for neuronal APP, we unexpectedly observed that hypo-O-glycosylated APP is externalized to the endothelial cell surface and transported back to the Golgi apparatus, where it then acquires additional O-glycans. Knockdown of genes encoding enzymes initiating APP O-glycosylation significantly reduced Αβ production, suggesting this non-classical glycosylation pathway contributes to CAA pathology and is a novel therapeutic target.

    DOI: 10.1016/j.jbc.2023.104905

    PubMed

    researchmap

  • Quantitative Proteomics for the Development and Manufacturing of Human-Induced Pluripotent Stem Cell-Derived Neural Stem Cells Using Data-Independent Acquisition Mass Spectrometry. 国際誌

    Takaya Urasawa, Takumi Koizumi, Kazumasa Kimura, Yuki Ohta, Nana Kawasaki

    Journal of proteome research   22 ( 6 )   1843 - 1854   2023年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Human-induced pluripotent stem cell (iPSC)-derived neural stem cells (NSCs) have several potential applications in regenerative medicine. A deep understanding of stem cell characteristics is critical for developing appropriate products for use in the clinic. This study aimed to develop approaches for characterizing iPSC-derived NSCs. Data-independent acquisition mass spectrometry (DIA-MS) was used to obtain temporal proteomic profiles of differentiating cells. Principal component analysis of the proteome profiles allowed for the discrimination of cells cultured for different periods. Cells were characterized by Gene Ontology analysis to annotate the upregulated proteins based on their functions. We found that trophoblast glycoprotein (TPBG), a membrane glycoprotein that inhibits the Wnt/β-catenin pathway, was elevated in NSC and that silencing TPBG promoted proliferation rather than neuronal differentiation. Treatment with Wnt/β-catenin pathway activators and inhibitors showed that modulating the Wnt/β-catenin pathway is crucial for differentiation into NSC. These results suggest that the level of TPBG is critical for differentiation into NSC, and TPBG is a potentially critical quality attribute of differentiating cells. In summary, DIA-MS-based proteomics is a promising multi-attribute method for characterizing stem cell-derived products.

    DOI: 10.1021/acs.jproteome.2c00841

    PubMed

    researchmap

  • Comprehensive Membrane N-Glycoproteomics Using Human Breast Cancer Cell Line Pairs.

    Daisuke Takakura, Haruka Yoshida, Shoko Ohashi, Nana Kawasaki

    Mass spectrometry (Tokyo, Japan)   12 ( 1 )   A0117   2023年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Aberrant glycosylation of membrane proteins is a hallmark of cancer and a useful molecular marker for the diagnosis of breast cancer (BC). However, the molecular mechanisms by which altered glycosylation affects the malignant transformations associated with BC are poorly understood. Accordingly, we performed comparative membrane N-glycoproteomics using the human BC cell line pair, Hs578T, and its syngeneic normal cell line, Hs578Bst. A total of 359 N-glycoforms derived from 113 proteins were identified in both cell lines, of which 27 were found only in Hs578T cells. Significant changes in N-glycosylation were found in the lysosome-associated membrane protein 1 (LAMP1), the integrin family, and laminin. Confocal immunofluorescence microscopy images revealed the accumulation of lysosomes in the perinuclear space in cancer cells, which could be associated with marked changes in LAMP1 glycosylation, such as a decreased level of polylactosamine chains. Overall, the alterations in glycosylation may be involved in changes in the adhesion and degradation of BC cells.

    DOI: 10.5702/massspectrometry.A0117

    PubMed

    researchmap

  • Beta-1,4-galactosyltransferase-3 deficiency suppresses the growth of immunogenic tumors in mice. 国際誌

    Heng Wei, Chie Naruse, Daisuke Takakura, Kazushi Sugihara, Xuchi Pan, Aki Ikeda, Nana Kawasaki, Masahide Asano

    Frontiers in immunology   14   1272537 - 1272537   2023年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND: Beta-1,4-galactosyltransferase-3 (B4GALT3) belongs to the family of beta-1,4-galactosyltransferases (B4GALTs) and is responsible for the transfer of UDP-galactose to terminal N-acetylglucosamine. B4GALT3 is differentially expressed in tumors and adjacent normal tissues, and is correlated with clinical prognosis in several cancers, including neuroblastoma, cervical cancer, and bladder cancer. However, the exact role of B4GALT3 in the tumor immune microenvironment (TIME) remains unclear. Here, we aimed to elucidate the function of B4GALT3 in the TIME. METHODS: To study the functions of B4GALT3 in cancer immunity, either weakly or strongly immunogenic tumor cells were subcutaneously transplanted into wild-type (WT) and B4galt3 knockout (KO) mice. Bone marrow transplantation and CD8+ T cell depletion experiments were conducted to elucidate the role of immune cells in suppressing tumor growth in B4galt3 KO mice. The cell types and gene expression in the tumor region and infiltrating CD8+ T cells were analyzed using flow cytometry and RNA sequencing. N-glycosylated proteins from WT and B4galt3 KO mice were compared using the liquid chromatography tandem mass spectrometry (LC-MS/MS)-based glycoproteomic approach. RESULTS: B4galt3 KO mice exhibited suppressed growth of strongly immunogenic tumors with a notable increase in CD8+ T cell infiltration within tumors. Notably, B4galt3 deficiency led to changes in N-glycan modification of several proteins, including integrin alpha L (ITGAL), involved in T cell activity and proliferation. In vitro experiments suggested that B4galt3 KO CD8+ T cells were more susceptible to activation and displayed increased downstream phosphorylation of FAK linked to ITGAL. CONCLUSION: Our study demonstrates that B4galt3 deficiency can potentially boost anti-tumor immune responses, largely through enhancing the influx of CD8+ T cells. B4GALT3 might be suppressing cancer immunity by synthesizing the glycan structure of molecules on the CD8+ T cell surface, as evidenced by the changes in the glycan structure of ITGAL in immune cells. Importantly, B4galt3 KO mice showed no adverse effects on growth, development, or reproduction, underscoring the potential of B4GALT3 as a promising and safe therapeutic target for cancer treatment.

    DOI: 10.3389/fimmu.2023.1272537

    PubMed

    researchmap

  • Targeted O-glycoproteomics for the development of diagnostic markers for advanced colorectal cancer. 国際誌

    Daisuke Takakura, Shoko Ohashi, Noritoshi Kobayashi, Motohiko Tokuhisa, Yasushi Ichikawa, Nana Kawasaki

    Frontiers in oncology   13   1104936 - 1104936   2023年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Aberrant glycosylation is a prominent feature of cancer, that can be used as targets to improve the existing cancer biomarkers, and help to assess metastasis risks, and therapeutic effects. We developed a targeted O-glycoproteomics method using serum specimens, and evaluated its utility in identifying advanced colorectal cancer (CRC) markers. To this end, we combined consecutive lectin affinity purification using Maclura pomifera lectin (MPL), jacalin, and Sambucus nigra lectin, which have affinities for the following O-glycans, that have received attention as cancer-related antigens, Tn (GalNAc-Ser/Thr), Sialyl Tn (Siaα2-6GalNAc-Ser/Thr), T (Galβ1-3GalNAc-Ser/Thr), Sialyl T (Siaα2-3Galβ1-GalNAc-Ser/Thr), and di-Sialyl T (Siaα2-3Galβ1-3[Siaα2-6] GalNAc-Ser/Thr), with a unique O-glycoproteomics approach. A total of 2,068 O-glycoforms derived from 265 proteins were identified in healthy individuals and patients with advanced CRC, of which 44 CRC-specific O-glycoforms were extracted. Particularly, five glycoproteins with T, Sialyl T, and di-Sialyl T antigens in specific peptide regions were evaluated quantitatively and statistically. We found that fibulin-2 (FBLN2) (aa330-349)/T antigen (area under the curve [AUC] = 0.92); macrophage colony-stimulating factor 1 (CSF1) (aa370-395)/(T + di-Sialyl T) (AUC = 0.94); macrophage mannose receptor 1 (MRC1) (aa1083-1101 and aa1215-1229)/T (AUC = 0.96 and 0.99); fibrinogen alpha chain (FGA) (aa354-367, aa511-527 and aa559-573)/Sialyl T (AUC = 0.98, 0.90 and 0.94); and complement component C7 (C7) (aa692-701)/di-Sialyl T (AUC = 1.00), can have high diagnostic efficacy to strategically predict advanced CRC groups. Hence, they could be promising markers for detection of advanced CRC, and provide new clinical test indicators along with lectins, such as MPL and jacalin. Our O-glycoproteomics platform provides a novel tool and resource, for researchers and clinicians seeking to better understand and treat advanced CRC.

    DOI: 10.3389/fonc.2023.1104936

    PubMed

    researchmap

  • International nonproprietary names for monoclonal antibodies: an evolving nomenclature system. 国際誌

    Sofia S Guimaraes Koch, Robin Thorpe, Nana Kawasaki, Marie-Paule Lefranc, Sarel Malan, Andrew C R Martin, Gilles Mignot, Andreas Plückthun, Menico Rizzi, Stephanie Shubat, Karin Weisser, Raffaella Balocco

    mAbs   14 ( 1 )   2075078 - 2075078   2022年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Appropriate nomenclature for all pharmaceutical substances is important for clinical development, licensing, prescribing, pharmacovigilance, and identification of counterfeits. Nonproprietary names that are unique and globally recognized for all pharmaceutical substances are assigned by the International Nonproprietary Names (INN) Programme of the World Health Organization (WHO). In 1991, the INN Programme implemented the first nomenclature scheme for monoclonal antibodies. To accompany biotechnological development, this nomenclature scheme has evolved over the years; however, since the scheme was introduced, all pharmacological substances that contained an immunoglobulin variable domain were coined with the stem -mab. To date, there are 879 INN with the stem -mab. Owing to this high number of names ending in -mab, devising new and distinguishable INN has become a challenge. The WHO INN Expert Group therefore decided to revise the system to ease this situation. The revised system was approved and adopted by the WHO at the 73rd INN Consultation held in October 2021, and the radical decision was made to discontinue the use of the well-known stem -mab in naming new antibody-based drugs and going forward, to replace it with four new stems: -tug, -bart, -mig, and -ment.

    DOI: 10.1080/19420862.2022.2075078

    PubMed

    researchmap

  • Postsynaptic structure formation of human iPS cell-derived neurons takes longer than presynaptic formation during neural differentiation in vitro. 国際誌

    Kazuyuki Togo, Hayato Fukusumi, Tomoko Shofuda, Hiroshi Ohnishi, Hiroyuki Yamazaki, Mariko Kato Hayashi, Nana Kawasaki, Nobuyuki Takei, Takanobu Nakazawa, Yumiko Saito, Kousuke Baba, Hitoshi Hashimoto, Yuko Sekino, Tomoaki Shirao, Hideki Mochizuki, Yonehiro Kanemura

    Molecular brain   14 ( 1 )   149 - 149   2021年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    The generation of mature synaptic structures using neurons differentiated from human-induced pluripotent stem cells (hiPSC-neurons) is expected to be applied to physiological studies of synapses in human cells and to pathological studies of diseases that cause abnormal synaptic function. Although it has been reported that synapses themselves change from an immature to a mature state as neurons mature, there are few reports that clearly show when and how human stem cell-derived neurons change to mature synaptic structures. This study was designed to elucidate the synapse formation process of hiPSC-neurons. We propagated hiPSC-derived neural progenitor cells (hiPSC-NPCs) that expressed localized markers of the ventral hindbrain as neurospheres by dual SMAD inhibition and then differentiated them into hiPSC-neurons in vitro. After 49 days of in vitro differentiation, hiPSC-neurons significantly expressed pre- and postsynaptic markers at both the transcript and protein levels. However, the expression of postsynaptic markers was lower than in normal human or normal rat brain tissues, and immunostaining analysis showed that it was relatively modest and was lower than that of presynaptic markers and that its localization in synaptic structures was insufficient. Neurophysiological analysis using a microelectrode array also revealed that no synaptic activity was generated on hiPSC-neurons at 49 days of differentiation. Analysis of subtype markers by immunostaining revealed that most hiPSC-neurons expressed vesicular glutamate transporter 2 (VGLUT2). The presence or absence of NGF, which is required for the survival of cholinergic neurons, had no effect on their cell fractionation. These results suggest that during the synaptogenesis of hiPSC-neurons, the formation of presynaptic structures is not the only requirement for the formation of postsynaptic structures and that the mRNA expression of postsynaptic markers does not correlate with the formation of their mature structures. Technically, we also confirmed a certain level of robustness and reproducibility of our neuronal differentiation method in a multicenter setting, which will be helpful for future research. Synapse formation with mature postsynaptic structures will remain an interesting issue for stem cell-derived neurons, and the present method can be used to obtain early and stable quality neuronal cultures from hiPSC-NPCs.

    DOI: 10.1186/s13041-021-00851-1

    PubMed

    researchmap

  • Glycoproteomic analysis of the changes in protein N-glycosylation during neuronal differentiation in human-induced pluripotent stem cells and derived neuronal cells. 国際誌

    Kazumasa Kimura, Takumi Koizumi, Takaya Urasawa, Yuki Ohta, Daisuke Takakura, Nana Kawasaki

    Scientific reports   11 ( 1 )   11169 - 11169   2021年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    N-glycosylation of glycoproteins, a major post-translational modification, plays a crucial role in various biological phenomena. In central nervous systems, N-glycosylation is thought to be associated with differentiation and regeneration; however, the state and role of N-glycosylation in neuronal differentiation remain unclear. Here, we conducted sequential LC/MS/MS analyses of tryptic digest, enriched glycopeptides, and deglycosylated peptides of proteins derived from human-induced pluripotent stem cells (iPSCs) and iPSC-derived neuronal cells, which were used as a model of neuronal differentiation. We demonstrate that the production profiles of many glycoproteins and their glycoforms were altered during neuronal differentiation. Particularly, the levels of glycoproteins modified with an N-glycan, consisting of five N-acetylhexosamines, three hexoses, and a fucose (HN5H3F), increased in dopaminergic neuron-rich cells (DAs). The N-glycan was deduced to be a fucosylated and bisected biantennary glycan based on product ion spectra. Interestingly, the HN5H3F-modified proteins were predicted to be functionally involved in neural cell adhesion, axon guidance, and the semaphorin-plexin signaling pathway, and protein modifications were site-selective and DA-selective regardless of protein production levels. Our integrated method for glycoproteome analysis and resultant profiles of glycoproteins and their glycoforms provide valuable information for further understanding the role of N-glycosylation in neuronal differentiation and neural regeneration.

    DOI: 10.1038/s41598-021-90102-z

    PubMed

    researchmap

  • Glycan Epitopes on 201B7 Human-Induced Pluripotent Stem Cells Using R-10G and R-17F Marker Antibodies. 国際誌

    Yuko Nagai, Hiromi Nakao, Aya Kojima, Yuka Komatsubara, Yuki Ohta, Nana Kawasaki, Nobuko Kawasaki, Hidenao Toyoda, Toshisuke Kawasaki

    Biomolecules   11 ( 4 )   2021年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    We developed two human-induced pluripotent stem cell (hiPSC)/human embryonic stem cell (hESC)-specific glycan-recognizing mouse antibodies, R-10G and R-17F, using the Tic (JCRB1331) hiPSC line as an antigen. R-10G recognizes a low-sulfate keratan sulfate, and R-17F recognizes lacto-N-fucopentaose-1. To evaluate the general characteristics of stem cell glycans, we investigated the hiPSC line 201B7 (HPS0063), a prototype iPSC line. Using an R-10G affinity column, an R-10G-binding protein was isolated from 201B7 cells. The protein yielded a single but very broad band from 480 to 1236 kDa by blue native gel electrophoresis. After trypsin digestion, the protein was identified as podocalyxin by liquid chromatography/mass spectrometry. According to Western blotting, the protein reacted with R-10G and R-17F. The R-10G-positive band was resistant to digestion with glycan-degrading enzymes, including peptide N-glycanase, but the intensity of the band was decreased significantly by digestion with keratanase, keratanase II, and endo-β-galactosidase, suggesting the R-10G epitope to be a keratan sulfate. These results suggest that keratan sulfate-type epitopes are shared by hiPSCs. However, the keratan sulfate from 201B7 cells contained a polylactosamine disaccharide unit (Galβ1-4GlcNAc) at a significant frequency, whereas that from Tic cells consisted mostly of keratan sulfate disaccharide units (Galβ1-4GlcNAc(6S)). In addition, the abundance of the R-10G epitope was significantly lower in 201B7 cells than in Tic cells.

    DOI: 10.3390/biom11040508

    PubMed

    researchmap

  • Monitoring the glycosylation of α-amino-3-hydroxy-5-methyl-4-isoxazole-propionate-type glutamate receptors using specific antibodies reveals a novel regulatory mechanism of N-glycosylation occupancy by molecular chaperones in mice. 査読 国際誌

    Ryosuke Midorikawa, Daisuke Takakura, Jyoji Morise, Yoshihiko Wakazono, Nana Kawasaki, Shogo Oka, Kogo Takamiya

    Journal of neurochemistry   153 ( 5 )   567 - 585   2020年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    In the mammalian nervous system, protein N-glycosylation plays an important role in neuronal physiology. In this study, we performed a comprehensive N-glycosylation analysis of mouse GluA1, one of the major subunits of α-amino-3-hydroxy-5-methyl-4-isoxazole-propionate type glutamate receptor, which possesses six potential N-glycosylation sites in the N-terminal domain. By mass spectrometry-based analysis, we identified the N-glycoforms and semiquantitatively determined the site-specific N-glycosylation occupancy of GluA1. In addition, only the N401-glycosylation site demonstrated incomplete N-glycosylation occupancy. Therefore, we generated a peptide antibody that specifically detects the N401-glycan-free form to precisely quantify N401-glycosylation occupancy. Using this antibody, we clarified that N401 occupancy varies between cell types and increases in an age-dependent manner in mouse forebrains. To address the regulatory mechanism of N401-glycosylation, binding proteins of GluA1 around the N401 site were screened. HSP70 family proteins, including Bip, were identified as candidates. Bip has been known as a molecular chaperone that plays a key role in protein folding in the ER (endoplasmic reticulum). To examine the involvement of Bip in N401-glycosylation, the effect of Bip over-expression on N401 occupancy was evaluated in HEK293T cells, and the results demonstrated Bip increases the N401 glycan-free form by mediating selective prolongation of its protein half-life. Taken together, we propose that the N401-glycosite of GluA1 receives a unique control of modification, and we also propose a novel N-glycosylation occupancy regulatory mechanism by Bip that might be associated with α-amino-3-hydroxy-5-methyl-4-isoxazole-propionate receptors function in the brain.

    DOI: 10.1111/jnc.14964

    PubMed

    researchmap

  • Glycan-Dependent and -Independent Dual Recognition between DC-SIGN and Type II Serine Protease MSPL/TMPRSS13 in Colorectal Cancer Cells 査読

    Motohiro Nonaka, Shogo Matsumoto, Bruce Yong Ma, Hiroshi Kido, Nana Kawasaki, Nobuko Kawasaki, Toshisuke Kawasaki

    Applied Sciences   10 ( 8 )   2687 - 2687   2020年4月

     詳細を見る

    掲載種別:研究論文(学術雑誌)   出版者・発行元:MDPI AG  

    A class of glycoproteins such as carcinoembryonic antigen (CEA)/CEA-related cell adhesion molecule 1(CEACAM1), CD26 (DPPIV), and mac-2 binding protein (Mac-2BP) harbor tumor-associated glycans in colorectal cancer. In this study, we identified type II transmembrane mosaic serine protease large-form (MSPL) and its splice variant transmembrane protease serine 13 (TMPRSS13) as ligands of Dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin (DC-SIGN) on the colorectal cancer cells. DC-SIGN is a C-type lectin expressed on dendritic cells, serves as a pattern recognition receptor for numerous pathogens such as human immunodeficiency virus (HIV) and M. tuberculosis. DC-SIGN recognizes these glycoproteins in a Ca2+ dependent manner. Meanwhile, we found that MSPL proteolytically cleaves DC-SIGN in addition to the above glycan-mediated recognition. DC-SIGN was degraded more efficiently by MSPL when treated with ethylenediaminetetraacetic acid (EDTA), suggesting that glycan-dependent interaction of the two molecules partially blocked DC-SIGN degradation. Our findings uncovered a dual recognition system between DC-SIGN and MSPL/TMPRSS13, providing new insight into the mechanism underlying colorectal tumor microenvironment.

    DOI: 10.3390/app10082687

    researchmap

  • Influence of N-glycosylation on effector functions and thermal stability of glycoengineered IgG1 monoclonal antibody with homogeneous glycoforms 査読 国際誌

    Ryuta Wada, Makoto Matsui, Nana Kawasaki

    mAbs   11 ( 2 )   350 - 372   2019年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Informa UK Limited  

    Glycosylation of the conserved asparagine residue in each heavy chain of IgG in the CH2 domain is known as N-glycosylation. It is one of the most common post-translational modifications and important critical quality attributes of monoclonal antibody (mAb) therapeutics. Various studies have demonstrated the effects of the Fc N-glycosylation on safety, Fc effector functions, and pharmacokinetics, both dependent and independent of neonatal Fc receptor (FcRn) pathway. However, separation of various glycoforms to investigate the biological and functional relevance of glycosylation is a major challenge, and existing studies often discuss the overall impact of N-glycans, without considering the individual contributions of each glycoform when evaluating mAbs with highly heterogeneous distributions. In this study, chemoenzymatic glycoengineering incorporating an endo-β-N-acetylglucosaminidase (ENGase) EndoS2 and its mutant with transglycosylation activity was used to generate mAb glycoforms with highly homogeneous and well-defined N-glycans to better understand and precisely evaluate the effect of each N-glycan structure on Fc effector functions and protein stability. We demonstrated that the core fucosylation, non-reducing terminal galactosylation, sialylation, and mannosylation of IgG1 mAb N-glycans impact not only on FcγRIIIa binding, antibody-dependent cell-mediated cytotoxicity, and C1q binding, but also FcRn binding, thermal stability and propensity for protein aggregation.

    DOI: 10.1080/19420862.2018.1551044

    PubMed

    researchmap

  • Characteristic glycopeptides associated with extreme human longevity identified through plasma glycoproteomics. 査読 国際誌

    Yuri Miura, Noritaka Hashii, Yuki Ohta, Yoko Itakura, Hiroki Tsumoto, Junya Suzuki, Daisuke Takakura, Yukiko Abe, Yasumichi Arai, Masashi Toyoda, Nana Kawasaki, Nobuyoshi Hirose, Tamao Endo

    Biochimica et biophysica acta. General subjects   1862 ( 6 )   1462 - 1471   2018年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND: Glycosylation is highly susceptible to changes of the physiological conditions, and accordingly, is a potential biomarker associated with several diseases and/or longevity. Semi-supercentenarians (SSCs; older than 105 years) are thought to be a model of human longevity. Thus, we performed glycoproteomics using plasma samples of SSCs, and identified proteins and conjugated N-glycans that are characteristic of extreme human longevity. METHODS: Plasma proteins from Japanese semi-supercentenarians (SSCs, 106-109 years), aged controls (70-88 years), and young controls (20-38 years) were analysed by using lectin microarrays and liquid chromatography/mass spectrometry (LC/MS). Peak area ratios of glycopeptides to corresponding normalising peptides were subjected to orthogonal projections to latent structures discriminant analysis (OPLS-DA). Furthermore, plasma levels of clinical biomarkers were measured. RESULTS: We found two lectins such as Phaseolus vulgaris, and Erythrina cristagalli (ECA), of which protein binding were characteristically increased in SSCs. Peak area ratios of ECA-enriched glycopeptides were successfully discriminated between SSCs and controls using OPLS-DA, and indicated that tri-antennary and sialylated N-glycans of haptoglobin at Asn207 and Asn211 sites were characterized in SSCs. Sialylated glycans of haptoglobin are a potential biomarker of several diseases, such as hepatocellular carcinoma, liver cirrhosis, and IgA-nephritis. However, the SSCs analysed here did not suffer from these diseases. CONCLUSIONS: Tri-antennary and sialylated N-glycans on haptoglobin at the Asn207 and Asn211 sites were abundant in SSCs and characteristic of extreme human longevity. GENERAL SIGNIFICANCE: We found abundant glycans in SSCs, which may be associated with human longevity.

    DOI: 10.1016/j.bbagen.2018.03.025

    PubMed

    researchmap

  • Collaborative study using common samples to evaluate the performance of anti-drug antibody assays constructed by different companies. 査読 国際誌

    Shingo Niimi, Kazuhiro Nishimiya, Masanobu Nishidate, Tetsu Saito, Kyoko Minoura, Kenta Kadotsuji, Jin Shimakura, Hiroko Shigemizu, Jun Hosogi, Maiko Adachi, Tsutomu Hashimoto, Tamiki Mori, Hideki Harada, Ken-Ichi Yamamoto, Takahiro Nakamura, Tatsuki Nomura, Itadaki Yamaguchi, Kazuhiko Sonehara, Akiko Ishii-Watabe, Nana Kawasaki

    Drug metabolism and pharmacokinetics   33 ( 2 )   125 - 132   2018年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Japanese Society for the Study of Xenobiotics  

    This study was undertaken to evaluate the performance of anti-drug antibody (ADA) assays constructed by each participating company using common samples including ADA, drug and human serum. The ADA assays constructed by each company showed good sensitivity and precision for evaluation of ADA. Cut points for screening and confirmatory assays and assay selectivity were determined by various calculation methods. In evaluations of blind ADA samples, nearly similar results were obtained by the study companies in determinations of whether samples were positive or negative except at the lowest sample concentration (5 ng/mL). In measurement of drug tolerance, for almost samples containing ADA and drugs, more positive results were obtained in assays using acid dissociation compared to those without acid dissociation. Overall, the performance of ADA assays constructed by the 10 companies participating in this study was acceptable in terms of sensitivity and reproducibility for detection and evaluation of immunogenicity in both patients and healthy subjects. On the other hand, based on results for samples containing ADA and drugs, validity of results for ADA assays conducted without acid dissociation was less meaningful and more difficult to evaluate. Thus, acid dissociation was confirmed to be useful for improving drug tolerance.

    DOI: 10.1016/j.dmpk.2018.03.002

    Scopus

    PubMed

    researchmap

  • Site-specific N-glycosylation analysis of soluble Fcγ receptor IIIb in human serum, 査読 国際誌

    Yagi, H, Takakura, D, Roumenina, L. T, Fridman, W. H, Sautès-Fridman, C, Kawasaki, N, Kato, K

    Sci. Rep.   8 ( 1 )   2719 - 2719   2018年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1038/s41598-018-21145-y

    PubMed

    researchmap

  • Characterization of glycoproteins expressing the blood group H type 1 epitope on human induced pluripotent stem (hiPS) cells 査読

    Hiromi Nakao, Shogo Matsumoto, Yuko Nagai, Aya Kojima, Hidenao Toyoda, Noritaka Hashii, Daisuke Takakura, Nana Kawasaki, Tomoko Yamaguchi, Kenji Kawabata, Nobuko Kawasaki, Toshisuke Kawasaki

    GLYCOCONJUGATE JOURNAL   34 ( 6 )   779 - 787   2017年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:SPRINGER  

    Recently, we established two mouse monoclonal antibodies (R-10G and R-17F). The R-17F antibody (IgG1 subtype) exhibited a strong cytotoxic effect on hiPS/ES cells. The R-17F antigen isolated from a total lipid extract of hiPS (Tic) cells was identified as LNFP I (Fuc alpha 1-2Gal beta 1-3GlcNAc beta 1-3Gal beta 1-4Glc). In the present study, R-17F binding proteins were isolated from hiPS (Tic) cell lysates with an affinity column of R-17F. They gave one major R-17F positive band around 250 kDa, and several minor bands between 150 kDa and 25 kDa. The former band was identified as podocalyxin by LC/MS/MS after SDS-PAGE. Hapten inhibition studies on R-17F binding to R-17F column-purified proteins with various synthetic oligosaccharides revealed that the blood group H type 1 triaose structure (Fuc alpha 1-2Gal beta 1-3GlcNAc) was the predominant epitope on all the R-17F binding proteins. These bands disappeared completely on digestion with alpha 1-2 fucosidase, but not with alpha 1-3/4 fucosidase. Upon PNGase F digestion, the R-17F positive band around and above 250 kDa did not show any change, while the minor bands between 150 kDa and 25 kDa disappeared completely, suggesting that the epitope is expressed on N-glycans in the latter and probably on O-glycans in the former. These results, together with those obtained in our previous studies on R-10G (Kawabe et al. Glycobiology, 23, 322-336 (2013)), indicated that both R-10G and R-17F epitopes are carried on the same podocalyxin molecule. The R-17F epitopes on these glycoproteins expressed on hiPS cells could be associated with the molecular mechanism underlying the carbohydrate-mediated cytotoxic activity of R-17F.

    DOI: 10.1007/s10719-016-9710-2

    Web of Science

    researchmap

  • Rapid glycopeptide enrichment using cellulose hydrophilic interaction/styrene-divinylbenzene StageTips. 招待 査読

    Ohta, Y, Kameda, K, Matsumoto, M, Kawasaki, N

    Mass Spectrom (Tokyo)   6 ( 1 )   A0061   2017年8月

     詳細を見る

    記述言語:英語  

    researchmap

  • Lethality of mice bearing a knockout of the Ngly1-gene is partially rescued by the additional deletion of the Engase gene 査読

    Haruhiko Fujihira, Yuki Masahara-Negishi, Masaru Tamura, Chengcheng Huang, Yoichiro Harada, Shigeharu Wakana, Daisuke Takakura, Nana Kawasaki, Naoyuki Taniguchi, Gen Kondoh, Tadashi Yamashita, Yoko Funakoshi, Tadashi Suzuki

    PLOS GENETICS   13 ( 4 )   e1006696   2017年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:PUBLIC LIBRARY SCIENCE  

    The cytoplasmic peptide: N-glycanase (Ngly1 in mammals) is a de-N-glycosylating enzyme that is highly conserved among eukaryotes. It was recently reported that subjects harboring mutations in the NGLY1 gene exhibited severe systemic symptoms (NGLY1-deficiency). While the enzyme obviously has a critical role in mammals, its precise function remains unclear. In this study, we analyzed Ngly1-deficient mice and found that they are embryonic lethal in C57BL/6 background. Surprisingly, the additional deletion of the gene encoding endo-beta N--acetylglucosaminidase (Engase), which is another de-N-glycosylating enzyme but leaves a single GlcNAc at glycosylated Asn residues, resulted in the partial rescue of the lethality of the Ngly1-deficient mice. Additionally, we also found that a change in the genetic background of C57BL/6 mice, produced by crossing the mice with an outbred mouse strain (ICR) could partially rescue the embryonic lethality of Ngly1-deficient mice. Viable Ngly1deficient mice in a C57BL/6 and ICR mixed background, however, showed a very severe phenotype reminiscent of the symptoms of NGLY1-deficiency subjects. Again, many of those defects were strongly suppressed by the additional deletion of Engase in the C57BL/6 and ICR mixed background. The defects observed in Ngly1/Engase-deficient mice (C57BL/6 background) and Ngly1-deficient mice (C57BL/6 and ICR mixed background) closely resembled some of the symptoms of patients with an NGLY1-deficiency. These observations strongly suggest that the Ngly1-or Ngly1/Engase-deficient mice could serve as a valuable animal model for studies related to the pathogenesis of the NGLY1-deficiency, and that cytoplasmic ENGase represents one of the potential therapeutic targets for this genetic disorder.

    DOI: 10.1371/journal.pgen.1006696

    Web of Science

    researchmap

  • Comparison of analytical methods for profiling N- and O-linked glycans from cultured cell lines : HUPO Human Disease Glycomics/Proteome Initiative multi-institutional study. 査読 国際誌

    Hiromi Ito, Hiroyuki Kaji, Akira Togayachi, Parastoo Azadi, Mayumi Ishihara, Rudolf Geyer, Christina Galuska, Hildegard Geyer, Kazuaki Kakehi, Mitsuhiro Kinoshita, Niclas G Karlsson, Chunsheng Jin, Koichi Kato, Hirokazu Yagi, Sachiko Kondo, Nana Kawasaki, Noritaka Hashii, Daniel Kolarich, Kathrin Stavenhagen, Nicolle H Packer, Morten Thaysen-Andersen, Miyako Nakano, Naoyuki Taniguchi, Ayako Kurimoto, Yoshinao Wada, Michiko Tajiri, Pengyuan Yang, Weiqian Cao, Hong Li, Pauline M Rudd, Hisashi Narimatsu

    Glycoconjugate journal   33 ( 3 )   405 - 415   2016年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    The Human Disease Glycomics/Proteome Initiative (HGPI) is an activity in the Human Proteome Organization (HUPO) supported by leading researchers from international institutes and aims at development of disease-related glycomics/glycoproteomics analysis techniques. Since 2004, the initiative has conducted three pilot studies. The first two were N- and O-glycan analyses of purified transferrin and immunoglobulin-G and assessed the most appropriate analytical approach employed at the time. This paper describes the third study, which was conducted to compare different approaches for quantitation of N- and O-linked glycans attached to proteins in crude biological samples. The preliminary analysis on cell pellets resulted in wildly varied glycan profiles, which was probably the consequence of variations in the pre-processing sample preparation methodologies. However, the reproducibility of the data was not improved dramatically in the subsequent analysis on cell lysate fractions prepared in a specified method by one lab. The study demonstrated the difficulty of carrying out a complete analysis of the glycome in crude samples by any single technology and the importance of rigorous optimization of the course of analysis from preprocessing to data interpretation. It suggests that another collaborative study employing the latest technologies in this rapidly evolving field will help to realize the requirements of carrying out the large-scale analysis of glycoproteins in complex cell samples.

    DOI: 10.1007/s10719-015-9625-3

    PubMed

    researchmap

  • Sialylation converts arthritogenic IgG into inhibitors of collagen-induced arthritis. 査読

    Ohmi Y, Ise W, Harazono A, Takakura D, Fukuyama H, Baba Y, Narazaki M, Shoda H, Takahashi N, Ohkawa Y, Ji S, Sugiyama F, Fujio K, Kumanogoh A, Yamamoto K, Kawasaki N, Kurosaki T, Takahashi Y, Furukawa K

    Nature communications   7 ( 1 )   11205   2016年4月

     詳細を見る

    掲載種別:研究論文(学術雑誌)  

    DOI: 10.1038/ncomms11205

    PubMed

    researchmap

    その他リンク: http://www.nature.com/articles/ncomms11205

  • Membrane glycoproteomics of fetal lung fibroblasts using LC/MS 査読

    Daisuke Takakura, Minoru Tada, Nana Kawasaki

    PROTEOMICS   16 ( 1 )   47 - 59   2016年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:WILEY-BLACKWELL  

    Some aberrant N-glycosylations are being used as tumor markers, and glycoproteomics is expected to provide novel diagnosis markers and targets of drug developments. However, one has trouble in mass spectrometric glycoproteomics of membrane fraction because of lower intensity of glycopeptides in the existence of surfactants. Previously, we developed a glycopeptide enrichment method by acetone precipitation, and it was successfully applied to human serum glycoproteomics. In this study, we confirmed that this method is useful to remove the surfactants and applicable to membrane glycoproteomics. The glycoproteomic approach to the human fetal lung fibroblasts membrane fraction resulted in the identification of over 272 glycoforms on 63 sites of the 44 glycoproteins. According to the existing databases, the structural features on 41 sites are previously unreported. The most frequently occurring forms at N-glycosylation site were high-mannose type containing nine mannose residues (M9) and monosialo-fucosylated biantennary oligosaccharides. Several unexpected N-glycans, such as fucosylated complex-type and fucosylated high-mannose and/or fucosylated pauci-mannose types were found in ER and lysosome proteins. Our method provides new insights into transport, biosynthesis, and degradation of glycoproteins.

    DOI: 10.1002/pmic.201500003

    Web of Science

    researchmap

  • A Sulfated Glycosaminoglycan Linkage Region Is a Novel Type of Human Natural Killer-1 (HNK-1) Epitope Expressed on Aggrecan in Perineuronal Nets 査読

    Keiko Yabuno, Jyoji Morise, Yasuhiko Kizuka, Noritaka Hashii, Nana Kawasaki, Satoru Takahashi, Shinji Miyata, Tomomi Izumikawa, Hiroshi Kitagawa, Hiromu Takematsu, Shogo Oka

    PLOS ONE   10 ( 12 )   e0144560   2015年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:PUBLIC LIBRARY SCIENCE  

    Human natural killer-1 (HNK-1) carbohydrate (HSO3-3GlcA beta 1-3Gal beta 1-4GlcNAc-R) is highly expressed in the brain and required for learning and neural plasticity. We previously demonstrated that expression of the HNK-1 epitope is mostly abolished in knockout mice for GlcAT-P (B3gat1), a major glucuronyltransferase required for HNK-1 biosynthesis, but remained in specific regions such as perineuronal nets (PNNs) in these mutant mice. Considering PNNs are mainly composed of chondroitin sulfate proteoglycans (CSPGs) and regulate neural plasticity, GlcAT-P-independent expression of HNK-1 in PNNs is suggested to play a role in neural plasticity. However, the function, structure, carrier glycoprotein and biosynthetic pathway for GlcAT-P-irrelevant HNK-1 epitope remain unclear. In this study, we identified a unique HNK-1 structure on aggrecan in PNNs. To determine the biosynthetic pathway for the novel HNK-1, we generated knockout mice for GlcAT-S (B3gat2), the other glucuronyltransferase required for HNK-1 biosynthesis. However, GlcAT-P and GlcAT-S double-knockout mice did not exhibit reduced HNK-1 expression compared with single GlcAT-P-knockout mice, indicating an unusual biosynthetic pathway for the HNK-1 epitope in PNNs. Aggrecan was purified from cultured cells in which GlcAT-P and -S are not expressed and we determined the structure of the novel HNK-1 epitope using liquid chromatography/mass spectrometry (LC/MS) as a sulfated linkage region of glycosaminoglycans (GAGs), HSO3-GlcA-Gal-Gal-Xyl-R. Taken together, we propose a hypothetical model where GlcAT-I, the sole glucuronyltransferase required for synthesis of the GAG linkage, is also responsible for biosynthesis of the novel HNK-1 on aggrecan. These results could lead to discovery of new roles of the HNK-1 epitope in neural plasticity.

    DOI: 10.1371/journal.pone.0144560

    Web of Science

    PubMed

    researchmap

  • Characterization of anti-CD20 monoclonal antibody produced by transgenic silkworms (Bombyx mori) 査読

    Minoru Tada, Ken-ichiro Tatematsu, Akiko Ishii-Watabe, Akira Harazono, Daisuke Takakura, Noritaka Hashii, Hideki Sezutsu, Nana Kawasaki

    MABS   7 ( 6 )   1138 - 1150   2015年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:TAYLOR & FRANCIS INC  

    In response to the successful use of monoclonal antibodies (mAbs) in the treatment of various diseases, systems for expressing recombinant mAbs using transgenic animals or plants have been widely developed. The silkworm (Bombyx mori) is a highly domesticated insect that has recently been used for the production of recombinant proteins. Because of their cost-effective breeding and relatively easy production scale-up, transgenic silkworms show great promise as a novel production system for mAbs. In this study, we established a transgenic silkworm stably expressing a human-mouse chimeric anti-CD20mAb having the same amino acid sequence as rituximab, and compared its characteristics with rituximab produced by Chinese hamster ovary (CHO) cells (MabThera (R)). The anti-CD20mAb produced in the transgenic silkworm showed a similar antigen-binding property, but stronger antibody-dependent cell-mediated cytotoxicity (ADCC) and weaker complement-dependent cytotoxicity (CDC) compared to MabThera. Post-translational modification analysis was performed by peptide mapping using liquid chromatography/mass spectrometry. There was a significant difference in the N-glycosylation profile between the CHO- and the silkworm-derived mAbs, but not in other post-translational modifications including oxidation and deamidation. The mass spectra of the N-glycosylated peptide revealed that the observed biological properties were attributable to the characteristic N-glycan structures of the anti-CD20mAbs produced in the transgenic silkworms, i.e., the lack of the core-fucose and galactose at the non-reducing terminal. These results suggest that the transgenic silkworm may be a promising expression system for the tumor-targeting mAbs with higher ADCC activity.

    DOI: 10.1080/19420862.2015.1078054

    Web of Science

    researchmap

  • 日本薬局方各条ヘパリン定量法の改良に関わる研究

    鈴木 琢雄, 石井 明子, 西村 和子, 日向 昌司, 橋井 則貴, 中川 ゆかり, 森岡 知子, 田邉 利史, 藤田 奈穂, 余田 光, 嶋村 英雄, 倉田 康憲, 福田 純也, 小山 定利, 川崎 ナナ

    医薬品医療機器レギュラトリーサイエンス   46 ( 11 )   797 - 806   2015年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)医薬品医療機器レギュラトリーサイエンス財団  

    第十六改正日局第二追補ヘパリン定量法に従い測定を実施し、第IIa因子液、アンチトロンビン液について、それぞれ日局記載の濃度の1〜2倍、0.125〜1倍を用い測定し、これらの試験濃度を限定しない試験法の設定について検討した。現在流通しているトロンビン試薬、アンチトロンビン試薬中から第十六改正日局第二追補ヘパリン定量法で良好な定量が可能な試薬を選定した。また、トロンビンおよびアンチトロンビンの濃度を限定せず、空試験液の反応液の吸光度が2.0以下、ヘパリン標準液S4の反応液の吸光度が0.2以上1.0以下と設定することで、良好な試験が可能であることが明らかとなった。

    researchmap

  • レクチン及び糖加水分解酵素を用いた抗精子自己抗体Ts4認識糖鎖構造の同定

    吉武 洋, 橋井 則貴, 川崎 ナナ, 小田 理沙子, 川崎 優, 櫻庭 真弓, 遠藤 周一郎, 高森 建二, 長谷川 昭子, 藤原 浩, 荒木 慶彦

    Reproductive Immunology and Biology   30 ( 1-2 )   105 - 105   2015年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本生殖免疫学会  

    researchmap

  • Identification and confirmation of carbohydrate structure recognized by an anti-sperm monoclonal antibody, Ts4, using lectin-binding and glycohydrolase-digestion assays

    Hiroshi Yoshitake, Noritaka Hashii, Nana Kawasaki, Risako Oda, Yu Kawasaki, Mayumi Sakuraba, Shuichiro Endo, Kenji Takamori, Akiko Hasegawa, Hiroshi Fujiwara, Yoshihiko Araki

    JOURNAL OF REPRODUCTIVE IMMUNOLOGY   112   131 - 131   2015年11月

     詳細を見る

    記述言語:英語   出版者・発行元:ELSEVIER IRELAND LTD  

    DOI: 10.1016/j.jri.2015.09.034

    Web of Science

    researchmap

  • Degradation of Stop Codon Read-through Mutant Proteins via the Ubiquitin-Proteasome System Causes Hereditary Disorders 査読

    Norihito Shibata, Nobumichi Ohoka, Yusuke Sugaki, Chiaki Onodera, Mizuho Inoue, Yoshiyuki Sakuraba, Daisuke Takakura, Noritaka Hashii, Nana Kawasaki, Yoichi Gondo, Mikihiko Naito

    Journal of Biological Chemistry   290 ( 47 )   28428 - 28437   2015年10月

     詳細を見る

    掲載種別:研究論文(学術雑誌)   出版者・発行元:American Society for Biochemistry {\&} Molecular Biology ({ASBMB})  

    DOI: 10.1074/jbc.m115.670901

    researchmap

  • Chemical Characterization of N-Linked Oligosaccharide As the Antigen Epitope Recognized by an Anti-Sperm Auto-Monoclonal Antibody, Ts4 査読

    Hiroshi Yoshitake, Noritaka Hashii, Nana Kawasaki, Shuichiro Endo, Kenji Takamori, Akiko Hasegawa, Hiroshi Fujiwara, Yoshihiko Araki

    PLOS ONE   10 ( 7 )   e0133784   2015年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:PUBLIC LIBRARY SCIENCE  

    Ts4, an anti-sperm auto-monoclonal antibody, possesses immunoreactivity to the acrosomal region of mouse epididymal spermatozoa. In addition, the mAb shows specific immunoreactivity to reproduction-related regions such as testicular germ cells and early embryo. Our qualitative study previously showed that the antigen epitope for Ts4 contained a N-linked common oligosaccharide (OS) chain on testicular glycoproteins as determined by Western blotting for testicular glycoproteins after treatment with several glycohydrolases. Since the distribution of the Ts4-epitope is unique, the OS chain in Ts4-epitope may have role(s) in the reproductive process. The aim of this study was to clarify the molecular structure of the Ts4-epitope, particularly its OS moiety. Using Ts4 immunoprecipitation combined with liquid chromatography and multiple-stage mass spectrometry, the candidate carbohydrate structure in the Ts4-epitope is proposed to be N-linked fucosylated agalacto-biantennary with bisecting N-acetylglucosamine (GlcNAc) or with N-acetylgalactosamine-GlcNAc motif. Further binding analyses using various lectins against the mouse testicular Ts4-immunoprecipitants revealed that Phaseolus vulgaris erythroagglutinin and Pisum sativum agglutinin showed positive staining of the bands corresponding to Ts4 reactive proteins. Moreover, the immunoreactivity of Ts4 against the testicular extract was completely abrogated after digestion with beta-N-acetylglucosaminidase. These results show that the Ts4-epitope contains agalacto-biantennary N-glycan with bisecting GlcNAc carrying fucose residues.

    DOI: 10.1371/journal.pone.0133784

    Web of Science

    PubMed

    researchmap

  • 次世代バイオ医薬開発に向けた創薬イノベーション 次世代抗体医薬品の非臨床評価

    石井 明子, 多田 稔, 鈴木 琢雄, 川崎 ナナ

    薬学雑誌   135 ( 7 )   857 - 866   2015年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本薬学会  

    抗体医薬品は、抗原の中和や、fragment crystallizable(Fc)受容体の活性化を介した細胞傷害活性などにより、薬理作用を発揮する。ヒト蛋白質に対して特異的に作用する抗体医薬品は、しばしば動物の相同蛋白質との反応性を欠き、非臨床試験での有効性・安全性評価が難しくなる。非臨床試験系の妥当性を評価する際には、Fc受容体についても十分に考慮する必要がある。Fc受容体との関連を中心に、次世代抗体医薬品の非臨床評価の課題について考察した。

    researchmap

    その他リンク: https://search.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2015&ichushi_jid=J01459&link_issn=&doc_id=20150715300003&doc_link_id=130005085757&url=http%3A%2F%2Fci.nii.ac.jp%2Fnaid%2F130005085757&type=CiNii&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00003_3.gif

  • A fluorescent imaging method for analyzing the biodistribution of therapeutic monoclonal antibodies that can distinguish intact antibodies from their breakdown products 査読

    Takuo Suzuki, Chihiro Miyazaki, Akiko Ishii-Watabe, Minoru Tada, Kumiko Sakai-Kato, Toru Kawanishi, Nana Kawasaki

    MABS   7 ( 4 )   759 - 769   2015年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:TAYLOR & FRANCIS INC  

    Many monoclonal antibodies have been developed for therapy over the last 2 decades. In the development of therapeutic antibodies, the preclinical assessment of an antibody's biodistribution is important for the prediction of the antibody's efficacy and safety. For imaging analyses of such biodistributions, radioisotope (RI) labeling and fluorescence labeling methods are typically used, but the resulting data are limited because these methods cannot distinguish breakdown products from intact antibodies. To resolve this problem, we developed a novel method using fluorescent resonance energy transfer (FRET)-type labeling and a spectral unmixing tool. With FRET-type labeling (labeling with 2 species of fluorophore), different fluorescence properties of labeled intact antibodies and their breakdown products (the hydrolyzed/digested type of breakdown products) are made visible. With the spectral unmixing tool, the fluorescence of a solution containing the intact antibody and its breakdown products could be unmixed in proportion to their contents. Moreover, when labeled antibodies that targeted either human epidermal growth factor receptor-2 or epidermal growth factor receptor were injected into nude mice implanted subcutaneously with tumor cells, the accumulation of the injected labeled antibodies and their breakdown products in the tumor could be separately analyzed by both whole-mouse imaging and a tumor homogenate analysis. These results suggest that our method using FRET-type labeling and a spectral unmixing tool could be useful in distinguishing breakdown products from intact antibodies.

    DOI: 10.1080/19420862.2015.1038683

    Web of Science

    PubMed

    researchmap

  • Stable isotope labeling of glycoprotein expressed in silkworms using immunoglobulin G as a test molecule. 国際誌

    Hirokazu Yagi, Masatoshi Nakamura, Jun Yokoyama, Ying Zhang, Takumi Yamaguchi, Sachiko Kondo, Jun Kobayashi, Tatsuya Kato, Enoch Y Park, Shiori Nakazawa, Noritaka Hashii, Nana Kawasaki, Koichi Kato

    Journal of biomolecular NMR   62 ( 2 )   157 - 67   2015年6月

     詳細を見る

    記述言語:英語  

    Silkworms serve as promising bioreactors for the production of recombinant proteins, including glycoproteins and membrane proteins, for structural and functional protein analyses. However, lack of methodology for stable isotope labeling has been a major deterrent to using this expression system for nuclear magnetic resonance (NMR) structural biology. Here we developed a metabolic isotope labeling technique using commercially available silkworm larvae. The fifth instar larvae were infected with baculoviruses for co-expression of recombinant human immunoglobulin G (IgG) as a test molecule, with calnexin as a chaperone. They were subsequently reared on an artificial diet containing (15)N-labeled yeast crude protein extract. We harvested 0.1 mg of IgG from larva with a (15)N-enrichment ratio of approximately 80%. This allowed us to compare NMR spectral data of the Fc fragment cleaved from the silkworm-produced IgG with those of an authentic Fc glycoprotein derived from mammalian cells. Therefore, we successfully demonstrated that our method enables production of isotopically labeled glycoproteins for NMR studies.

    DOI: 10.1007/s10858-015-9930-y

    PubMed

    researchmap

  • NMR-based structural validation of therapeutic antibody produced in Nicotiana benthamiana. 国際誌

    Hirokazu Yagi, Noriho Fukuzawa, Yasushi Tasaka, Kouki Matsuo, Ying Zhang, Takumi Yamaguchi, Sachiko Kondo, Shiori Nakazawa, Noritaka Hashii, Nana Kawasaki, Takeshi Matsumura, Koichi Kato

    Plant cell reports   34 ( 6 )   959 - 68   2015年6月

     詳細を見る

    記述言語:英語  

    KEY MESSAGE: We successfully developed a method for metabolic isotope labeling of recombinant proteins produced in transgenic tobacco. This enabled assessment of structural integrity of plant-derived therapeutic antibodies by NMR analysis. A variety of expression vehicles have been developed for the production of promising biologics, including plants, fungi, bacteria, insects, and mammals. Glycoprotein biologics often experience altered folding and post-translational modifications that are typified by variant glycosylation patterns. These differences can dramatically affect their efficacy, as exemplified by therapeutic antibodies. However, it is generally difficult to validate the structural integrity of biologics produced using different expression vehicles. To address this issue, we have developed and applied a stable-isotope-assisted nuclear magnetic resonance (NMR) spectroscopy method for the conformational characterization of recombinant antibodies produced in plants. Nicotiana benthamiana used as a vehicle for the production of recombinant immunoglobulin G (IgG) was grown in a (15)N-enriched plant growth medium. The Fc fragment derived from the (15)N-labeled antibody thus prepared was subjected to heteronuclear two-dimensional (2D) NMR measurements. This approach enabled assessment of the structural integrity of the plant-derived therapeutic antibodies by comparing their NMR spectral properties with those of an authentic IgG-Fc derived from mammalian cells.

    DOI: 10.1007/s00299-015-1757-1

    PubMed

    researchmap

  • バイオ医薬品の現状と展望

    石井 明子, 川崎 ナナ

    ファルマシア   51 ( 5 )   403 - 407   2015年5月

  • 日本薬局方収載に向けて 糖鎖試験法の解説

    原園 景, 石井 明子, 川崎 ナナ

    PHARM TECH JAPAN   31 ( 1 )   81 - 91   2015年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)じほう  

    researchmap

  • Change in N-Glycosylation of Plasma Proteins in Japanese Semisupercentenarians. 査読

    Miura Y, Hashii N, Tsumoto H, Takakura D, Ohta Y, Abe Y, Arai Y, Kawasaki N, Hirose N, Endo T, SONIC (Septuagenarians, Octogenarians, Nonagenarians, Investigation with Centenarians

    PloS one   10 ( 11 )   e0142645   2015年

  • β-Galactoside α2,6-sialyltranferase 1 promotes transforming growth factor-β-mediated epithelial-mesenchymal transition. 査読 国際誌

    Jishun Lu, Tomoya Isaji, Sanghun Im, Tomohiko Fukuda, Noritaka Hashii, Daisuke Takakura, Nana Kawasaki, Jianguo Gu

    The Journal of biological chemistry   289 ( 50 )   34627 - 41   2014年12月

     詳細を見る

    記述言語:英語  

    β-Galactoside α2,6-sialyltranferase 1 (ST6GAL1) catalyzes the addition of terminal α2,6-sialylation to N-glycans. Increased expression of ST6GAL1 has been reported in diverse carcinomas and highly correlates with tumor progression. Here, we report that St6gal1 transcription and α2,6-sialylated N-glycans are up-regulated during TGF-β-induced epithelial-mesenchymal transition (EMT) in GE11 cells, requiring the Sp1 element within the St6gal1 promoter. Knockdown of St6gal1 strongly suppressed TGF-β-induced EMT with a concomitant increase in E-cadherin expression, a major determinant of epithelial cell adherens junctions. Conversely, overexpression of ST6GAL1 increased the turnover of cell surface E-cadherin and promoted TGF-β-induced EMT. Overexpressing β-galactoside α2,3-sialyltranferase 4 had little influence on EMT, indicating specificity for α2,6-sialylation. The basal mesenchymal phenotype of MDA-MB-231 human breast cancer cells was partially reversed by ST6GAL1 silencing. Moreover, ST6GAL1 knockdown inhibited the phosphorylation of Akt, but not Smad2, suggesting that ST6GAL1 contributes to EMT through a non-Smad signaling pathway. Taken together, our data indicate that ST6GAL1 promotes TGF-β-dependent EMT as well as maintenance of the mesenchymal state by growth signaling, providing a plausible mechanism whereby up-regulated ST6GAL1 may promote malignant progression.

    DOI: 10.1074/jbc.M114.593392

    PubMed

    researchmap

  • Sweet Role of Platelet Endothelial Cell Adhesion Molecule (PECAM) in Understanding Angiogenesis 査読

    Shinobu Kitazume, Rie Imamaki, Ayako Kurimoto, Kazuko Ogawa, Masaki Kato, Yoshiki Yamaguchi, Katsunori Tanaka, Hideharu Ishida, Hiromune Ando, Makoto Kiso, Noritaka Hashii, Nana Kawasaki, Naoyuki Taniguchi

    GLYCOBIOLOGY   24 ( 11 )   1218 - 1218   2014年11月

     詳細を見る

    記述言語:英語   出版者・発行元:OXFORD UNIV PRESS INC  

    Web of Science

    researchmap

  • Functional analysis of the expression of N-glycans in epithelial-mesenchymal transition: Importance of alpha 2,6 sialylation 査読

    Jianguo Gu, Jishun Lu, Sanghun Im, Tomohiko Fukuda, Noritaka Hashii, Daisuke Takakura, Nana Kawasaki, Tomoya Isaji

    GLYCOBIOLOGY   24 ( 11 )   1177 - 1177   2014年11月

     詳細を見る

    記述言語:英語   出版者・発行元:OXFORD UNIV PRESS INC  

    Web of Science

    researchmap

  • 平成23年度「日本薬局方の試験法等に関する研究」研究報告ペプチドマップ法の国際調和に関する研究

    原園 景, 栗林 亮佑, 高久 明美, 橋井 則貴, 川崎 ナナ

    医薬品医療機器レギュラトリーサイエンス   45 ( 10 )   848 - 858   2014年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)医薬品医療機器レギュラトリーサイエンス財団  

    researchmap

  • Interaction of Platelet Endothelial Cell Adhesion Molecule (PECAM) with alpha 2,6-Sialylated Glycan Regulates Its Cell Surface Residency and Anti-apoptotic Role 査読

    Shinobu Kitazume, Rie Imamaki, Ayako Kurimoto, Kazuko Ogawa, Masaki Kato, Yoshiki Yamaguchi, Katsunori Tanaka, Hideharu Ishida, Hiromune Ando, Makoto Kiso, Noritaka Hashii, Nana Kawasaki, Naoyuki Taniguchi

    JOURNAL OF BIOLOGICAL CHEMISTRY   289 ( 40 )   27604 - 27613   2014年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC  

    Background:N-Glycan 2,6-sialylation regulates the cell surface residency of an anti-apoptotic molecule, platelet endothelial cell adhesion molecule (PECAM). Results: An 2,6-sialylated oligosaccharide inhibited the homophilic PECAM interaction and a cluster-type 2,6-sialyl N-glycan probe bound to PECAM-immobilized beads. Conclusion: PECAM is a weak sialic acid binding lectin. Significance: There is a possibility of using a glycan-based method to modulate angiogenesis.
    The luminal sides of vascular endothelial cells are heavily covered with a so-called glycocalyx, but the precise role of the endothelial glycocalyx remains unclear. Our previous study showed that N-glycan 2,6-sialylation regulates the cell surface residency of an anti-apoptotic molecule, platelet endothelial cell adhesion molecule (PECAM), as well as the sensitivity of endothelial cells toward apoptotic stimuli. As PECAM itself was shown to be modified with biantennary N-glycans having 2,6-sialic acid, we expected that PECAM would possess lectin-like activity toward 2,6-sialic acid to ensure its homophilic interaction. To verify this, a series of oligosaccharides were initially added to observe their inhibitory effects on the homophilic PECAM interaction in vitro. We found that a longer 2,6-sialylated oligosaccharide exhibited strong inhibitory activity. Furthermore, we found that a cluster-type 2,6-sialyl N-glycan probe specifically bound to PECAM-immobilized beads. Moreover, the addition of the 2,6-sialylated oligosaccharide to endothelial cells enhanced the internalization of PECAM as well as the sensitivity to apoptotic stimuli. Collectively, these findings suggest that PECAM is a sialic acid binding lectin and that this binding property supports endothelial cell survival. Notably, our findings that 2,6-sialylated glycans influenced the susceptibility to endothelial cell apoptosis shed light on the possibility of using a glycan-based method to modulate angiogenesis.

    DOI: 10.1074/jbc.M114.563585

    Web of Science

    researchmap

  • An Oncogenic Protein Golgi Phosphoprotein 3 Up-regulates Cell Migration via Sialylation 査読

    Tomoya Isaji, Sanghun Im, Wei Gu, Yuqin Wang, Qinglei Hang, Jishun Lu, Tomohiko Fukuda, Noritaka Hashii, Daisuke Takakura, Nana Kawasaki, Hiroyuki Miyoshi, Jianguo Gu

    JOURNAL OF BIOLOGICAL CHEMISTRY   289 ( 30 )   20694 - 20705   2014年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC  

    Recently, the Golgi phosphoprotein 3 (GOLPH3) and its yeast homolog Vps74p have been characterized as essential for the Golgi localization of glycosyltransferase in yeast. GOLPH3 has been identified as a new oncogene that is commonly amplified in human cancers to modulate mammalian target of rapamycin signaling. However, the molecular mechanisms of the carcinogenic signaling pathway remain largely unclear. To investigate whether the expression of GOLPH3 was involved in the glycosylation processes in mammalian cells, and whether it affected cell behavior, we performed a loss-of-function study. Cell migration was suppressed in GOLPH3 knockdown (KD) cells, and the suppression was restored by a re-introduction of the GOLPH3 gene. HPLC and LC/MS analysis showed that the sialylation of N-glycans was specifically decreased in KD cells. The specific interaction between sialyltransferases and GOLPH3 was important for the sialylation. Furthermore, overexpression of alpha 2,6-sialyltransferase-I rescued cell migration and cellular signaling, both of which were blocked in GOLPH3 knockdown cells. These results are the first direct demonstration of the role of GOLPH3 in N-glycosylation to regulate cell biological functions.

    DOI: 10.1074/jbc.M113.542688

    Web of Science

    PubMed

    researchmap

  • Selective glycopeptide profiling by acetone enrichment and LC/MS 査読

    Daisuke Takakura, Akira Harazono, Noritaka Hashii, Nana Kawasaki

    JOURNAL OF PROTEOMICS   101   17 - 30   2014年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ELSEVIER SCIENCE BV  

    LC/MS is commonly used for site-specific glycosylation analysis of glycoproteins in cells and tissues. A limitation of this technique is the difficulty in acquiring reliable mass spectra for glycopeptides, mainly due to their high heterogeneity and poor hydrophobicity. Here, we establish a versatile method for efficient glycopeptide enrichment to acquire reliable mass spectra. Several lines of evidence using model glycoproteins suggest that our method is based on the different solubility between non-glycosylated and glycosylated peptides in acetone. We also provide data showing that the acetone-precipitated glycopeptide enrichment was successful in acquiring a more comprehensive MS/MS data set for the various glycoforms of each glycopeptide in crude human serum. We propose that this method is a powerful tool for the acquisition of reliable mass spectra from trace amounts of glycopeptides and an alternative to lectin affinity enrichment.
    Biological significance In this study, we established a versatile method for glycopeptide enrichment to acquire reliable mass spectra because of the limitation of conventional enrichment methods, such as lectin affinity chromatography. Our enrichment method is capable of isolating glycopeptides from complex peptide mixtures such as crude serum. (C) 2014 Elsevier B.V. All rights reserved.

    DOI: 10.1016/j.jprot.2014.02.005

    Web of Science

    PubMed

    researchmap

  • Development of a Cell-Based Assay Measuring the Activation of Fc gamma RIIa for the Characterization of Therapeutic Monoclonal Antibodies 査読

    Minoru Tada, Akiko Ishii-Watabe, Takuo Suzuki, Nana Kawasaki

    PLOS ONE   9 ( 4 )   2014年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:PUBLIC LIBRARY SCIENCE  

    Antibody-dependent cellular cytotoxicity (ADCC) is one of the important mechanisms of action of the targeting of tumor cells by therapeutic monoclonal antibodies (mAbs). Among the human Fcc receptors (Fc gamma Rs), Fc gamma RIIIa is well known as the only receptor expressed in natural killer (NK) cells, and it plays a pivotal role in ADCC by IgG1-subclass mAbs. In addition, the contributions of Fc gamma RIIa to mAb-mediated cytotoxicity have been reported. Fc gamma RIIa is expressed in myeloid effector cells including neutrophils and macrophages, and it is involved in the activation of these effector cells. However, the measurement of the cytotoxicity via Fc gamma RIIa-expressing effector cells is complicated and inconvenient for the characterization of therapeutic mAbs. Here we report the development of a cell-based assay using a human Fc gamma RIIa-expressing reporter cell line. The Fc gamma RIIa reporter cell assay was able to estimate the activation of Fc gamma RIIa by antigen-bound mAbs by a very simple method in vitro. The usefulness of this assay for evaluating the activity of mAbs with different abilities to activate Fc gamma RIIa was confirmed by the examples including the comparison of the activity of the anti-CD20 mAb rituximab and its Fc-engineered variants, and two anti-EGFR mAbs with different IgG subclasses, cetuximab (IgG1) and panitumumab (IgG2). We also applied this assay to the characterization of a force-oxidized mAb, and we observed that oxidation significantly decreased the Fc gamma RIIa activation by EGFR-bound cetuximab. These results suggest that our Fc gamma RIIa reporter assay is a promising tool for the characterization of therapeutic mAbs, including Fc-engineered mAbs, IgG2-subclass mAbs, and their product-related variants.

    DOI: 10.1371/journal.pone.0095787

    Web of Science

    researchmap

  • Characterization of N-glycan heterogeneities of erythropoietin products by liquid chromatography/mass spectrometry and multivariate analysis 査読

    Noritaka Hashii, Akira Harazono, Ryosuke Kuribayashi, Daisuke Takakura, Nana Kawasaki

    RAPID COMMUNICATIONS IN MASS SPECTROMETRY   28 ( 8 )   921 - 932   2014年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:WILEY-BLACKWELL  

    RATIONALEGlycan heterogeneity on recombinant human erythropoietin (rEPO) product is considered to be one of the critical quality attributes, and similarity tests of glycan heterogeneities are required in the manufacturing process changes and developments of biosimilars. A method for differentiating highly complex and diverse glycosylations is needed to evaluate comparability and biosimilarity among rEPO batches and products manufactured by different processes.
    METHODSThe glycan heterogeneities of nine rEPO products (four innovator products and five biosimilar products) were distinguished by multivariate analysis (MVA) using the peak area ratios of each glycan to the total peak area of glycans in mass spectra obtained by liquid chromatography/mass spectrometry (LC/MS) of N-glycans from rEPOs.
    RESULTSPrincipal component analysis (PCA) using glycan profiles obtained by LC/MS proved to be a useful method for differentiating glycan heterogeneities among nine rEPOs. Using PC values as indices, we were able to visualize and digitalize the glycan heterogeneities of each rEPO. The characteristic glycans of each rEPO were also successfully identified by orthogonal partial least-squares discrimination analysis (OPLS-DA), an MVA method, using the glycan profile data.
    CONCLUSIONSPCA values were useful for evaluating the relative differences among the glycan heterogeneities of rEPOs. The characteristic glycans that contributed to the differentiation were also successfully identified by OPLS-DA. PCA and OPLS-DA based on mass spectrometric data are applicable for distinguishing glycan heterogeneities, which are virtually indistinguishable on rEPO products. Copyright (c) 2014 John Wiley & Sons, Ltd.

    DOI: 10.1002/rcm.6858

    Web of Science

    PubMed

    researchmap

  • Structural and biochemical characterization of O-mannose-linked human natural killer-1 glycan expressed on phosphacan in developing mouse brains 査読

    Jyoji Morise, Yasuhiko Kizuka, Keiko Yabuno, Yasuhiro Tonoyama, Noritaka Hashii, Nana Kawasaki, Hiroshi Manya, Yuko Miyagoe-Suzuki, Shin'ichi Takeda, Tamao Endo, Nobuaki Maeda, Hiromu Takematsu, Shogo Oka

    GLYCOBIOLOGY   24 ( 3 )   314 - 324   2014年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:OXFORD UNIV PRESS INC  

    The human natural killer-1 (HNK-1) carbohydrate comprising a sulfated trisaccharide (HSO3-3GlcA beta 1-3Gal beta 1-4GlcNAc-) is expressed on N-linked and O-mannose-linked glycans in the nervous system and involved in learning and memory functions. Although whole/core glycan structures and carrier glycoproteins for the N-linked HNK-1 epitope have been studied, carrier glycoproteins and the biosynthetic pathway of the O-mannose-linked HNK-1 epitope have not been fully characterized. Here, using mass spectrometric analyses, we identified the major carrier glycoprotein of the O-linked HNK-1 as phosphacan in developing mouse brains and determined the major O-glycan structures having the terminal HNK-1 epitope from partially purified phosphacan. The O-linked HNK-1 epitope on phosphacan almost disappeared due to the knockout of protein O-mannose beta 1,2-N-acetylglucosaminyltransferase 1, an N-acetylglucosaminyltransferase essential for O-mannose-linked glycan synthesis, indicating that the reducing terminal of the O-linked HNK-1 is mannose. We also showed that glucuronyltransferase-P (GlcAT-P) was involved in the biosynthesis of O-mannose-linked HNK-1 using the gene-deficient mice of GlcAT-P, one of the glucuronyltransferases for HNK-1 synthesis. Consistent with this result, we revealed that GlcAT-P specifically synthesized O-linked HNK-1 onto phosphacan using cultured cells. Furthermore, we characterized the as-yet-unknown epitope of the 6B4 monoclonal antibody (mAb), which was thought to recognize a unique phosphacan glycoform. The reactivity of the 6B4 mAb almost completely disappeared in GlcAT-P-deficient mice, and exogenously expressed phosphacan was selectively recognized by the 6B4 mAb when co-expressed with GlcAT-P, suggesting that the 6B4 mAb preferentially recognizes O-mannose-linked HNK-1 on phosphacan. This is the first study to show that 6B4 mAb-reactive O-mannose-linked HNK-1 in the brain is mainly carried by phosphacan.

    DOI: 10.1093/glycob/cwt116

    Web of Science

    PubMed

    researchmap

  • 抗体医薬品親和性ペプチドのバイオアナリシスへの応用

    橋井 則貴, 栗林 亮佑, 太田 悠葵, 原園 景, 鈴木 琢雄, 川崎 ナナ

    日本薬学会年会要旨集   134年会 ( 2 )   308 - 308   2014年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本薬学会  

    researchmap

  • An improved in-gel digestion method for efficient identification of protein and glycosylation analysis of glycoproteins using guanidine hydrochloride 査読

    Daisuke Takakura, Noritaka Hashii, Nana Kawasaki

    PROTEOMICS   14 ( 2-3 )   196 - 201   2014年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:WILEY-BLACKWELL  

    In-gel digestion followed by LC/MS/MS is widely used for the identification of trace amounts of proteins and for the site-specific glycosylation analysis of glycoproteins in cells and tissues. A major limitation of this technique is the difficulty in acquiring reliable mass spectra for peptides present in minute quantities and glycopeptides with high heterogeneity and poor hydrophobicity. It is considered that the SDS used in electrophoresis can interact with proteins noncovalently and impede the ionization of peptides/glycopeptides. In this study, we report an improved in-gel digestion method to acquire reliable mass spectra of a trace amount of peptides/glycopeptides. A key innovation of our improved method is the use of guanidine hydrochloride, which forms complexes with the residual SDS molecules in the sample. The precipitation and removal of SDS by addition of the guanidine hydrochloride was successful in improving the S/N of peptides/glycopeptides in mass spectra and acquiring a more comprehensive MS/MS data set for the various glycoforms of each glycopeptide.

    DOI: 10.1002/pmic.201300332

    Web of Science

    PubMed

    researchmap

  • 【進化するペプチド・抗体医薬品開発】抗体医薬品の分子設計

    石井 明子, 鈴木 琢雄, 多田 稔, 川崎 ナナ

    薬剤学: 生命とくすり   74 ( 1 )   4 - 11   2014年1月

  • 【新薬展望2014】(第I部)新薬創出に向けた日本の戦略 バイオ後続品の今後の動向

    川崎 ナナ, 石井 明子

    医薬ジャーナル   50 ( 増刊 )   258 - 264   2014年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)医薬ジャーナル社  

    日本ではソマトロピン、エポエチンアルファ、およびフィルグラスチムバイオ後続品(バイオシミラー)が上市され、さらに現在インフリキシマブ後続品が承認申請中である。バイオシミラー販売で先行する欧州では、ジェネリック医薬品市場で見られるほどの大きなインパクトはないが、バイオシミラー製品の販売実績はゆっくりと伸びている。日本におけるバイオ後続品の今後を考える時、欧州での取り組みや動向が参考になると思われる。(著者抄録)

    researchmap

  • Site-specific classification of N-linked oligosaccharides of the extracellular regions of Fcγ receptor IIIb expressed in baby hamster kidney cells 査読

    N.Kawasaki, T.Okumoto, Y.Yamaguchi, N.Takahashi, W.H.Fridman, C.Sautès-Fridman, H.Yagi, K.Kato

    J. Glycomics Lipidomics   4   2014年

  • アセトン濃縮と LC/MS による糖ペプチドの選択的プロファイリングと膜グライコミクスへの応用

    高倉 大輔, 多田 稔, 川崎 ナナ

    日本プロテオーム学会大会要旨集   2014   119 - 119   2014年

     詳細を見る

    記述言語:日本語   出版者・発行元:日本プロテオーム学会(日本ヒトプロテオーム機構)  

    DOI: 10.14889/jhupo.2014.0.119.0

    researchmap

  • Determination of galactosamine impurities in heparin sodium using fluorescent labeling and conventional high-performance liquid chromatography 査読

    Satsuki Itoh, Yoko Hiruta, Noritaka Hashii, Naho Fujita, Toru Natsuga, Toshiaki Hattori, Aya Bando, Yuko Sekimoto, Kazuyoshi Miyata, Hiroshi Namekawa, Kazunori Mabuchi, Toru Sakai, Hirotoshi Shimahashi, Kenzo Kawai, Hikaru Yoden, Sadatoshi Koyama, Susanne Odgaard Herr, Shunji Natsuka, Teruhide Yamaguchi, Nana Kawasaki

    BIOLOGICALS   41 ( 6 )   355 - 363   2013年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD  

    Heparin is a sulfated glycosaminoglycan (GAG), which contains N-acetylated or N-sulfated glucosamine (GlcN). Heparin, which is generally obtained from the healthy porcine intestines, is widely used as an anticoagulant during dialysis and treatments of thrombosis such as disseminated intravascular coagulation. Dermatan sulfate (DS) and chondroitin sulfate (CS), which are galactosamine (GalN)-containing GAGs, are major process-related impurities of heparin products. The varying DS and CS contents between heparin products can be responsible for the different anticoagulant activities of heparin. Therefore, a test to determine the concentrations of GalN-containing GAG is essential to ensure the quality and safety of heparin products. In this study, we developed a method for determination of relative content of GalN from GalN-containing GAG in heparin active pharmaceutical ingredients (APIs). The method validation and collaborative study with heparin manufacturers and suppliers showed that our method has enough specificity, sensitivity, linearity, repeatability, reproducibility, and recovery as the limiting test for GalN from GalN-containing GAGs. We believe that our method will be useful for ensuring quality, efficacy, and safety of pharmaceutical heparins. On July 30, 2010, the GalN limiting test based on our method was adopted in the heparin sodium monograph in the Japanese Pharmacopoeia. (C) 2013 The International Alliance for Biological Standardization. Published by Elsevier Ltd. All rights reserved.

    DOI: 10.1016/j.biologicals.2013.06.002

    Web of Science

    PubMed

    researchmap

  • The establishment and validation of efficient assays for anti-IIa and anti-Xa activities of heparin sodium and heparin calcium 査読

    Takuo Suzuki, Akiko Ishii-Watabe, Noritaka Hashii, Yukari Nakagawa, Tomoko Takahashi, Akiko Ebisawa, Seiichi Nishi, Naho Fujita, Aya Bando, Yuko Sekimoto, Kazuyoshi Miyata, Toshio Endo, Takuma Otsu, Shiori Sugimoto, Tadashi Kondou, Yuji Fujita, Naoyuki Miyanaga, Masahiro Mashimo, Norihiko Shimada, Hikaru Yoden, Hideo Shimamura, Yasunori Kurata, Sadatoshi Koyama, Nana Kawasaki

    BIOLOGICALS   41 ( 6 )   415 - 423   2013年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD  

    Heparin is used as an anticoagulant drug. The anticoagulation process is mainly caused by the interaction of heparin with antithrombin followed by inhibition of anticoagulant factor IIa and factor Xa. The anti-factor Ha and anti-factor Xa activities of heparin are critical for its anticoagulant effect; however, physicochemical methods that can reflect these activities have not been established. Thus, the measurements of anti-IIa and anti-Xa activities by biological assay are critical for the quality control of heparin products. Currently in the Japanese Pharmacopoeia UP), the activities of heparin sodium and heparin calcium are measured by an anti-Xa activity assay (anti-Xa assay), but anti-IIa activity is not measured. Here, we established an anti-IIa activity assay (anti-IIa assay) and an anti-Xa assay having good accuracy and precision. When samples having a relative activity of 0.8, 1.0 and 1.2 were measured by the established anti-IIa and anti-Xa assays in nine laboratories, good accuracy (100.0-102.8% and 101.6-102.8%, respectively), good intermediate precision (1.9-2.1% and 2.4-4.2%, respectively) and good reproducibility (4.0-4.8% and 3.6-6.4%, respectively) were obtained. The established anti-IIa and anti-Xa assays have similar protocols, and could be performed by a single person without a special machine. The established assays would be useful for quality control of heparin. (C) 2013 The International Alliance for Biological Standardization. Published by Elsevier Ltd. All rights reserved.

    DOI: 10.1016/j.biologicals.2013.09.003

    Web of Science

    researchmap

  • Mass spectrometric glycoform profiling of the innovator and biosimilar erythropoietin and darbepoetin by LC/ESI-MS. 査読 国際誌

    Harazono A, Hashii N, Kuribayashi R, Nakazawa S, Kawasaki N

    Journal of pharmaceutical and biomedical analysis   83   65 - 74   2013年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1016/j.jpba.2013.04.031

    PubMed

    researchmap

  • Campylobacter jejuni pdxA Affects Flagellum-Mediated Motility to Alter Host Colonization 査読

    Hiroshi Asakura, Noritaka Hashii, Masashi Uema, Nana Kawasaki, Yoshiko Sugita-Konishi, Shizunobu Igimi, Shigeki Yamamoto

    PLoS ONE   8 ( 8 )   2013年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Vitamin B6 (pyridoxal-5'-phosphate, PLP) is linked to a variety of biological functions in prokaryotes. Here, we report that the pdxA (putative 4-hydroxy-L-threonine phosphate dehydrogenase) gene plays a pivotal role in the PLP-dependent regulation of flagellar motility, thereby altering host colonization in a leading foodborne pathogen, Campylobacter jejuni. A C. jejuni pdxA mutant failed to produce PLP and exhibited a coincident loss of flagellar motility. Mass spectrometric analyses showed a 3-fold reduction in the main flagellar glycan pseudaminic acid (Pse) associated with the disruption of pdxA. The pdxA mutant also exhibited reduced growth rates compared with the WT strain. Comparative metabolomic analyses revealed differences in respiratory/energy metabolism between WT C. jejuni and the pdxA mutant, providing a possible explanation for the differential growth fitness between the two strains. Consistent with the lack of flagellar motility, the pdxA mutant showed impaired motility-mediated responses (bacterial adhesion, ERK1/2 activation, and IL-8 production) in INT407 cells and reduced colonization of chickens compared with the WT strain. Overall, this study demonstrated that the pdxA gene affects the PLP-mediated flagellar motility function, mainly through alteration of Pse modification, and the disruption of this gene also alters the respiratory/energy metabolisms to potentially affect host colonization. Our data therefore present novel implications regarding the utility of PLP and its dependent enzymes as potent target(s) for the control of this pathogen in the poultry host. © 2013 Asakura et al.

    DOI: 10.1371/journal.pone.0070418

    Scopus

    PubMed

    researchmap

  • 蛍光標識抗体医薬品とその分解物の分離イメージング法

    鈴木 琢雄, 宮崎 ちひろ, 石井 明子, 多田 稔, 川西 徹, 川崎 ナナ

    バイオイメージング   22 ( 2 )   134 - 135   2013年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本バイオイメージング学会  

    researchmap

  • Analysis of the local dynamics of human insulin and a rapid-acting insulin analog by hydrogen/deuterium exchange mass spectrometry 査読

    Shiori Nakazawa, Joomi Ahn, Noritaka Hashii, Kenji Hirose, Nana Kawasaki

    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS   1834 ( 6 )   1210 - 1214   2013年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ELSEVIER SCIENCE BV  

    Human insulin and insulin lispro (lispro), a rapid-acting insulin analog, have identical primary structures, except for the transposition of a pair of amino adds. This mutation results in alterations in their higher order structures, with lispro dissociating more easily than human insulin. In our previous study performed using hydrogen/deuterium exchange mass spectrometry (HDX/MS), differences were observed in the rates and levels of deuteration among insulin analog products, which were found to be related to their self-association stability. In this study, we carried out peptide mapping of deuterated human insulin and lispro to determine the regions responsible for these deuteration differences and to elucidate the type of structural changes that affect their HDX reactivity. We identified A3-6 and B22-24 as the 2 regions that showed distinct differences in the number of deuterium atoms incorporated between human insulin and lispro. These regions contain residues that are thought to participate in hexamerization and dimerization, respectively. We also determined that over time, the differences in deuteration levels decreased in A3-6, whereas they increased in B22-24, suggesting a difference in the dynamics between these 2 regions. This article is part of a Special Issue entitled: Mass spectrometry in structural biology. (C) 2012 Elsevier B.V. All rights reserved.

    DOI: 10.1016/j.bbapap.2012.11.012

    Web of Science

    researchmap

  • A novel antibody for human induced pluripotent stem cells and embryonic stem cells recognizes a type of keratan sulfate lacking oversulfated structures 査読

    Keiko Kawabe, Daiki Tateyama, Hidenao Toyoda, Nana Kawasaki, Noritaka Hashii, Hiromi Nakao, Shogo Matsumoto, Motohiro Nonaka, Hiroko Matsumura, Yoshinori Hirose, Ayaha Morita, Madoka Katayama, Makoto Sakuma, Nobuko Kawasaki, Miho Kusuda Furue, Toshisuke Kawasaki

    GLYCOBIOLOGY   23 ( 3 )   322 - 336   2013年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:OXFORD UNIV PRESS INC  

    We have generated a monoclonal antibody (R-10G) specific to human induced pluripotent stem (hiPS)/embryonic stem (hES) cells by using hiPS cells (Tic) as an antigen, followed by differential screening of mouse hybridomas with hiPS and human embryonal carcinoma (hEC) cells. Upon western blotting with R-10G, hiPS/ES cell lysates gave a single but an unusually diffuse band at a position corresponding to > 250 kDa. The antigen protein was isolated from the induced pluripotent stem (iPS) cell lysates with an affinity column of R-10G. The R-10G positive band was resistant to digestion with peptide N-glycanase F (PNGase F), neuraminidase, fucosidase, chondrotinase ABC and heparinase mix, but it disappeared almost completely on digestion with keratanase, keratanase II and endo-beta-galactosidase, indicating that the R-10G epitope is a keratan sulfate. The carrier protein of the R-10G epitope was identified as podocalyxin by liquid chromatography/mass spectrometry (LC/MS/MS) analysis of the R-10G positive-protein band material obtained on sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). The R-10G epitope is a type of keratan sulfate with some unique properties. (1) The epitope is expressed only on hiPS/ES cells, i.e. not on hEC cells, unlike those recognized by the conventional hiPS/ES marker antibodies. (2) The epitope is a type of keratan sulfate lacking oversulfated structures and is not immunologically cross-reactive with high-sulfated keratan sulfate. (3) The R-10G epitope is distributed heterogeneously on hiPS cells, suggesting that a single colony of undifferentiated hiPS cells consists of different cell subtypes. Thus, R-10G is a novel antibody recognizing hiPS/ES cells, and should be a new molecular probe for disclosing the roles of glycans on these cells.

    DOI: 10.1093/glycob/cws159

    Web of Science

    PubMed

    researchmap

  • バイオ医薬品開発最前線とレギュラトリーサイエンス バイオ医薬品ヒト初回投与試験のリスク低減に向けて 抗体医薬品作用機序の解析

    川崎 ナナ, 中澤 志織, 栗林 亮佑, 多田 稔, 石井 明子, 橋井 則貴

    日本薬学会年会要旨集   133年会 ( 1 )   193 - 193   2013年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本薬学会  

    researchmap

  • 液体クロマトグラフィー、キャピラリー電気泳動及び質量分析を用いた抗体医薬品糖鎖プロファイリング法の比較

    原園 景, 橋井 則貴, 寺崎 さち子, 栗林 亮佑, 川崎 ナナ

    日本薬学会年会要旨集   133年会 ( 3 )   237 - 237   2013年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本薬学会  

    researchmap

  • バイオ後続品/バイオシミラーに関する国内外の規制動向と品質評価

    石井 明子, 原園 景, 川崎 ナナ

    PHARM TECH JAPAN   29 ( 1 )   23 - 42   2013年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)じほう  

    researchmap

  • Genetic polymorphisms of FCGR2A encoding Fc gamma receptor IIa in a Japanese population and functional analysis of the L273P variant 査読

    Minoru Tada, Akiko Ishii-Watabe, Keiko Maekawa, Hiromi Fukushima-Uesaka, Kouichi Kurose, Takuo Suzuki, Nahoko Kaniwa, Jun-ichi Sawada, Nana Kawasaki, Takako Eguchi Nakajima, Ken Kato, Yasuhide Yamada, Yasuhiro Shimada, Teruhiko Yoshida, Takashi Ura, Miyuki Saito, Kei Muro, Toshihiko Doi, Nozomu Fuse, Takayuki Yoshino, Atsushi Ohtsu, Nagahiro Saijo, Haruhiro Okuda, Tetsuya Hamaguchi, Yoshiro Saito, Yasuhiro Matsumura

    IMMUNOGENETICS   64 ( 12 )   869 - 877   2012年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:SPRINGER  

    Fc gamma receptor IIa (Fc gamma RIIa) plays an important role in antibody-dependent cellular cytotoxicity and inflammation. Changes in Fc gamma RIIa expression levels or activity caused by genetic polymorphisms in FCGR2A, the gene encoding Fc gamma RIIa, may lead to differences in disease progression as well as efficacy of antibody therapeutics between individuals. In this study, we sequenced the 5'-flanking region along with all exons and their flanking regions of FCGR2A from 111 Japanese subjects. Forty-eight genetic variations were found including 12 novel ones. Beside the well-known functional 497A > G (H166R) polymorphism, we detected 818T > C (L273P) at 0.005 frequency. Since the functional significance of this polymorphism has not been revealed, we next assessed the functions of the L273P substitution by expressing wild-type and the variant proteins in human Jurkat cells. The L273P variant protein showed similar cell surface expression and IgG-binding properties as the wild-type, but it exhibited a stronger signal transduction activity based on the approximately 2-fold enhancement of tyrosine phosphorylation of Fc gamma RIIa itself. The current results suggest that L273P could have functional significance in the antibody-dependent clinical responses through Fc gamma RIIa.

    DOI: 10.1007/s00251-012-0646-9

    Web of Science

    researchmap

  • Genetic polymorphisms of FCGR2A encoding Fcγ receptor IIa in a Japanese population and functional analysis of the L273P variant. 査読 国際誌

    Minoru Tada, Akiko Ishii-Watabe, Keiko Maekawa, Hiromi Fukushima-Uesaka, Kouichi Kurose, Takuo Suzuki, Nahoko Kaniwa, Jun-Ichi Sawada, Nana Kawasaki, Takako Eguchi Nakajima, Ken Kato, Yasuhide Yamada, Yasuhiro Shimada, Teruhiko Yoshida, Takashi Ura, Miyuki Saito, Kei Muro, Toshihiko Doi, Nozomu Fuse, Takayuki Yoshino, Atsushi Ohtsu, Nagahiro Saijo, Haruhiro Okuda, Tetsuya Hamaguchi, Yoshiro Saito, Yasuhiro Matsumura

    Immunogenetics   64 ( 12 )   869 - 77   2012年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Fcγ receptor IIa (FcγRIIa) plays an important role in antibody-dependent cellular cytotoxicity and inflammation. Changes in FcγRIIa expression levels or activity caused by genetic polymorphisms in FCGR2A, the gene encoding FcγRIIa, may lead to differences in disease progression as well as efficacy of antibody therapeutics between individuals. In this study, we sequenced the 5'-flanking region along with all exons and their flanking regions of FCGR2A from 111 Japanese subjects. Forty-eight genetic variations were found including 12 novel ones. Beside the well-known functional 497A > G (H166R) polymorphism, we detected 818T > C (L273P) at 0.005 frequency. Since the functional significance of this polymorphism has not been revealed, we next assessed the functions of the L273P substitution by expressing wild-type and the variant proteins in human Jurkat cells. The L273P variant protein showed similar cell surface expression and IgG-binding properties as the wild-type, but it exhibited a stronger signal transduction activity based on the approximately 2-fold enhancement of tyrosine phosphorylation of FcγRIIa itself. The current results suggest that L273P could have functional significance in the antibody-dependent clinical responses through FcγRIIa.

    DOI: 10.1007/s00251-012-0646-9

    PubMed

    researchmap

  • ヘパリン純度試験に関する研究(第7報) 日本薬局方各条ヘパリンナトリウム及びヘパリンカルシウムのタンパク質及び核酸純度試験法に関する研究

    橋井 則貴, 蛭田 葉子, 石井 明子, 鈴木 琢雄, 夏賀 徹, 鈴木 律子, 杉山 和喜, 渡部 沙木絵, 中川 ゆかり, 坂東 綾, 関本 祐子, 宮田 一義, 大津 卓磨, 宮澤 亜矢子, 近藤 匡, 藤田 裕司, 宮永 直幸, 嶋田 徳彦, 石賀 肇, 余田 光, 嶋村 英雄, 川崎 ナナ

    医薬品医療機器レギュラトリーサイエンス   43 ( 11 )   1050 - 1058   2012年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)医薬品医療機器レギュラトリーサイエンス財団  

    ローリー法及び吸光度測定法を用いたヘパリンナトリウム及びヘパリンカルシウムのタンパク質及び核酸限度試験法について検討した。フォリン試液を2倍に希釈したときに反応溶液のpHが至適範囲に入ること、750nmにおける吸光度が最も強くなることを確認した。ヘパリンナトリウムを用いて試験法の回収率及び再現性を確認したところ良好であった。ヘパリンカルシウムは、ヘパリンナトリウムと同様に試験を実施すると反応溶液が白濁し、吸光度を測定する直前に遠心分離操作を行うこととした。この改良した試験法について適用可能性を確認した結果、回収率及び再現性ともに良好な結果が得られた。ヘパリンナトリウム及びヘパリンカルシウムの核酸限度試験としての吸光度測定法の適用可能性を検討し、ヘパリンナトリウム及びヘパリンカルシウムに含まれる0.5μg/mL程度のDNAを検出できた。

    researchmap

  • The human CD10 lacking an N-glycan at Asn628 is deficient in surface expression and neutral endopeptidase activity 査読

    Ban Sato, Yohko U. Katagiri, Kazutoshi Iijima, Hiroyuki Yamada, Satsuki Ito, Nana Kawasaki, Hajime Okita, Junichiro Fujimoto, Nobutaka Kiyokawa

    Biochimica et Biophysica Acta - General Subjects   1820 ( 11 )   1715 - 1723   2012年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Background: CD10, also known as neprilysin or enkephalinase exhibiting neutral endopeptidase (NEP) activity, is expressed by B-lineage hematopoietic cells as well as a variety of cells from normal tissues. It cleaves peptides such as cytokines to act for terminating inflammatory responses. Although CD10 molecules of the human pre-B-cell line NALM-6 have 6 consensus N-glycosylation sites, three of them are known to be N-glycosylated by X-ray crystallography. Methods: In order to investigate the role of N-glycans in the full expression of NEP activity, we modified N-glycans by treatment of NALM6 cells with various glycosidases or alter each of the consensus N-glycosylation sites by generating site-directed mutagenesis and compared the NEP activities of the sugar-altered CD10 with those of intact CD10. Results: CD10 of the human B-cell line NALM-6 was dominantly localized in raft microdomains and heterogeneously N-glycosylated. Although neither desialylation nor further degalactosylation caused defective NEP activity, removal of only a small part of N-glycans by treatment with glycopeptidase F under non-denaturing conditions decreased NEP activity completely. All of the three consensus sites of CD10 in HEK293 cells introduced with wild type-CD10 were confirmed to be N-glycosylated. Surface expression of N-glycan at Asn628-deleted CD10 by HEK293 cells was greatly decreased as well as it lost entire NEP activities. Conclusions: N-glycosylation at Asn628 is essential not only for NEP activities, but also for surface expression. General significance: Quality control system does not allow dysfunctional ecto-type proteases to express on plasma membrane. © 2012 Elsevier B.V.

    DOI: 10.1016/j.bbagen.2012.06.017

    Scopus

    PubMed

    researchmap

  • Carbohydrate-specific interaction of mammalian pancreatic alpha-amylases with glycoproteins on intestinal mucosa regulates glucose as similation for homeostasis

    Kimie Date, Nana Kawasaki, Noritaka Hashii, Hiromi Sakagami, Haruko Ogawa

    GLYCOBIOLOGY   22 ( 11 )   1540 - 1540   2012年11月

     詳細を見る

    記述言語:英語   出版者・発行元:OXFORD UNIV PRESS INC  

    Web of Science

    researchmap

  • バイオ医薬品の品質・安全性評価シリーズ(第11回) バイオ医薬品原薬のクオリティバイデザイン

    川崎 ナナ, 石井 明子, 奥田 晴宏

    PHARM TECH JAPAN   28 ( 12 )   2491 - 2501   2012年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)じほう  

    researchmap

  • Tetrameric Interaction of the Ectoenzyme CD38 on the Cell Surface Enables Its Catalytic and Raft-Association Activities 査読

    Miki Hara-Yokoyama, Mutsuko Kukimoto-Niino, Kazue Terasawa, Satoru Harumiya, Katarzyna A. Podyma-Inoue, Nobumasa Hino, Kensaku Sakamoto, Satsuki Itoh, Noritaka Hashii, Yoko Hiruta, Nana Kawasaki, Chiemi Mishima-Tsumagari, Yoko Kaitsu, Tomoko Matsumoto, Motoaki Wakiyama, Mikako Shirouzu, Takeshi Kasama, Hiroshi Takayanagi, Naoko Utsunomiya-Tate, Kiyoshi Takatsu, Toshiaki Katada, Yoshio Hirabayashi, Shigeyuki Yokoyama, Masaki Yanagishita

    STRUCTURE   20 ( 9 )   1585 - 1595   2012年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:CELL PRESS  

    The leukocyte cell-surface antigen CD38 is the major nicotinamide adenide dinucleotide glycohydrolase in mammals, and its ectoenzyme activity is involved in calcium mobilization. CD38 is also a raft-dependent signaling molecule. CD38 forms a tetramer on the cell surface, but the structural basis and the functional significance of tetramerization have remained unexplored. We identified the interfaces contributing to the homophilic interaction of mouse CD38 by site-specific crosslinking on the cell surface with an expanded genetic code, based on a crystallographic analysis. A combination of the three interfaces enables CD38 to tetramerize: one interface involving the juxtamembrane alpha-helix is responsible for the formation of the core dimer, which is further dimerized via the other two interfaces. This dimerization of dimers is required for the catalytic activity and the localization of CD38 in membrane rafts. The glycosylation prevents further self-association of the tetramer. Accordingly, the tetrameric interaction underlies the multifaceted actions of CD38.

    DOI: 10.1016/j.str.2012.06.017

    Web of Science

    researchmap

  • バイオ医薬品の品質・安全性評価シリーズ(第10回) バイオ医薬品の安定性の評価

    新見 伸吾, 石井 明子, 川崎 ナナ

    PHARM TECH JAPAN   28 ( 11 )   2297 - 2302   2012年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)じほう  

    researchmap

  • 【抗体を用いた医療-血清療法から抗体医薬まで】抗体医薬品のバイオ後続品の将来展望

    川崎 ナナ, 石井 明子

    臨床と微生物   39 ( 5 )   459 - 465   2012年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)近代出版  

    抗体医薬品の市場規模は拡大を続け、世界の医薬品市場の上位を抗体医薬品が占めるようになってきた。2000年前後に日米欧で承認された抗体医薬品製品の多くが特許期間満了となる時期を迎え、世界中で抗体医薬品のバイオ後続品/biosimilars開発への関心が高まっている。また、薬価の高い抗体医薬品の普及は、患者の経済的負担を増大させていることから、7割の薬価で供給されるバイオ後続品の普及は、患者の経済的負担を軽減させる効果があると期待されている。本稿では、我が国におけるバイオ後続品に対する規制要件と承認状況、並びに抗体医薬品バイオ後続品の展望を概説する。(著者抄録)

    researchmap

  • バイオ後続品

    川崎 ナナ, 石井 明子

    日本病院薬剤師会雑誌   48 ( 9 )   1079 - 1086   2012年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本病院薬剤師会  

    1990年前後に開発された初期のバイオ医薬品の特許期間・再審査期間が終了し、低コストでの開発が期待できる「バイオ後続品/バイオシミラー」に世界的な注目が集まるようになった。バイオ後続品の、1)新有効成分含有医薬品との違い、2)ジェネリック医薬品との違い、3)バイオシミラーとの違い、4)一般的名称、5)薬価、6)ソマトロピン後続品、7)エポエチンアルファ後続品、8)フィルグラスチム後続品、について概説した。

    researchmap

  • Rapid evaluation for heterogeneities in monoclonal antibodies by liquid chromatography/mass spectrometry with a column-switching system. 査読

    Kuribayashi R, Hashii N, Harazono A, Kawasaki N

    Journal of pharmaceutical and biomedical analysis   67-68   1 - 9   2012年8月

     詳細を見る

    掲載種別:研究論文(学術雑誌)  

    DOI: 10.1016/j.jpba.2012.04.005

    PubMed

    researchmap

  • バイオ医薬品の品質・安全性評価シリーズ(第7回) バイオ医薬品の製造工程管理

    石井 明子, 多田 稔, 川崎 ナナ

    PHARM TECH JAPAN   28 ( 8 )   1463 - 1474   2012年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)じほう  

    researchmap

  • Functional analysis of the Notch ligand Jagged1 missense mutant proteins underlying Alagille syndrome 査読

    Minoru Tada, Satsuki Itoh, Akiko Ishii-Watabe, Takuo Suzuki, Nana Kawasaki

    FEBS JOURNAL   279 ( 12 )   2096 - 2107   2012年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:WILEY  

    Heterozygous mutations in the JAG1 gene, encoding Notch ligand Jagged1, cause Alagille syndrome (ALGS). As most of the mutations are nonsense or frameshift mutations producing inactive truncated proteins, haplo-insufficiency is considered the major pathogenic mechanism of ALGS. However, the molecular mechanisms by which the missense mutations cause ALGS remain unclear. Here we analyzed the functional properties of four ALGS missense mutant proteins, P163L, R184H, G386R and C714Y, using transfected mammalian cells. P163L and R184H showed Notch-binding activities similar to that of the wild-type when assessed by immunoprecipitation. However, their trans-activation and cis-inhibition activities were almost completely impaired. These mutant proteins localized mainly to the endoplasmic reticulum (ER), suggesting that the mutations induced improper protein folding. Furthermore, the mutant proteins bound more strongly to the ER chaperone proteins calnexin and calreticulin than the wild-type did. C714Y also localized to the ER, but possessed significant trans-activation activity and lacked enhanced binding to the chaperones, indicating a less severe phenotype. The properties of G386R were the same as those of the wild-type. Dominant-negative effects were not detected for any mutant protein. These results indicate that accumulation in the ER and binding to the chaperones correlate with the impaired signal-transduction activities of the missense mutant proteins, which may contribute to the pathogenic mechanism of ALGS. Our findings, which suggest the requirement for cell-surface localization of Jagged1 for cis-inhibition activities, also provide important information for understanding the molecular basis of Notch-signaling pathways.

    DOI: 10.1111/j.1742-4658.2012.08595.x

    Web of Science

    researchmap

  • Functional Regulation of Sugar Assimilation by N-Glycan-specific Interaction of Pancreatic alpha-Amylase with Glycoproteins of Duodenal Brush Border Membrane 査読

    Kimie Asanuma-Date, Yuki Hirano, Na Le, Kotone Sano, Nana Kawasaki, Noritaka Hashii, Yoko Hiruta, Ken-ichi Nakayama, Mariko Umemura, Kazuhiko Ishikawa, Hiromi Sakagami, Haruko Ogawa

    JOURNAL OF BIOLOGICAL CHEMISTRY   287 ( 27 )   23104 - 23118   2012年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC  

    Porcine pancreatic alpha-amylase (PPA) binds to N-linked glycans of glycoproteins (Matsushita, H., Takenaka, M., and Ogawa, H. (2002) J. Biol Chem., 277, 4680-4686). Immunostaining revealed that PPA is located at the brush-border membrane (BBM) of enterocytes in the duodenum and that the binding is inhibited by mannan but not galactan, indicating that PPA binds carbohydrate-specifically to BBM. The ligands for PPA in BBM were identified as glycoprotein N-glycans that are significantly involved in the assimilation of glucose, including sucrase-isomaltase (SI) and Na+/Glc cotransporter 1 (SGLT1). Binding of SI and SGLT1 in BBM to PPA was dose-dependent and inhibited by mannan. Using BBM vesicles, we found functional changes in PPA and its ligands in BBM due to the N-glycanspecific interaction. The starch-degrading activity of PPA and maltose-degrading activity of SI were enhanced to 240 and 175%, respectively, while Glc uptake by SGLT1 was markedly inhibited by PPA at high but physiologically possible concentrations, and the binding was attenuated by the addition of mannose-specific lectins, especially from Galanthus nivalis. Additionally, recombinant human pancreatic alpha-amylases expressed in yeast and purified by single-step affinity chromatography exhibited the same carbohydrate binding specificity as PPA in binding assays with sugar-biotinyl polymer probes. The results indicate that mammalian pancreatic alpha-amylases share a common carbohydrate binding activity and specifically bind to the intestinal BBM. Interaction with N-glycans in the BBM activated PPA and SI to produce much Glc on the one hand and to inhibit Glc absorption by enterocytes via SGLT1 in order to prevent a rapid increase in blood sugar on the other.

    DOI: 10.1074/jbc.M111.314658

    Web of Science

    researchmap

  • a1-3/4 fucosylation at Asn 241 of ss-haptoglobin is a novel marker for colon cancer: A combinatorial approach for development of glycan biomarkers 査読

    Seung-Yeol Park, Sung-Hyeon Lee, Nana Kawasaki, Satsuki Itoh, Keunsoo Kang, Soo Hee Ryu, Noritaka Hashii, Jin-Man Kim, Ji-Yeon Kim, Jung Hoe Kim

    INTERNATIONAL JOURNAL OF CANCER   130 ( 10 )   2366 - 2376   2012年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:WILEY-BLACKWELL  

    Aberrant glycosylation has been observed in many types of cancer, but the mechanism of glycosylation change is still poorly understood. To elucidate relationships between glycosylation and colon cancer progression, we analyzed glycosylation status of beta-haptoglobin (beta-Hp) obtained from 46 cancer patients, 14 inflammatory bowel disease patients and 38 normal subjects. Aleuria aurantia lectin reactivity with cancer beta-Hp was much higher than in the other two study groups. These results were confirmed by lectin blotting and microarray assay using other lectins directed to fucosyl residues. Levels of such glycans were correlated with stage of colon cancer progression. Reactivity with fucosylated glycans was eliminated by treatment with a1-3/4 fucosidase but not a1-6 fucosidase, indicating that enhanced lectin reactivity with the fucose moiety of colon cancer beta-Hp is due to Fuca1-3/4GlcNAc. Moreover, site-specific glycan occupancy was determined by sequential LC/MS analysis. Mass spectrometric analysis showed that fucosylation of beta-Hp was higher in colon cancer patients than in other subjects. In particular, fucosylation at Asn 241 of beta-Hp in sera of colon cancer patients was clearly higher than in the other groups, and the ratio of fucosylated glycopeptides containing Asn 241 decreased greatly after treatment with a1-3/4 fucosidase. In conclusion, the level of a1-3/4 fucosyl epitope at Asn 241 of beta-Hp is potentially useful as a novel marker for colon cancer.

    DOI: 10.1002/ijc.26288

    Web of Science

    researchmap

  • バイオ医薬品の品質・安全性評価シリーズ(第6回) バイオ医薬品の生産用基材

    石井 明子, 多田 稔, 川崎 ナナ

    PHARM TECH JAPAN   28 ( 7 )   1291 - 1300   2012年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)じほう  

    researchmap

  • Novel anti-HIV-1 activity produced by conjugating unsulfated dextran with polyl-lysine 査読

    Kosuke Nakamura, Takahiro Ohtsuki, Haruyo Mori, Hiroo Hoshino, Ariful Hoque, Atsushi Oue, Fumie Kano, Hiromi Sakagami, Ken-ichi Tanamoto, Hiroshi Ushijima, Nana Kawasaki, Hiroshi Akiyama, Haruko Ogawa

    Antiviral Research   94 ( 1 )   89 - 97   2012年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    A conjugate of polyl-lysine (PLL) with unsulfated dextran produced by reductive amination was found to have remarkable anti-HIV-1 activity against both the macrophage-tropic R5 virus Ba-L and T-cell line tropic X4 virus IIIB strains, although neither PLL nor dextran has such activity. The conjugate is a pseudoproteoglycan (pseudoPG) that simulates the structure of a proteoglycan. Conjugation with dextran was found to produce an antiviral effect in three kinds of assay systems including a human CD4 + T-cell line, and the pseudoPG synthesized using 10kDa PLL and 10kDa dextran showed EC 50 4-40 times lower than that of sulfated dextran or heparin against Ba-L and EC 50 equal to that against IIIB, indicating that PLL-dextran (PLL-Dex) was more effective against R5 virus than sulfated polysaccharides. PLL-Dex significantly suppressed a clinically isolated R5 virus from primary peripheral blood mononuclear cells. PLL-Dex interacted with the virus during adsorption to the cell and also decreased virus entry into the cell, suggesting PLL-Dex has multiple preventive mechanisms against HIV-1. © 2012 Elsevier B.V.

    DOI: 10.1016/j.antiviral.2012.02.011

    Scopus

    PubMed

    researchmap

  • GPI-anchor synthesis is indispensable for the germline development of the nematode Caenorhabditis elegans 査読

    Daisuke Murata, Kazuko H. Nomura, Katsufumi Dejima, Souhei Mizuguchi, Nana Kawasaki, Yukari Matsuishi-Nakajima, Satsuki Ito, Keiko Gengyo-Ando, Eriko Kage-Nakadai, Shohei Mitani, Kazuya Nomura

    Molecular Biology of the Cell   23 ( 6 )   982 - 995   2012年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Glycosylphosphatidylinositol (GPI)-anchor attachment is one of the most common posttranslational protein modifications. Using the nematode Caenorhabditis elegans, we determined that GPI-anchored proteins are present in germline cells and distal tip cells, which are essential for the maintenance of the germline stem cell niche. We identified 24 C. elegans genes involved in GPI-anchor synthesis. Inhibition of various steps of GPI-anchor synthesis by RNA interference or gene knockout resulted in abnormal development of oocytes and early embryos, and both lethal and sterile phenotypes were observed. The piga-1 gene (orthologue of human PIGA) codes for the catalytic subunit of the phosphatidylinositol N-acetylglucosaminyltransferase complex, which catalyzes the first step of GPI-anchor synthesis. We isolated piga-1 - knockout worms and found that GPI-anchor synthesis is indispensable for the maintenance of mitotic germline cell number. The knockout worms displayed 100% lethality, with decreased mitotic germline cells and abnormal eggshell formation. Using cell-specific rescue of the null allele, we showed that expression of piga-1 in somatic gonads and/or in germline is sufficient for normal embryonic development and the maintenance of the germline mitotic cells. These results clearly demonstrate that GPI-anchor synthesis is indispensable for germline formation and for normal development of oocytes and eggs. © 2012 Murata et al.

    DOI: 10.1091/mbc.E10-10-0855

    Scopus

    PubMed

    researchmap

  • 液体クロマトグラフィー/質量分析及び主成分分析によるエリスロポエチン製剤先行品及び後続品の糖鎖プロファイル類似性評価

    橋井 則貴, 原園 景, 栗林 亮佑, 中澤 志織, 川崎 ナナ

    日本薬学会年会要旨集   132年会 ( 4 )   109 - 109   2012年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本薬学会  

    researchmap

  • バイオ医薬品の品質・安全性評価シリーズ(第4回) バイオ医薬品の不純物の評価(2)

    新見 伸吾, 石井 明子, 川崎 ナナ

    PHARM TECH JAPAN   28 ( 4 )   757 - 763   2012年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)じほう  

    researchmap

  • バイオ医薬品の品質・安全性評価シリーズ(第3回) バイオ医薬品の不純物の評価(1)

    新見 伸吾, 石井 明子, 川崎 ナナ

    PHARM TECH JAPAN   28 ( 3 )   523 - 528   2012年2月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)じほう  

    researchmap

  • Analysis of oligomeric stability of insulin analogs using hydrogen/deuterium exchange mass spectrometry. 査読 国際誌

    Nakazawa S, Hashii N, Harazono A, Kawasaki N

    Analytical biochemistry   420 ( 1 )   61 - 67   2012年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:1  

    DOI: 10.1016/j.ab.2011.09.002

    PubMed

    researchmap

  • 【バイオロジクス】バイオ医薬品の品質・安全性に関する最近の話題 バイオ医薬品の開発、製造、及び臨床試験の安全性確保における特性理解の重要性

    中澤 志織, 橋井 則貴, 鈴木 琢雄, 多田 稔, 石井 明子, 川崎 ナナ

    レギュラトリーサイエンス学会誌   2 ( 1 )   21 - 30   2012年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)レギュラトリーサイエンス学会  

    バイオ医薬品は、肝炎、糖尿病、及びある種の血液関連疾患やがん領域において標準的治療薬となっており、その医療上の重要性は増す一方である。治療法のない疾患への新たな治療法の提供やQOLの向上を目的として、新規な医薬品開発への期待はさらに高まっている。規制側からも、ICH Q11案、ICHS6(R1)案、並びに「治験対象医薬品ヒト初回投与試験の安全性に関するガイダンス(FIH)案」などが立て続けに示された。Q11案では、重要品質特性を特定するために、徹底した特性解析が重要であること、また、S6(R1)案及びFIH案においても、新規な分子構造、複合型機能、及び高い分子標的性を有するバイオ医薬品及びその被験薬の安全性確保には、特性への十分な理解が不可欠であることが示された。新規なバイオ医薬品の研究開発から生産に至る過程において、作用機構と安全性の予測につながる新たな特性解析法の開発の必要性が高まっている。(著者抄録)

    researchmap

  • [Glycomics in quality control of tissue-engineered medical products]. 査読

    Hashii N, Nakazawa S, Kawasaki N

    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan   132 ( 4 )   489 - 497   2012年

     詳細を見る

    記述言語:日本語   出版者・発行元:4  

    Glycosylation of cells is known to alter with several biological events such as cell differentiations and proliferations as well as some diseases. "Glycomic approaches", comprehensive qualitative and quantitative glycan analyses of the cells, have become increasingly important as a means of discovering biomarkers that have the potential of being used as disease diagnostic markers and molecular markers for cell characterizations. In this paper, we introduce a method of quantitative glycan profiling by liquid chromatography/mass spectrometry with a combination of an isotope tagging method. In addition, we demonstrate the potential of glycan profiling as a tool for the identification of differentiated human bone marrow mesenchymal stem cell (hMSC) and non-differentiated hMSC.<br>

    DOI: 10.1248/yakushi.132.489

    PubMed

    CiNii Books

    researchmap

    その他リンク: https://jlc.jst.go.jp/DN/JALC/10000140880?from=CiNii

  • カラムスイッチング法を用いた液体クロマトグラフィー/質量分析による抗体医薬品の糖鎖不均一性解析法の開発

    栗林 亮佑, 橋井 則貴, 原園 景, 川崎 ナナ

    日本生化学会大会プログラム・講演要旨集   84回   2P - 0019   2011年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本生化学会  

    researchmap

  • 間葉系幹細胞の分化初期における糖鎖プロファイルの変化

    橋井 則貴, 黄 笑宇, 栗林 亮佑, 川崎 ナナ

    日本生化学会大会プログラム・講演要旨集   84回   2P - 0018   2011年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本生化学会  

    researchmap

  • Sperm-specific C-terminal processing of the proteasome PSMA-1/alpha 6 subunit 査読

    Naoto Yokota, Yohei Kataoka, Noritaka Hashii, Nana Kawasaki, Hitoshi Sawada

    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS   410 ( 4 )   809 - 815   2011年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ACADEMIC PRESS INC ELSEVIER SCIENCE  

    We previously reported that the ascidian sperm proteasome degrades the egg-coat protein extracellularly during fertilization. In order to explore an extracellular transport signal, we purified the proteasome from ascidian sperm and compared its subunit structure with egg and muscle proteasomes. The results showed that PSMA1/alpha 6 subunit of the sperm proteasome is distinct from egg and muscle proteasomes. LC/MS/MS analysis revealed that the C-terminal 16 residues of sperm alpha 6 subunit are processed. Whereas sperm-specific paralogous genes of alpha subunits are reported, its sperm-specific C-terminal processing is a newly discovered novel post-translational modification of the proteasome. (C) 2011 Elsevier Inc. All rights reserved.

    DOI: 10.1016/j.bbrc.2011.06.069

    Web of Science

    researchmap

  • Dendritic Cell-specific Intercellular Adhesion Molecule 3-grabbing Non-integrin (DC-SIGN) Recognizes a Novel Ligand, Mac-2-binding Protein, Characteristically Expressed on Human Colorectal Carcinomas 査読

    Motohiro Nonaka, Bruce Yong Ma, Hirotsugu Imaeda, Keiko Kawabe, Nobuko Kawasaki, Keiko Hodohara, Nana Kawasaki, Akira Andoh, Yoshihide Fujiyama, Toshisuke Kawasaki

    JOURNAL OF BIOLOGICAL CHEMISTRY   286 ( 25 )   22403 - 22413   2011年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC  

    Dendritic cell (DC)-specific intercellular adhesion molecule-3-grabbing non-integrin (DC-SIGN) is a type II transmembrane C-type lectin expressed on DCs such as myeloid DCs and monocyte-derived DCs (MoDCs). Recently, we have reported that DC-SIGN interacts with carcinoembryonic antigen (CEA) expressed on colorectal carcinoma cells. CEA is one of the most widely used tumor markers for gastrointestinal cancers such as colorectal cancer. On the other hand, other groups have reported that the level of Mac-2-binding protein (Mac-2BP) increases in patients with pancreatic, breast, and lung cancers, virus infections such as human immunodeficiency virus and hepatitis C virus, and autoimmune diseases. Here, we first identified Mac-2BP expressed on several colorectal carcinoma cell lines as a novel DC-SIGN ligand through affinity chromatography and mass spectrometry. Interestingly, we found that DC-SIGN selectively recognizes Mac-2BP derived from some colorectal carcinomas but not from the other ones. Furthermore, we found that the alpha 1-3,4-fucose moieties of Le glycans expressed on DC-SIGN-binding Mac-2BP were important for recognition. DC-SIGN-dependent cellular interactions between immature MoDCs and colorectal carcinoma cells significantly inhibited MoDC functional maturation, suggesting that Mac-2BP may provide a tolerogenic microenvironment for colorectal carcinoma cells through DC-SIGN-dependent recognition. Importantly, Mac-2BP was detected as a predominant DC-SIGN

    DOI: 10.1074/jbc.M110.215301

    Web of Science

    researchmap

  • A comparative study of monosaccharide composition analysis as a carbohydrate test for biopharmaceuticals 査読

    Akira Harazono, Tetsu Kobayashi, Nana Kawasaki, Satsuki Itoh, Minoru Tada, Noritaka Hashii, Akiko Ishii, Teruyo Arato, Shigehiro Yanagihara, Yuki Yagi, Akiko Koga, Yuriko Tsuda, Mikiko Kimura, Masashi Sakita, Satoshi Kitamura, Hideto Yamaguchi, Hisashi Mimura, Yoshimi Murata, Yasuki Hamazume, Takayuki Sato, Shunji Natsuka, Kazuaki Kakehi, Mitsuhiro Kinoshita, Sakie Watanabe, Teruhide Yamaguchi

    BIOLOGICALS   39 ( 3 )   171 - 180   2011年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD  

    The various monosaccharide composition analysis methods were evaluated as monosaccharide test for glycoprotein-based pharmaceuticals. Neutral and amino sugars were released by hydrolysis with 4-7 N trifluoroacetic acid. The monosaccharides were N-acetylated if necessary, and analyzed by high-performance liquid chromatography (HPLC) with fluorometric or UV detection after derivatization with 2-aminopyridine, ethyl 4-aminobenzoate, 2-aminobenzoic acid or 1-phenyl-3-methyl-5-pyrazolone, or high pH anion exchange chromatography with pulsed amperometric detection (HPAEC-PAD). Sialic acids were released by mild acid hydrolysis or sialidase digestion, and analyzed by HPLC with fluorometric detection after derivatization with 1,2-diamino-4,5-methylenedioxybenzene, or HPAECPAD. These methods were verified for resolution, linearity, repeatability, and accuracy using a monosaccharide standard solution, a mixture of epoetin alfa and beta, and alteplase as models. It was confirmed that those methods were useful for ensuring the consistency of glycosylation. It is considered essential that the analytical conditions including desalting, selection of internal standards, release of monosaccharides, and gradient time course should be determined carefully to eliminate interference of sample matrix.
    Various HPLC-based monosaccharide analysis methods were evaluated as a carbohydrate test for glycoprotein pharmaceuticals by an inter-laboratory study. (C) 2011 The International Alliance for Biologicals. Published by Elsevier Ltd. All rights reserved.

    DOI: 10.1016/j.biologicals.2011.04.002

    Web of Science

    PubMed

    researchmap

  • ヘパリン製剤の品質確保に関する国際的動向 第4回ヘパリン製剤の品質評価に関するワークショップ報告

    石井 明子, 橋井 則貴, 鈴木 琢雄, 川崎 ナナ

    医薬品医療機器レギュラトリーサイエンス   42 ( 5 )   448 - 464   2011年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)医薬品医療機器レギュラトリーサイエンス財団  

    researchmap

  • Helicobacter pylori HP0518 affects flagellin glycosylation to alter bacterial motility 査読 国際誌

    ASAKURA Hiroshi, ASAKURA Hiroshi, CHURIN Yuri, BAUER Bianca, BOETTCHER Jan Peter, BARTFELD Sina, HASHII Noritaka, KAWASAKI Nana, MOLLENKOPF Hans J, JUNGBLUT, Peter R, BRINKMANN Volker, MEYER Thomas F

    Mol. Microbiol.   78 ( 5 )   1130 - 1144   2010年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1111/j.1365-2958.2010.07393.x

    PubMed

    researchmap

  • バイオ医薬品開発における潮流と規制(第6回)(最終回) バイオ治験薬の品質・安全性確保

    石井 明子, 川崎 ナナ

    PHARM TECH JAPAN   26 ( 11 )   2097 - 2108   2010年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)じほう  

    researchmap

  • Heparin identification test and purity test for OSCS in heparin sodium and heparin calcium by weak anion-exchange high-performance liquid chromatography 査読

    Noritaka Hashii, Nana Kawasaki, Satsuki Itoh, Yan Qin, Naho Fujita, Toshiaki Hattori, Kazuyoshi Miyata, Aya Bando, Yuko Sekimoto, Takeshi Hama, Masaki Kashimura, Masashi Tatsumi, Kazunori Mabuchi, Hiroshi Namekawa, Toru Sakai, Mio Hirose, Sei Dobashi, Hirotoshi Shimahashi, Sadatoshi Koyama, Susanne Odgaard Herr, Kenzo Kawai, Hikaru Yoden, Teruhide Yamaguchi

    BIOLOGICALS   38 ( 5 )   539 - 543   2010年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD  

    Heparin sodium and heparin calcium, which are widely used as anti-coagulants, are known to potentially contain the natural impurity dermatan sulfate (DS). Recently serious adverse events occurred in patients receiving heparin sodium in the US, and a contaminant oversulfated chondroitin sulfate (OSCS) was found to be a cause of the events. To ensure the quality and safety of pharmaceutical heparins, there is need of a physicochemical identification test that can discriminate heparin from the heparin-related substances as well as a sensitive purity test for OSCS. Recently, HPLC with a strong-anion exchange column was proposed as the methods for identifying heparin and determination of OSCS in heparin sodium. Although this method is convenient and easy to perform, the only column suitable for this purpose is the Dionex IonPac AS11-HC column. In this study, we developed alternative identification test and test for OSCS in both heparin sodium and heparin calcium using a weak anion-exchange column. The identification test allowed for separation of heparin from the impurity DS and contaminant OSCS in a shorter time. The purity test provided enough sensitivity, specificity, linearity, recovery and repeatability for OSCS. We believe that our methods will be useful for quality control of pharmaceutical heparins. (C) 2010 The International Association for Biologicals. Published by Elsevier Ltd. All rights reserved.

    DOI: 10.1016/j.biologicals.2010.04.002

    Web of Science

    researchmap

  • Survival Signals of Hepatic Stellate Cells in Liver Regeneration Are Regulated by Glycosylation Changes in Rat Vitronectin, Especially Decreased Sialylation 査読

    Kotone Sano, Yasunori Miyamoto, Nana Kawasaki, Noritaka Hashii, Satsuki Itoh, Misaki Murase, Kimie Date, Miki Yokoyama, Chihiro Sato, Ken Kitajima, Haruko Ogawa

    JOURNAL OF BIOLOGICAL CHEMISTRY   285 ( 23 )   17301 - 17309   2010年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC  

    The extracellular matrix (ECM) molecules play important roles in many biological and pathological processes. During tissue remodeling, the ECM molecules that are glycosylated are different from those of normal tissue owing to changes in the expression of many proteins that are responsible for glycan synthesis. Vitronectin (VN) is a major ECM molecule that recognizes integrin on hepatic stellate cells (HSCs). The present study attempted to elucidate how changes in VN glycans modulate the survival of HSCs, which play a critical role in liver regeneration. Plasma VN was purified from partially hepatectomized (PH) and sham-operated (SH) rats at 24 h after operation and non-operated (NO) rats. Adhesion of rat HSCs (rHSCs), together with phosphorylation of focal adhesion kinase, in PH-VN was decreased to one-half of that in NO-or SH-VN. Spreading of rHSCs on desialylated NO-VN was decreased to one-half of that of control VN, indicating the importance of sialylation of VN for activation of HSCs. Liquid chromatography/multiple-stage mass spectrometry analysis of Glu-C glycopeptides of each VN determined the site-specific glycosylation. In addition to the major biantennary complex-type N-glycans, hybrid-type N-glycans were site-specifically present at Asn(167). Highly sialylated O-glycans were found to be present in the Thr(110)-Thr(124) region. In PH-VN, the disialyl O-glycans and complex-type N-glycans were decreased while core-fucosylated N-glycans were increased. In addition, immunodetection after two-dimensional PAGE indicated the presence of hyper- and hyposialylated molecules in each VN and showed that hypersialylation was markedly attenuated in PH-VN. This study proposes that the alteration of VN glycosylation modulates the substrate adhesion to rat HSCs, which is responsible for matrix restructuring.

    DOI: 10.1074/jbc.M109.077016

    Web of Science

    researchmap

  • Comparison of methods for profiling O-glycosylation: Human Proteome Organisation Human Disease Glycomics/Proteome Initiative multi-institutional study of IgA1. 国際誌

    Yoshinao Wada, Anne Dell, Stuart M Haslam, Bérangère Tissot, Kévin Canis, Parastoo Azadi, Malin Bäckström, Catherine E Costello, Gunnar C Hansson, Yoshiyuki Hiki, Mayumi Ishihara, Hiromi Ito, Kazuaki Kakehi, Niclas Karlsson, Catherine E Hayes, Koichi Kato, Nana Kawasaki, Kay-Hooi Khoo, Kunihiko Kobayashi, Daniel Kolarich, Akihiro Kondo, Carlito Lebrilla, Miyako Nakano, Hisashi Narimatsu, Jan Novak, Milos V Novotny, Erina Ohno, Nicolle H Packer, Elizabeth Palaima, Matthew B Renfrow, Michiko Tajiri, Kristina A Thomsson, Hirokazu Yagi, Shin-Yi Yu, Naoyuki Taniguchi

    Molecular & cellular proteomics : MCP   9 ( 4 )   719 - 27   2010年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    The Human Proteome Organisation Human Disease Glycomics/Proteome Initiative recently coordinated a multi-institutional study that evaluated methodologies that are widely used for defining the N-glycan content in glycoproteins. The study convincingly endorsed mass spectrometry as the technique of choice for glycomic profiling in the discovery phase of diagnostic research. The present study reports the extension of the Human Disease Glycomics/Proteome Initiative's activities to an assessment of the methodologies currently used for O-glycan analysis. Three samples of IgA1 isolated from the serum of patients with multiple myeloma were distributed to 15 laboratories worldwide for O-glycomics analysis. A variety of mass spectrometric and chromatographic procedures representative of current methodologies were used. Similar to the previous N-glycan study, the results convincingly confirmed the pre-eminent performance of MS for O-glycan profiling. Two general strategies were found to give the most reliable data, namely direct MS analysis of mixtures of permethylated reduced glycans in the positive ion mode and analysis of native reduced glycans in the negative ion mode using LC-MS approaches. In addition, mass spectrometric methodologies to analyze O-glycopeptides were also successful.

    DOI: 10.1074/mcp.M900450-MCP200

    PubMed

    researchmap

  • Complete NMR analysis of oxytocin in phosphate buffer 査読

    Akiko Ohno, Nana Kawasaki, Kiyoshi Fukuhara, Haruhiro Okuda, Teruhide Yamaguchi

    Magnetic Resonance in Chemistry   48 ( 2 )   168 - 172   2010年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Complete NMR analysis of oxytocin (OXT) in phosphate buffer was elucidated by one-dimensional (1D)-and two-dimensional (2D)-NMR techniques, which involve the assignment of peptide amide NH protons and carbamoyl NH2 protons. The1H-15N correlation of seven amide NH protons and three carbamoyl NH2 protons were also shown by HSQC NMR of OXT without15N enrichment. Copyright © 2009 John Wiley &amp
    Sons, Ltd.

    DOI: 10.1002/mrc.2557

    Scopus

    PubMed

    researchmap

  • Genetic polymorphisms of FCGRT encoding FcRn in a Japanese population and their functional analysis. 査読 国際誌

    Akiko Ishii-Watabe, Yoshiro Saito, Takuo Suzuki, Minoru Tada, Maho Ukaji, Keiko Maekawa, Kouichi Kurose, Nahoko Kaniwa, Jun-ichi Sawada, Nana Kawasaki, Teruhide Yamaguchi, Takako Eguchi Nakajima, Ken Kato, Yasuhide Yamada, Yasuhiro Shimada, Teruhiko Yoshida, Takashi Ura, Miyuki Saito, Kei Muro, Toshihiko Doi, Nozomu Fuse, Takayuki Yoshino, Atsushi Ohtsu, Nagahiro Saijo, Tetsuya Hamaguchi, Haruhiro Okuda, Yasuhiro Matsumura

    Drug metabolism and pharmacokinetics   25 ( 6 )   578 - 87   2010年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Neonatal Fc receptor (FcRn) plays an important role in regulating IgG homeostasis in the body. Changes in FcRn expression levels or activity caused by genetic polymorphisms of FCGRT, which encodes FcRn, may lead to interindividual differences in pharmacokinetics of therapeutic antibodies. In this study, we sequenced the 5'-flanking region, all exons and their flanking regions of FCGRT from 126 Japanese subjects. Thirty-three genetic variations, including 17 novel ones, were found. Of these, two novel non-synonymous variations, 629G>A (R210Q) and 889T>A (S297T), were found as heterozygous variations. We next assessed the functional significance of the two novel non-synonymous variations by expressing wild-type and variant proteins in HeLa cells. Both variant proteins showed similar intracellular localization as well as antibody recycling efficiencies. These results suggested that at least no common functional polymorphic site with amino acid change was present in the FCGRT of our Japanese population.

    PubMed

    researchmap

  • Genetic Polymorphisms of FCGRT Encoding FcRn in a Japanese Population and Their Functional Analysis 査読

    Akiko Ishii-Watabe, Yoshiro Saito, Takuo Suzuki, Minoru Tada, Maho Ukaji, Keiko Maekawa, Kouichi Kurose, Nahoko Kaniwa, Jun-ichi Sawada, Nana Kawasaki, Teruhide Yamaguchi, Takako Eguchi Nakajima, Ken Kato, Yasuhide Yamada, Yasuhiro Shimada, Teruhiko Yoshida, Takashi Ura, Miyuki Saito, Kei Muro, Toshihiko Doi, Nozomu Fuse, Takayuki Yoshino, Atsushi Ohtsu, Nagahiro Saijo, Tetsuya Hamaguchi, Haruhiro Okuda, Yasuhiro Matsumura

    DRUG METABOLISM AND PHARMACOKINETICS   25 ( 6 )   578 - 587   2010年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:JAPANESE SOC STUDY XENOBIOTICS  

    Neonatal Fc receptor (FcRn) plays an important role in regulating IgG homeostasis in the body. Changes in FcRn expression levels or activity caused by genetic polymorphisms of FCGRT, which encodes FcRn, may lead to interindividual differences in pharmacokinetics of therapeutic antibodies. In this study, we sequenced the 5'-flanking region, all exons and their flanking regions of FCGRT from 126 Japanese subjects. Thirty-three genetic variations, including 17 novel ones, were found. Of these, two novel non-synonymous variations, 629G > A (R210Q) and 889T > A (S297T), were found as heterozygous variations. We next assessed the functional significance of the two novel non-synonymous variations by expressing wild-type and variant proteins in HeLa cells. Both variant proteins showed similar intracellular localization as well as antibody recycling efficiencies. These results suggested that at least no common functional polymorphic site with amino acid change was present in the FCGRT of our Japanese population.

    DOI: 10.2133/dmpk.DMPK-10-RG-067

    Web of Science

    researchmap

  • Time-dependent changes of oxytocin using 1H-NMR coupled with multivariate analysis: A new approach for quality evaluation of protein/peptide biologic drugs 査読

    Akiko Ohno, Nana Kawasaki, Kiyoshi Fukuhara, Haruhiro Okuda, Teruhide Yamaguchi

    Chemical and Pharmaceutical Bulletin   57 ( 12 )   1396 - 1399   2009年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    A new method that combines 1H-NMR and principal component analysis (PCA) was employed to obtain the quality evaluation of biopharmaceuticals, with regard to their quality, consistency, and differences in protein modification patterns. To assess the feasibility of the method, three 1H-NMR spectra of oxytocin (OXT) were collected every 7 d (at Day 0, 7 and 14), and time-dependent changes in the spectra were found by PCA of the 1H-NMR signals from 0.5-9.0 ppm, excluding the region around the water signal (4.6-5.0 ppm). Although the three OXT spectra seemed similar by simple visual inspection, time-dependent differences among the three spectra were clearly distinguished by a PCA scores plot. Peak changes indicating both OXT decomposition and the emergence of new OXT decomposition products within the timeframe of the experiment were also observed by a PCA loading plot. The results demonstrate that this method can evaluate the consistency of biopharmaceutical quality. © 2009 Pharmaceutical Society of Japan.

    DOI: 10.1248/cpb.57.1396

    Scopus

    PubMed

    researchmap

  • Comparative study of GH-transgenic and non-transgenic amago salmon (Oncorhynchus masou ishikawae) allergenicity and proteomic analysis of amago salmon allergens 査読

    Rika Nakamura, Rie Satoh, Yukari Nakajima, Nana Kawasaki, Teruhide Yamaguchi, Jun-ichi Sawada, Hiroyuki Nagoya, Reiko Teshima

    Regulatory Toxicology and Pharmacology   55 ( 3 )   300 - 308   2009年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Genetically modified (GM) foods are beneficial from the standpoint of ensuring a constant supply of foodstuffs, but they must be tested for safety before being released on the market, including by allergenicity tests to ensure that they do not contain new allergens or higher concentrations of known allergens than the same non-GM foods. In this study we used GM-amago salmon into which a growth hormone gene had been introduced and compared the allergens contained in the GM and the non-GM-amago salmons. We used a combination of Western blotting with allergen-specific antibodies and a proteomic analysis of their allergens with patients' sera, a so-called allergenome analysis, to analyze allergens. Western blotting with specific antibodies showed no increase in the content of the known allergens fish parvalbumin and fish type-I collagen in GM-amago salmon, in comparison with their content in non-GM-amago salmon. The allergenome analysis of two fish-allergic patients allowed us to identify several IgE-binding proteins in amago salmon, including parvalbumin, triose-phosphate isomerase, fructose-bisphosphate aldolase A, and serum albumin, and there were no qualitative differences in these proteins between GM and non-GM-amago salmons. These results indicate that amago salmon endogenous allergen expression does not seem to be altered by genetic modification. © 2009 Elsevier Inc. All rights reserved.

    DOI: 10.1016/j.yrtph.2009.08.002

    Scopus

    PubMed

    researchmap

  • HNK-1 glyco-epitope regulates the stability of the glutamate receptor subunit GluR2 on the neuronal cell surface 査読

    Ippei Morita, Shinako Kakuda, Yusuke Takeuchi, Satsuki Itoh, Nana Kawasaki, Yasuhiko Kizuka, Toshisuke Kawasaki, Shogo Oka

    Journal of Biological Chemistry   284 ( 44 )   30209 - 30217   2009年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    HNK-1 (human natural killer-1) glyco-epitope, a sulfated glucuronic acid attached to N-acetyllactosamine on the nonreducing termini of glycans, is highly expressed in the nervous system. Our previous report showed that mice lacking a glucuronyltransferase (GlcAT-P), a key enzyme for biosynthesis of the HNK-1 epitope, showed reduced long term potentiation at hippocampal CA1 synapses. In this study, we identified an α-amino-3-hydroxy-5-methylisoxazole propionate (AMPA)-type glutamate receptor subunit, GluR2, which directly contributes to excitatory synaptic transmission and synaptic plasticity, as a novel HNK-1 carrier molecule. We demonstrated that the HNK-1 epitope is specifically expressed on the N-linked glycan(s) on GluR2 among the glutamate receptors tested, and the glycan structure, including HNK-1 on GluR2, was determined using liquid chromatography-tandem mass spectrometry. As for the function of HNK-1 on GluR2, we found that the GluR2 not carrying HNK-1 was dramatically endocytosed and expressed less on the cell surface compared with GluR2 carrying HNK-1 in both cultured hippocampal neurons and heterologous cells. These results suggest that HNK-1 stabilizes GluR2 on neuronal surface membranes and regulates the number of surface AMP A receptors. Moreover, we showed that the expression of the HNK-1 epitope enhanced the interaction between GluR2 and N-cadherin, which has important roles in AMPA receptor trafficking. Our findings suggest that the HNK-1 epitope on GluR2 regulates cell surface stability of GluR2 by modulating the interaction with N-cadherin. © 2009 by The American Society for Biochemistry and Molecular Biology, Inc.

    DOI: 10.1074/jbc.M109.024208

    Scopus

    PubMed

    researchmap

  • Capillary Electrophoresis Analysis of Contaminants in Heparin Sodium for the Japanese Pharmacopoeia Purity Test 査読

    Naotaka Kakoi, Mitsuhiro Kinoshita, Nana Kawasaki, Teruhide Yamaguchi, Takao Hayakawa, Kazuaki Kakehi

    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN   129 ( 10 )   1255 - 1264   2009年10月

     詳細を見る

    記述言語:日本語   掲載種別:研究論文(学術雑誌)   出版者・発行元:PHARMACEUTICAL SOC JAPAN  

    Heparin is widely used as an anticoagulant for the treatment and prevention of thrombotic disorders. Recently, hundreds of cases of anaphylactic reaction as adverse effects were reported by the presence of contaminating oversulfated chondroitin sulfate (OSCS) in some heparin preparations. In addition, these heparin preparations often contaminated dermatan sulfate (DS). Unfortunately, the Japanese Pharmacopoeia (JP) does not include appropriate purity tests. In the present paper, we show that capillary electrophoresis (CE) is a powerful tool for the analysis of OSCS and DS ill heparin preparations. CE method shows high resolution and good quantification of OSCS in heparin preparations. This method (OSCS method) was evaluated for accuracy (93.7%), repeatability (R.S.D. = 2.11), linearity (R-2 = 0.9996), detection limit (0.1% OSCS) and specificity. In contrast, DS was not able to be detected in high sensitivity by OSCS method. However, a modified CE method (DS method) using the buffer at lower pHs showed good parameters for accuracy (88.1%,), repeatability (R.S.D. = 1.99), linearity (R-2 = 0.9998), detection limit (0.25% DS) and specificity. In conclusion, CE will be an alternative to the NMR method which is being adopted for purification test of heparin sodium in the present version of JP.

    DOI: 10.1248/yakushi.129.1255

    Web of Science

    PubMed

    researchmap

  • 肝再生時ラットビトロネクチンの糖鎖構造と肝星細胞接着伸展における糖鎖の影響

    佐野 琴音, 宮本 泰則, 川崎 ナナ, 橋井 則貴, 伊藤 さつき, 横山 三紀, 佐藤 ちひろ, 北島 健, 小川 温子

    日本生化学会大会プログラム・講演要旨集   82回   4P - 034   2009年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本生化学会  

    researchmap

  • Identification of glycoproteins carrying a target glycan-motif by liquid chromatography/multiple-stage mass spectrometry: identification of Lewis x-conjugated glycoproteins in mouse kidney. 査読 国際誌

    Hashii N, Kawasaki N, Itoh S, Nakajima Y, Harazono A, Kawanishi T, Yamaguchi T

    Journal of proteome research   8 ( 7 )   3415 - 3429   2009年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:7  

    DOI: 10.1021/pr9000527

    PubMed

    researchmap

  • The Significance of Glycosylation Analysis in Development of Biopharmaceuticals 査読

    Nana Kawasaki, Satsuki Itoh, Noritaka Hashii, Daisuke Takakura, Yan Qin, Xiaoyu Huang, Teruhide Yamaguchi

    BIOLOGICAL & PHARMACEUTICAL BULLETIN   32 ( 5 )   796 - 800   2009年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:PHARMACEUTICAL SOC JAPAN  

    Many glycoproteins and glycosaminoglycans are approved for clinical use. Carbohydrate moieties in biopharmaceuticals affect not only their physicochemical properties and thermal stability, but also their reactivity with their receptors and circulating half-life. Modification of glycans is one target of drug design for enhancement of efficacy. Meanwhile, there have been reports of serious adverse events caused by some carbohydrates. It is crucial to maintain the constancy of carbohydrate moieties for the efficient and safe use of glycosylated biopharmaceuticals. On the other hand, for scientific, safety-related, and economic reasons, changes in the manufacturing process are frequently made either during the development or after the approval of new biopharmaceuticals. Furthermore, the development of biosimilar glycoprotein products has been attempted by different manufacturers. Changes in pharmaceutical manufacturing processes possibly cause alteration of glycosylation and raise concerns about alteration of their quality, safety, and efficacy. In this review we provide some current topics of glycosylated biopharmaceuticals from the viewpoints of efficacy, safety, and the manufacturing process and discuss the significance of glycosylation analysis for development of biopharmaceuticals.

    DOI: 10.1248/bpb.32.796

    Web of Science

    researchmap

  • Alteration of N-glycosylation in the kidney in a mouse model of systemic lupus erythematosus: relative quantification of N-glycans using an isotope-tagging method 査読

    Noritaka Hashii, Nana Kawasaki, Satsuki Itoh, Yukari Nakajima, Toru Kawanishi, Teruhide Yamaguchi

    IMMUNOLOGY   126 ( 3 )   336 - 345   2009年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:WILEY-BLACKWELL PUBLISHING, INC  

    Changes in the glycan structures of some glycoproteins have been observed in autoimmune diseases such as systemic lupus erythematosus (SLE) and rheumatoid arthritis. A deficiency of alpha-mannosidase II, which is associated with branching in N-glycans, has been found to induce SLE-like glomerular nephritis in a mouse model. These findings suggest that the alteration of the glycosylation has some link with the development of SLE. An analysis of glycan alteration in the disordered tissues in SLE may lead to the development of improved diagnostic methods and may help to clarify the carbohydrate-related pathogenic mechanism of inflammation in SLE. In this study, a comprehensive and differential analysis of N-glycans in kidneys from SLE-model mice and control mice was performed by using the quantitative glycan profiling method that we have developed previously. In this method, a mixture of deuterium-labelled N-glycans from the kidneys of SLE-model mice and non-labelled N-glycans from kidneys of control mice was analysed by liquid chromatography/mass spectrometry. It was revealed that the low-molecular-mass glycans with simple structures, including agalactobiantennary and paucimannose-type oligosaccharides, markedly increased in the SLE-model mouse. On the other hand, fucosylated and galactosylated complex type glycans with high branching were decreased in the SLE-model mouse. These results suggest that the changes occurring in the N-glycan synthesis pathway may cause the aberrant glycosylations on not only specific glycoproteins but also on most of the glycoproteins in the SLE-model mouse. The changes in glycosylation might be involved in autoimmune pathogenesis in the model mouse kidney.

    DOI: 10.1111/j.1365-2567.2008.02898.x

    Web of Science

    PubMed

    researchmap

  • LC/MSn for glycoprotein analysis: N-linked glycosylation analysis and peptide sequencing of glycopeptides 査読

    Nana Kawasaki, Satsuki Itoh, Teruhide Yamaguchi

    Methods in Molecular Biology   534   239 - 248   2009年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Liquid chromatography/multiple-stage mass spectrometry (LC/MSn) is an effective means for the site-specific glycosylation analysis of a limited quantity of glycoproteins, such as gel-separated proteins. Generally, a tryptic digest of the glycoprotein is separated by reversed-phase LC, and peptide sequencing and glycosylation analysis are achieved with on-line MSn. In this chapter, a protocol for the LC/MS/MS/MS of a proteolytic digest of a gel-separated glycoprotein is described. © 2009 Humana Press, a part of Springer Science+Business Media, LLC.

    DOI: 10.1007/978-1-59745-022-5_18

    Scopus

    researchmap

  • Highly fucosylated N-glycan ligands for mannan-binding protein expressed specifically on CD26 (DPPVI) isolated from a human colorectal carcinoma cell line, SW1116 査読

    Nobuko Kawasaki, Chia-Wei Lin, Risa Inoue, Kay-Hooi Khoo, Nana Kawasaki, Bruce Yong Ma, Shogo Oka, Masaji Ishiguro, Toshihiko Sawada, Hideharu Ishida, Tomohiro Hashimoto, Toshisuke Kawasaki

    Glycobiology   19 ( 4 )   437 - 450   2009年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    The serum mannan-binding protein (MBP) is a host defense C-type lectin specific for mannose, N-acetylglucosamine, and fucose residues, and exhibits growth inhibitory activity toward human colorectal carcinoma cells. The MBP-ligand oligosaccharides (MLO) isolated from a human colorectal carcinoma cell line, SW1116, are large, multiantennary N-glycans with highly fucosylated polylactosamine-type structures having Leb Lea or tandem repeats of the Lea structure at their nonreducing ends. In this study, we isolated the major MBP-ligand glycoproteins from SW1116 cell lysates with an MBP column and identified them as CD26/dipeptidyl peptidase IV (DPPIV) (110 kDa) and CD98 heavy chain (CD98hc)/4F2hc (82 kDa). Glycosidase digestion revealed that CD26 contained such complex-type N-glycans that appear to mediate the MBP binding. MALDI-MS of the N-glycans released from CD26 by PNGase F demonstrated conclusively that CD26 is the major MLO-carrying protein. More interestingly, a comparison of the N-glycans released from the MBP-binding and non-MBP-binding glycopeptides suggested that complex-type N-glycans carrying a minimum of 4 Lea/ Leb epitopes arranged either as multimeric tandem repeats or terminal epitopes on multiantennary structures are critically important for the high affinity binding to MBP. Analysis of the N-glycan attachment sites demonstrated that the high affinity MLO was expressed preferentially at some N-glycosylation sites, but this site preference was not so stringent. Finally, hypothetical 3D models of tandem repeats of the Lea epitope and the MBP-Lewis oligosaccharide complex were presented. © The Author 2009. Published by Oxford University Press. All rights reserved.

    DOI: 10.1093/glycob/cwn158

    Scopus

    PubMed

    researchmap

  • N-glycosylation of laminin-332 regulates its biological functions: A novel function of the bisecting GlcNAc 査読

    Yoshinobu Kariya, Rika Kato, Satsuki Itoh, Tomohiko Fukuda, Yukinao Shibukawa, Noriko Sanzen, Kiyotoshi Sekiguchi, Yoshinao Wada, Nana Kawasaki, Jianguo Gu

    Journal of Biological Chemistry   283 ( 48 )   33036 - 33045   2008年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Laminin-332 (Lm332) is a large heterotrimeric glycoprotein that has been identified as a scattering factor, a regulator of cancer invasion as well as a prominent basement membrane component of the skin. Past studies have identified the functional domains of Lm332 and revealed the relationships between its activities and the processing of its subunits. However, there is little information available concerning the effects of N-glycosylation on Lm332 activities. In some cancer cells, an increase of β1,6-GlcNAc catalyzed by N-acetylglucosaminyltransferase V (GnT-V) is related to the promotion of cancer cell motility. By contrast, bisecting GlcNAc catalyzed by N- acetylglucosaminyltransferase III (GnT-III) suppresses the further processing with branching enzymes, such as GnT-V, and the elongation of N-glycans. To examine the effects of those N-glycosylations to Lm332 on its activities, we purified Lm332s from the conditioned media of GnT-III- and GnT-V-overexpressing MKN45 cells. Lectin blotting and mass spectrometry analyses revealed that N-glycans containing the bisecting GlcNAc and β1,6-GlcNAc structures were strongly expressed on Lm332 purified from GnT-III-overexpressing (GnT-III-Lm332) and GnT-V-overexpressing (GnTV-Lm332) cells, respectively. Interestingly, the cell adhesion activity of GnT-III-Lm332 was apparently decreased compared with those of control Lm332 and GnT-V-Lm332. In addition, the introduction of bisecting GlcNAc to Lm332 resulted in a decrease in its cell scattering and migration activities. The weakened activities were most likely derived from the impaired α3β1 integrin clustering and resultant focal adhesion formation. Taken together, our results clearly demonstrate for the first time that N-glycosylation may regulate the biological function of Lm332. This finding could introduce a new therapeutic strategy for cancer. © 2008 by The American Society for Biochemistry and Molecular Biology, Inc.

    DOI: 10.1074/jbc.M804526200

    Scopus

    PubMed

    researchmap

  • 糖鎖異常の網羅的解析 (糖鎖情報の独自性と普遍性) -- (構造糖鎖生物学と糖鎖創薬) 査読

    川崎 ナナ, 橋井 則貴, 山口 照英

    蛋白質核酸酵素   53 ( 12 )   1690 - 1696   2008年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:共立出版  

    PubMed

    CiNii Books

    researchmap

    その他リンク: http://search.jamas.or.jp/link/ui/2008351288

  • Glycosylation and ligand-binding activities of rat plasma fibronectin during liver regeneration after partial hepatectomy 査読

    Kotone Sano, Miho Asahi, Maiko Yanagibashi, Noritaka Hashii, Satsuki Itoh, Nana Kawasaki, Haruko Ogawa

    CARBOHYDRATE RESEARCH   343 ( 13 )   2329 - 2335   2008年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ELSEVIER SCI LTD  

    Fibronectin (FN) is a multifunctional glycoprotein present in the extracellular matrix (ECM) and plasma. We previously reported that the glycosylation and ligand-binding of vitronectin (VN) change markedly after partial hepatectomy (PH). Here we show the changes of FN during liver regeneration. The yields of purified sham-operated (SH-) and PH-FN were higher than that of non-operated (NO)-FN, while binding activities of FNs to ECM ligands were changed only slightly by hepatectomy. The carbohydrate concentration of PH-FN decreased to 66% of that of NO- and SH-FN. By using LC/MS '', eight kinds of complex-type N-glycan structures were found to be present in all FNs, and bi- and trisialobiantennary glycans were the major structures. Fucosylation was markedly increased, while O-acetylation of sialic acid was found to be decreased in PH-FN. The alterations in glycosylation and biological activities of FN after PH are different from those of VN, suggesting that these glycoproteins play different biological functions in tissue remodeling. (C) 2008 Elsevier Ltd. All rights reserved.

    DOI: 10.1016/j.carres.2008.03.027

    Web of Science

    PubMed

    researchmap

  • Glycosylation analysis of IgLON family proteins in rat brain by liquid chromatography and multiple-stage mass spectrometry 査読

    Satsuki Itoh, Akiko Hachisuka, Nana Kawasaki, Noritaka Hashii, Reiko Teshima, Takao Hayakawa, Toru Kawanishi, Teruhide Yamaguchi

    BIOCHEMISTRY   47 ( 38 )   10132 - 10154   2008年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:AMER CHEMICAL SOC  

    IgLON family proteins, including limbic-associated membrane protein (LAMP), opioid-binding cell adhesion molecule (OBCAM), neurotrimin, and Kilon, are immunoglobulin (Ig) superfamily cell adhesion molecules. These molecules are composed of three Ig domains and a glycosylphosphatidylinositol (GPI) anchor and contain six or seven potential N-glycosylation sites. Although their glycosylations are supposed to be associated with the development of the central nervous system like other Ig superfamily proteins, they are still unknown because of difficulty in isolating individual proteins with a high degree of homology in performing carbohydrate analysis. In this study, we conducted simultaneous site-specific glycosylation analysis of rat brain IgLON proteins by liquid chromatography and multiple-stage mass spectrometry (LC-MSn). The rat brain GPI-linked proteins were enriched and separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The four proteins were extracted from the gel, and subjected to LC-MSn after proteinase digestions. A set of glycopeptide MS data, including the mass spectrum, the mass spectrum in the selected ion monitoring mode, and the product ion spectra, was selected from all data based on carbohydrate-related ions in the MS/MS spectrum. The peptide portion and the carbohydrate structure were identified on the basis of peptide-related ion and carbohydrate-related ions, and the accurate mass. The site-specific glycosylations of four proteins were elucidated as follows. N-Glycans near the N-terminal were disialic acid-conjugated complex- and hybrid-type oligosaccharides. The first Ig domains were occupied by Man-5-9. Diverse oligosaccharides, including Lewis a/x-modified glycans, a brainspecific glycan known as BA-2, and Man-5, were found to be attached to the third Ig domain. Three common structures of glycans were found in the GPI moiety of LAMP, OBCAM, and neurotrimin.

    DOI: 10.1021/bi8009778

    Web of Science

    PubMed

    researchmap

  • Ascidian sperm glycosylphosphatidylinositol-anchored CRISP-like protein as a binding partner for an allorecognizable sperm receptor on the vitelline coat 査読

    Satoshi Urayama, Yoshito Harada, Yoko Nakagawa, Susumu Ban, Mari Akasaka, Nana Kawasaki, Hitoshi Sawada

    Journal of Biological Chemistry   283 ( 31 )   21725 - 21733   2008年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Although ascidians are hermaphroditic, many species including Halocynthia roretzi are self-sterile. We previously reported that a vitelline coat polymorphic protein HrVC70, consisting of 12 EGF (epidermal growth factor)-like repeats, is a candidate allorecognition protein in H. roretzi, because the isolated HrVC70 shows higher affinity to nonself-sperm than to self-sperm. Here, we show that a sperm 35-kDa glycosylphosphatidylinositol-anchored CRISP (cysteine-rich secretory protein)-like protein HrUrabin in a low density detergent-insoluble membrane fraction is a physiological binding partner for HrVC70. We found that HrVC70 specifically interacts with HrUrabin, which had been separated by SDS-PAGE and transferred onto a nitrocellulose membrane. HrUrabin has an N-linked sugar chain, essential for binding to HrVC70. Hr-Urabin mRNA is expressed in the testis but not in the ovary, and the protein appears to be localized on the surface of sperm head and tail. Anti-HrUrabin antibody, which neutralizes the interaction between HrUrabin and HrVC70, potently inhibited fertilization and allorecognizable sperm-binding to HrVC70-agarose. However, no significant difference in the binding ability of HrUrabin to HrVC70 was observed in autologous and allogeneic combinations by Far Western analyses. These results indicate that sperm-egg binding in H. roretzi is mediated by the molecular interaction between HrUrabin on the sperm surface and HrVC70 on the vitelline coat, but that HrUrabin per se is unlikely to be a direct allorecognition protein. © 2008 by The American Society for Biochemistry and Molecular Biology, Inc.

    DOI: 10.1074/jbc.M802631200

    Scopus

    PubMed

    researchmap

  • Simultaneous glycosylation analysis of human serum glycoproteins by high-performance liquid chromatography/tandem mass spectrometry. 査読

    Harazono A, Kawasaki N, Itoh S, Hashii N, Matsuishi-Nakajima Y, Kawanishi T, Yamaguchi T

    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences   869 ( 1-2 )   20 - 30   2008年6月

     詳細を見る

    記述言語:英語   出版者・発行元:1-2  

    DOI: 10.1016/j.jchromb.2008.05.006

    PubMed

    CiNii Books

    researchmap

  • Laminin-1 is a novel carrier glycoprotein for the nonsulfated HNK-1 epitope in mouse kidney 査読

    Yasuhiko Kizuka, Kyoko Kobayashi, Shinako Kakuda, Yukari Nakajima, Satsuki Itoh, Nana Kawasaki, Shogo Oka

    Glycobiology   18 ( 4 )   331 - 338   2008年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    The HNK-1 epitope has a unique structure comprising the sulfated trisaccharide (HSO3-3GlcAβ1-3Galβ1-4GlcNAc), and two glucuronyltransferases (GlcAT-P and GlcAT-S) are key enzymes for its biosynthesis. However, the different functional roles of these enzymes in its biosynthesis remain unclear. Recently, we reported that a nonsulfated form of this epitope, which is biosynthesized by GlcAT-S but not by GlcAT-P, is expressed on two metalloproteases in mouse kidney. In this study, we found that a novel glycoprotein carrying the nonsulfated HNK-1 epitope in mouse kidney was enriched in the nuclear fraction. The protein was affinity-purified and identified as laminin-1, and we also confirmed the N -linked oligosaccharide structure including nonsulfated HNK-1 epitope derived from laminin-1 by mass spectrometry. Curiously, immunofluorescence staining of kidney sections revealed that laminin-1 appeared not to be colocalized with the nonsulfated HNK-1 epitope. However, proteinase treatment strengthened the signals of both laminin-1 and the nonsulfated HNK-1 epitope, resulting in overlapping of them. These results indicate that the nonsulfated HNK-1 epitope on laminin-1 is usually embedded and masked in the robust basement membrane in tight association with other proteins. To clarify the associated proteins and the functional role of the carbohydrate epitope, we investigated the interaction between laminin-1 and alpha-dystroglycan through their glycans in mouse kidney using the overlay assay technique. We obtained evidence that glucuronic acid as well as sialic acid inhibited this interaction, suggesting that the nonsulfated HNK-1 epitope on laminin-1 may regulate its binding and play a role in maintenance of the proper structure in the kidney basal lamina. © The Author 2008. Published by Oxford University Press. All rights reserved.

    DOI: 10.1093/glycob/cwn012

    Scopus

    PubMed

    researchmap

  • Study on the quality control of cell therapy products. Determination of N-glycolylneuraminic acid incorporated into human cells by nano-flow liquid chromatography/Fourier transformation ion cyclotron mass spectrometry. 査読 国際誌

    Hashii N, Kawasaki N, Nakajima Y, Toyoda M, Katagiri Y, Itoh S, Harazono A, Umezawa A, Yamaguchi T

    Journal of chromatography. A   1160 ( 1-2 )   263 - 269   2007年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:1-2  

    DOI: 10.1016/j.chroma.2007.05.062

    PubMed

    researchmap

  • Comparison of the methods for profiling glycoprotein glycans - HUPO Human Disease Glycomics/Proteome Initiative multi-institutional study (vol 17, pg 411, 2007)

    Yoshinao Wada, Parastoo Azadi, Catherine E. Costello, Anne Dell, Raymond A. Dwek, Hildegard Geyer, Rudolf Geyer, Kazuaki Kakehi, Niclas G. Karlsson, Koichi Kato, Nana Kawasaki, Kay-Hooi Khoo, Soohyun Kim, Akihiro Kondo, Erika Lattova, Yehia Mechref, Eiji Miyoshi, Kazuyuki Nakamura, Hisashi Narimatsu, Milos V. Novotny, Nicolle H. Packer, Helene Perreault, Jasna Peter-Katalinic, Gottfried Pohlentz, Vernon N. Reinhold, Pauline M. Rudd, Akemi Suzuki, Naoyuki Taniguchi

    GLYCOBIOLOGY   17 ( 5 )   10 - 10   2007年5月

     詳細を見る

    記述言語:英語   出版者・発行元:OXFORD UNIV PRESS INC  

    DOI: 10.1093/glycob/cwm041

    Web of Science

    researchmap

  • Comparison of the methods for profiling glycoprotein glycans - HUPO Human Disease Glycomics/Proteome Initiative multi-institutional study 査読

    Yoshinao Wada, Parastoo Azadi, Catherine E. Costello, Anne Dell, Raymond A. Dwek, Hildegard Geyer, Rudolf Geyer, Kazuaki Kakehi, Niclas G. Karlsson, Koichi Kato, Nana Kawasaki, Kay-Hooi Khoo, Soohyun Kim, Akihiro Kondo, Erika Lattova, Yehia Mechref, Eiji Miyoshi, Kazuyuki Nakamura, Hisashi Narimatsu, Milos V. Novotny, Nicolle H. Packer, Helene Perreault, Jasna Peter-Katalinic, Gottfried Pohlentz, Vernon N. Reinhold, Pauline M. Rudd, Akemi Suzuki, Naoyuki Taniguchi

    GLYCOBIOLOGY   17 ( 4 )   411 - 422   2007年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:OXFORD UNIV PRESS INC  

    Mass spectrometry (MS) of glycoproteins is an emerging field in proteomics, poised to meet the technical demand for elucidation of the structural complexity and functions of the oligosaccharide components of molecules. Considering the divergence of the mass spectrometric methods employed for oligosaccharide analysis in recent publications, it is necessary to establish technical standards and demonstrate capabilities. In the present study of the Human Proteome Organisation (HUPO) Human Disease Glycomics/Proteome Initiative (HGPI), the same samples of transferrin and immunoglobulin-G were analyzed for N-linked oligosaccharides and their relative abundances in 20 laboratories, and the chromatographic and mass spectrometric analysis results were evaluated. In general, matrix-assisted laser desorption/ionization (MALDI) time-of-flight MS of permethylated oligosaccharide mixtures carried out in six laboratories yielded good quantitation, and the results can be correlated to those of chromatography of reductive amination derivatives. For underivatized oligosaccharide alditols, graphitized carbon-liquid chromatography (LC)/electrospray ionization (ESI) MS detecting deprotonated molecules in the negative ion mode provided acceptable quantitation. The variance of the results among these three methods was small. Detailed analyses of tryptic glycopeptides employing either nano LC/ESI MS/MS or MALDI MS demonstrated excellent capability to determine site-specific or subclass-specific glycan profiles in these samples. Taking into account the variety of MS technologies and options for distinct protocols used in this study, the results of this multi-institutional study indicate that MS-based analysis appears as the efficient method for identification and quantitation of oligosaccharides in glycomic studies and endorse the power of MS for glycopeptide characterization with high sensitivity in proteomic programs.

    DOI: 10.1093/glycob/cwl086

    Web of Science

    researchmap

  • Glycosylation-dependent interaction of Jacalin with CD45 induces T lymphocyte activation and Th1/Th2 cytokine secretion 査読

    Makoto Baba, Bruce Yong Ma, Motohiro Nonaka, Yukari Matsuishi, Makoto Hirano, Natsuko Nakamura, Nana Kawasaki, Nobuko Kawasaki, Toshisuke Kawasaki

    JOURNAL OF LEUKOCYTE BIOLOGY   81 ( 4 )   1002 - 1011   2007年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:FEDERATION AMER SOC EXP BIOL  

    Jacalin, an (alpha-O-glycoside of the disaccharide Thomsen-Friedenreich antigen (galactose (beta 1-3 N-acetylgalactosamine, T-antigen)-specific lectin from jackfruit seeds, has been shown to induce mitogenic responses and to block infection by HIV-1 in CD4(+) T lymphocytes. The molecular mechanism underlying Jacalin-induced T cell activation has not been elucidated completely yet. In the present study, protein tyrosine phosphatase (PTPase) CD45 was isolated from a Jurkat T cell membrane fraction as a major receptor for Jacalin through affinity chromatography and mass spectrometry. CD45, which is highly glycosylated and expressed exclusively on the surface of lymphocytes, is a key regulator of lymphocyte signaling, playing a pivotal role in activation and development. We found that the lectin induced significant IL-2 production by a CD45-positive Jurkat T cell line (JE6.1) and primary T cells. However, this effect did not occur in a CD45-negative Jurkat T cell line (J45.01) and was blocked completely by a specific CD45 PTPase inhibitor in Jurkat T (JE6.1) and primary T cells. Furthermore, we also observed that Jacalin caused a marked increase in IL-2 secretion in response to TCR ligation and CD28 costimulation and contributed to Th1/Th2 cytokine production by activating CD45. Jacalin increased CD45 tyrosine phosphatase activity, which resulted in activation of the ERK1/2 and p38 MAPK cascades. Based on these findings, we propose a new, immunoregulatory model for Jacalin, wherein glycosylation-dependent interactions of Jacalin with CD45 on T cells elevate TCR-mediated signaling, which thereby up-regulate T cell activation thresholds and Th1/Th2 cytokine secretion.

    DOI: 10.1189/jlb.1106660

    Web of Science

    researchmap

  • Deletion of core fucosylation on alpha 3 beta 1 integrin down-regulates its functions 査読

    Yanyang Zhao, Satsuki Itoh, Xiangchun Wang, Tomoya Isaji, Eiji Miyoshi, Yoshinobu Kariya, Kaoru Miyazaki, Nana Kawasaki, Naoyuki Taniguchi, Jianguo Gu

    JOURNAL OF BIOLOGICAL CHEMISTRY   281 ( 50 )   38343 - 38350   2006年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC  

    The core fucosylation (alpha 1,6-fucosylation) of glycoprotein is widely distributed in mammalian tissues. Recently alpha 1,6-fucosylation has been further reported to be very crucial by the study of alpha 1,6-fucosyltransferase (Fut8)-knock-out mice, which shows the phenotype of emphysema-like changes in the lung and severe growth retardation. In this study, we extensively investigated the effect of core fucosylation on alpha 3 beta 1 integrin and found for the first time that Fut8 makes an important contribution to the functions of this integrin. The role of core fucosylation in alpha 3 beta 1 integrin-mediated events has been studied by using Fut8(+/+) and Fut8(-/-) embryonic fibroblasts, respectively. We found that the core fucosylation of alpha 3 beta 1 integrin, the major receptor for laminin 5, was abundant in Fut8(+/+) cells but was totally abolished in Fut8(-/-) cells, which was associated with the deficient migration mediated by alpha 3 beta 1 integrin in Fut8(-/-) cells. Moreover integrin-mediated cell signaling was reduced in Fut8(-/-) cells. The reintroduction of Fut8 potentially restored laminin 5-induced migration and intracellular signaling. Collectively, these results suggested that core fucosylation is essential for the functions of alpha 3 beta 1 integrin.

    DOI: 10.1074/jbc.M608764200

    Web of Science

    researchmap

  • Glycoproteins carrying the characteristic MBP-ligand oligosaccharides on human colon cancer cells 査読

    Nobuko Kawasaki, Kay-Hooi Khoo, Risa Inoue, Nana Kawasaki, Bruce Yong Ma, Toshisuke Kawasaki

    GLYCOBIOLOGY   16 ( 11 )   1156 - 1156   2006年11月

     詳細を見る

    記述言語:英語   出版者・発行元:OXFORD UNIV PRESS INC  

    Web of Science

    researchmap

  • N-acetylglucosaminyltransferase III antagonizes the effect of N-acetylglucosaminyltransferase V on alpha 3 beta 1 integrin-mediated cell migration 査読

    Yanyang Zhao, Takatoshi Nakagawa, Satsuki Itoh, Kei-ichiro Inamori, Tomoya Isaji, Yoshinobu Kariya, Akihiro Kondo, Eiji Miyoshi, Kaoru Miyazaki, Nana Kawasaki, Naoyuki Taniguchi, Jianguo Gu

    JOURNAL OF BIOLOGICAL CHEMISTRY   281 ( 43 )   32122 - 32130   2006年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC  

    N-Acetylglucosaminyltransferase V (GnT-V) catalyzes the addition of beta 1,6-GlcNAc branching of N-glycans, which contributes to metastasis. N-Acetylglucosaminyltransferase III (GnT-III) catalyzes the formation of a bisecting GlcNAc structure in N-glycans, resulting in the suppression of metastasis. It has long been hypothesized that the suppression of GnT-V product formation by the action of GnT-III would also exist in vivo, which will consequently lead to the inhibition of biological functions of GnT-V. To test this, we draw a comparison among MKN45 cells, which were transfected with GnT-III, GnT-V, or both, respectively. We found that alpha 3 beta 1 integrin-mediated cell migration on laminin 5 was greatly enhanced in the case of GnT-V transfectant. This enhanced cell migration was significantly blocked after the introduction of GnT-III. Consistently, an increase in bisected GlcNAc but a decrease in beta 1,6-GlcNAc-branched N-glycans on integrin alpha 3 subunit was observed in the double transfectants of GnT-III and GnT-V. Conversely, GnT-III knockdown resulted in increased migration on laminin 5, concomitant with an increase in beta 1,6-GlcNAc-branched N-glycans on the alpha 3 subunit in CHP134 cells, a human neuroblastoma cell line. Therefore, in this study, the priority of GnT-III for the modification of the alpha 3 subunit may be an explanation for why GnT-III inhibits GnT-V-induced cell migration. Taken together, our results demonstrate for the first time that GnT-III and GnT-V can competitively modify the same target glycoprotein and furthermore positively or negatively regulate its biological functions.

    DOI: 10.1074/jbc.M607274200

    Web of Science

    PubMed

    researchmap

  • 平成16年度「日本薬局方の試験法に関する研究」研究報告 局方組換えタンパク質性医薬品の糖鎖試験法に関する研究 LC/MSnを用いた糖鎖プロファイリング 査読

    川崎 ナナ, 伊藤 さつき, 橋井 則貴, 日向 昌司, 川西 徹

    医薬品研究   37 ( 7 )   448 - 456   2006年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)医薬品医療機器レギュラトリーサイエンス財団  

    researchmap

  • Site-specific N-glycosylation analysis of human plasma ceruloplasmin using liquid chromatography with electrospray ionization tandem mass spectrometry. 査読 国際誌

    Harazono A, Kawasaki N, Itoh S, Hashii N, Ishii-Watabe A, Kawanishi T, Hayakawa T

    Analytical biochemistry   348 ( 2 )   259 - 268   2006年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:2  

    DOI: 10.1016/j.ab.2005.10.036

    PubMed

    researchmap

  • N-linked oligosaccharide analysis of rat brain Thy-1 by liquid chromatography with graphitized carbon column/ion trap-Fourier transform ion cyclotron resonance mass spectrometry in positive and negative ion modes 査読

    S Itoh, N Kawasaki, N Hashii, A Harazono, Y Matsuishi, T Hayakawa, T Kawanishi

    JOURNAL OF CHROMATOGRAPHY A   1103 ( 2 )   296 - 306   2006年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ELSEVIER SCIENCE BV  

    We have previously described the site-specific glycosylation analysis of rat brain Thy-1 by LC/multistage tandem mass spectrometry (MS') using proteinase-digested Thy-1. In the present study, detailed structures of oligosaccharides released from Thy-1 were elucidated by mass spectrometric oligosaccharide profiling using LC/MS with a graphitized carbon column (GCC-LC/MS). First, using model oligosaccharides, we improved the oligosaccharide profiling by ion trap mass spectrometry (IT-NIS) coupled with Fourier transform ion cyclotron resonance mass spectrometry (FT-ICR-MS). Sequential scanning of a full MSn scan with FT-ICR-MS followed by data-dependent MS' with IT-MS in positive ion mode, and a subsequent full MS1 scan with FT-ICR-MS followed by data-dependent MSn with IT-MS in negative ion mode enabled the monosaccharide composition analysis as well as profiling and sequencing of both neutral and acidic oligosaccharides in a single analysis. The improved oligosaccharide profiling was applied to elucidation of N-linked oligosaccharides from Thy-1 isolated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. It was demonstrated that Thy-1 possesses a significant variety of N-linked oligosaccharides, including Lewis a/x, Lewis b/y, and disialylated structure as a partial structure. Our method could be applicable to analysis of a small abundance of glycoproteins, and could become a powerful tool for glycoproteomics. (c) 2005 Elsevier B.V. All rights reserved.

    DOI: 10.1016/j.chroma.2005.11.043

    Web of Science

    researchmap

  • Glycomic/glycoproteomic analysis by liquid chromatography/mass spectrometry: analysis of glycan structural alteration in cells. 査読 国際誌

    Hashii N, Kawasaki N, Itoh S, Hyuga M, Kawanishi T, Hayakawa T

    Proteomics   5 ( 18 )   4665 - 4672   2005年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:18  

    DOI: 10.1002/pmic.200401330

    PubMed

    researchmap

  • LC/MSを用いたグライコーム解析 査読

    川崎 ナナ, 橋井 則貴, 伊藤 さつき, 原園 景, 川西 徹

    臨床化学   34 ( 4 )   309 - 318   2005年11月

     詳細を見る

  • Characterization of a gel-separated unknown glycoprotein by liquid chromatography/multistage tandem mass spectrometry - Analysis of rat brain Thy-1 separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis 査読

    S Itoh, N Kawasaki, A Harazono, N Hashii, Y Matsuishi, T Kawanishi, T Hayakawa

    JOURNAL OF CHROMATOGRAPHY A   1094 ( 1-2 )   105 - 117   2005年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ELSEVIER SCIENCE BV  

    We developed an efficient and convenient strategy for protein identification and glycosylation analysis of a small amount of unknown glycoprotein in a biological sample. The procedure involves isolation of proteins by electrophoresis and mass spectrometric peptide/glycopeptide mapping by LC/ion trap mass spectrometer. For the complete glycosylation analysis, proteins were extracted in intact form from the gel, and proteinase-digested glycoproteins were then subjected to LC/multistage tandem MS (MSn) incorporating a full mass scan, in-source collision-induced dissociation (CID), and data-dependent MSn. The glycopeptides were localized in the peptide/glycopeptide map by using oxonium ions such as HexNAc(+) and NeuAc(+), generated by in-source CID, and neutral loss by CID-MS/MS. We conducted the search analysis for the glycopeptide identification using search parameters containing a possible glycosylation at the Asn residue with N-acetylglucosamine (203 Da). We were able to identify the glycopeptides resulting from predictable digestion with proteinase. The glycopeptides caused by irregular cleavages were not identified by the database search analysis, but their elution positions were localized using oxonium ions produced by in-source CID, and neutral loss by the data-dependent MSn. Then, all glycopeptides could be identified based on the product ion spectra which were sorted from data-dependent CID-MSn spectra acquired around localized positions. Using this strategy, we successfully elucidated site-specific glycosylation of Thy-1, glycosylphosphatidylinositol (GPI)-anchored proteins glycosylated at Asn23, 74, and 98, and at Cys 111. High-mannose- type, complex-type, and hybrid-type oligosaccharides were all found to be attached to Asn23, 74 and 98. and four GPI structures could be characterized. Our method is simple, rapid and useful for the characterization of unknown glycoproteins in a complex mixture of proteins. (c) 2005 Elsevier B.V. All rights reserved.

    DOI: 10.1016/j.chroma.2005.07.100

    Web of Science

    researchmap

  • Mannan-binding protein blocks the activation of metalloproteases meprin α and β 査読

    Makoto Hirano, Bruce Yong Ma, Nana Kawasaki, Kazumichi Okimura, Makoto Baba, Tomoaki Nakagawa, Keiko Miwa, Nobuko Kawasaki, Shogo Oka, Toshisuke Kawasaki

    Journal of Immunology   175 ( 5 )   3177 - 3185   2005年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Mannan-binding protein (MBP) is a C-type serum lectin that is known to be a host defense factor involved in innate immunity, and recognizes mannose, fucose, and N-acetylglucosamine residues. Although some exogenous MBP ligands have been reported, little is known about its endogenous ligands. In the present study, we found that endogenous MBP ligands are highly expressed in the brush border epithelial cells of kidney-proximal tubules by immunohistochemistry, and both meprin α and β (meprins), as novel endogenous MBP ligands, have been identified through affinity chromatography and mass spectrometry. Meprins are membrane-bound and secreted zinc metalloproteases extensively glycosylated and highly expressed in kidney and small intestinal epithelial cells, leukocytes, and certain cancer cells. Meprins are capable of cleaving growth factors, extracellular matrix proteins, and biologically active peptides. Deglycosylation experiments indicated that the MBP ligands on meprins are high mannose- or complex-type N-glycans. The interaction of MBP with meprins resulted in significant decreases in the proteolytic activity and matrix-degrading ability of meprins. Our results suggest that core N-linked oligosaccharides on meprins are associated with the optimal enzymatic activity and that MBP is an important regulator for modulation of the localized meprin proteolytic activity via N-glycan binding. Because meprins are known to be some of the major matrix-degrading metalloproteases in the kidney and intestine, MBP, which functions as a natural and effective inhibitor of meprins, may contribute, as a potential therapeutic target, to tumor progression by facilitating the migration, intravasation, and metastasis of carcinoma cells, and to acute renal failure and inflammatory bowel diseases. Copyright © 2005 by The American Association of Immunologists, Inc.

    Scopus

    PubMed

    researchmap

  • A non-sulfated form of the HNK-1 carbohydrate is expressed in mouse kidney 査読

    Hideki Tagawa, Yasuhiko Kizuka, Tomoko Ikeda, Satsuki Itoh, Nana Kawasaki, Hidetake Kurihara, Maristela Lika Onozato, Akihiro Tojo, Tatsuo Sakai, Toshisuke Kawasaki, Shogo Oka

    Journal of Biological Chemistry   280 ( 25 )   23876 - 23883   2005年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    The HNK-1 carbohydrate, which is recognized by anti-HNK-1 antibody, is well known to be expressed predominantly in the nervous system. The characteristic structural feature of the HNK-1 carbohydrate is 3-sulfoglucuronyl residues attached to lactosamine structures (Galβ1-4GlcNAc) on glycoproteins and glycolipids. The biosynthesis of the HNK-1 carbohydrate is regulated mainly by two glucuronyltransferases (GlcAT-P and GlcAT-S) and a sulfotransferase. In this study, we found that GlcAT-S mRNA was expressed at higher levels in the kidney than in the brain, but that both GlcAT-P and HNK-1 sulfotransferase mRNAs, which were expressed at high levels in the brain, were not detected in the kidney. These results suggested that the HNK-1 carbohydrate without sulfate (non-sulfated HNK-1 carbohydrate) is expressed in the kidney. We substantiated this hypothesis using two different monoclonal antibodies: one (anti-HNK-1 antibody) requires sulfate on glucuronyl residues for its binding, and the other (antibody M6749) does not. Western blot analyses of mouse kidney revealed that two major bands (80 and 140 kDa) were detected with antibody M6749, but not with anti-HNK-1 antibody. The 80- and 140-kDa band materials were identified as meprin α and CD13/aminopeptidase N, respectively. We also confirmed the presence of the non-sulfated HNK-1 carbohydrate on N-linked oligosaccharides by multistage tandem mass spectrometry. Immunofluorescence staining with antibody M6749 revealed that the non-sulfated HNK-1 carbohydrate was expressed predominantly on the apical membranes of the proximal tubules in the cortex and was also detected in the thin ascending limb in the inner medulla. This is the first study indicating the presence of the non-sulfated HNK-1 carbohydrate being synthesized by GlcAT-S in the kidney. The results presented here constitute novel knowledge concerning the function of the HNK-1 carbohydrate. © 2005 by The American Society for Biochemistry and Molecular Biology, Inc.

    DOI: 10.1074/jbc.M501728200

    Scopus

    PubMed

    researchmap

  • Isotope tag method for quantitative analysis of carbohydrates by liquid chromatography-mass spectrometry 査読

    J Yuan, N Hashii, N Kawasaki, S Itoh, T Kawanishi, T Hayakawa

    JOURNAL OF CHROMATOGRAPHY A   1067 ( 1-2 )   145 - 152   2005年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ELSEVIER SCIENCE BV  

    We have previously demonstrated that liquid chromatography/mass spectrometry equipped with a graphitized carbon column (GCCLC/MS) is useful for the structural analysis of carbohydrates in a glycoprotein. Here, we studied the monosaccharide composition analysis and quantitative oligosaccharide profiling by GCC-LC/MS. Monosaccharides were labeled with 2-aminopyridine and then separated and monitored by GCC-LC/MS in the selective ion mode. The use of tetradeuterium-labeled pyridylamino (d(4)-PA) monosaccharides as internal standards, which were prepared by the tagging of standard monosaccharides with hexadeuterium-labeled 2-aminopyridine (d(6)-AP), afforded a good linearity and reproducibility in ESIMS analysis. This method was successfully applied to the monosaccharide composition analysis of model glycoproteins, fetuin, and erythropoietin. For quantitative oligosaccharide profiling, oligosaccharides released from an analyte and a standard glycoprotein were tagged with do- and d(6)-AP, respectively, and an equal amount of do- and d(4)-PA oligosaccharides were coinjected into GCC-LC/MS. In this procedure, the oligosaccharides that existed in either analyte or a standard glycoprotein appeared as single ions, and the oligosaccharides that existed in both analyte and a standard glycoprotein were detected as paired ions. The relative amount of analyte oligosaccharides could be determined on the basis of the analyte/internal standard ion-pair intensity ratio. The quantitative oligosaccharide profiling enabled us to make a quantitative and qualitative comparison of glycosylation between the analyte and standard glycoproteins. The isotope tag method can be applicable for quality control and comparability assessment of glycoprotein products as well as the analysis of glycan alteration in some diseases. (c) 2004 Elsevier B.V. All rights reserved.

    DOI: 10.1016/j.chroma.2004.11.070

    Web of Science

    researchmap

  • Monosaccharide composition analysis of glycoproteins by isotope-tag method and capillary LC/ESI-MS 査読

    Jin Yuan, Nana Kawasaki, Noritaka Hashii, Satsuki Itoh, Toru Kawanishi, Takao Hayakawa

    Yaoxue Xuebao   40 ( 1 )   43 - 48   2005年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Aim: To develop a rapid and sensitive method for monosaccharide composition analysis. Methods: Glycoprotein was first hydrolyzed to monosaccharides, which were subsequently reacetylated (amino monosaccharides), tagged with 2-aminopyridine and then separated and monitored in selected ion mode by CapGCC-LC/MS. The use of tetradeuterium labeled-aminopyridyl-monosaccharides prepared by tagging monosacahrides with hexadeuterium labeled 2-aminopyridine as internal standards improved the linearity and reproducibility in quantification. Results: This method was successfully applied to monosaccharide composition analysis of model glycoproteins, fetuin and erythropoietin down to 1 pmol monosaccharides. Conclusion: This method has been shown to be highly sensitive and is applicable to monosaccharide composition analysis of glycoproteins.

    Scopus

    PubMed

    researchmap

  • Specific detection of Lewis x-carbohydrates in biological samples using liquid chromatography/multiple-stage tandem mass spectrometry 査読

    N Hashii, N Kawasaki, S Itoh, A Harazono, Y Matsuishi, T Hayakawa, T Kawanishi

    RAPID COMMUNICATIONS IN MASS SPECTROMETRY   19 ( 22 )   3315 - 3321   2005年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:JOHN WILEY & SONS LTD  

    The Lewis x structure [Le(x), Gal beta 1-4(Fuc alpha 1-3)GlcNAc] motif is one of the tumor antigens and plays an important role in oncogenesis, development, cellular differentiation and adhesion. The detection of Le(x)-carbohydrates and their structural analysis are necessary to clarify the role of Le(x) in several biological events. Mass spectrometry has been preferably used for the structural analysis of carbohydrates. Especially, collision-induced dissociation (CID) tandem mass spectrometry (MS/MS), which causes a glycosidic bond cleavage, is used for carbohydrate sequencing. However, Le(x) cannot be identified by MS/MS due to the existence of the positional isomers, such as Lewis a [Gal beta 1-3(alpha 1-4Fuc)GlcNAc]. In the present study, we demonstrate the specific detection of Lex-carbohydrates in a biological sample by using multiple-stage MS/MS (MS'). Using pyridylaminated oligosaccharides bearing Lex, we found that the Le(x)-motif yields a cross-ring fragment by the cleavage of a bond between C-3 and C-4 of GlcNAc in Gal(Fuc)GlcNAc. The Le(x)-specific cross-ring fragment ion at m/z 259 was effectively detected by sequential scans, consisting of a full MS' scan, data-dependent CID MS2 scan, MS3 of [Gal(Fuc)GlcNAc+Na](+) at m/z 534, and MS4 of [GalGlcNAc+Na](+) at m/z 388. The sequential scan was applied to N-linked oligosaccharide profiling using a LC/ESI-MSn system equipped with a graphitized carbon column. We successfully detected the Le(x)-motif and elucidated the structures of several Le(x) and Lewis y [(Fuc alpha 1-2)Gal beta 1-4(Fuc alpha 1-3)GlcNAc] oligosaccharides in the murine kidney used as a model tissue. Our method is expected to be a powerful tool for the specific detection of the Lex-motif, and structural elucidation of Le(x)-carbohydrates in biological samples. Copyright) 2005 John Wiley & Sons, Ltd.

    DOI: 10.1002/rcm.2190

    Web of Science

    researchmap

  • Site-specific glycosylation analysis of human apolipoprotein B100 using LC/ESI MS/MS 査読

    Akira Harazono, Nana Kawasaki, Toru Kawanishi, Takao Hayakawa

    Glycobiology   15 ( 5 )   447 - 462   2005年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Human apolipoprotein B100 (apoB100) has 19 potential N-glycosylation sites, and 16 asparagine residues were reported to be occupied by high-inannose type, hybrid type, and monoantennary and biantennary complex type oligosaccharides. In the present study, a site-specific glycosylation analysis of apoB100 was carried out using reversed-phase high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry (LC/ESI MS/ MS). ApoB100 was reduced, carboxymethylated, and then digested by trypsin or chymotrypsin. The complex mixture of peptides and glycopeptides was subjected to LC/ESI MS/ MS, where product ion spectra of the molecular ions were acquired data-dependently. The glycopeptide ions were extracted and confirmed by the presence of carbohydrate-specific fragment ions, such as mlz 204 (HexNAc) and 366 (HexHexNAc), in the product ion spectra. The peptide moiety of glycopeptide was determined by the presence of the b- and y-series ions derived from its amino acid sequence in the product ion spectrum, and the oligosaccharide moiety was deduced from the calculated molecular mass of the oligosaccharide. The heterogeneity of carbohydrate structures at 17 glycosylation sites was determined using this methodology. Our data showed that Asn2212, not previously identified as a site of glycosylation, could be glycosylated. It was also revealed that Asn158, 1341, 1350, 3309, and 3331 were occupied by high-mannose type oligosaccharides, and Asn 956, 1496, 2212, 2752, 2955, 3074, 3197, 3438, 3868, 4210, and 4404 were predominantly occupied by mono- or disialylated oligosaccharides. Asn3384, the nearest N-glycosylation site to the LDL-receptor binding site (amino acids 3359-3369), was occupied by a variety of oligosaccharides, including high-mannose, hybrid, and complex types. These results are useful for understanding the structure of LDL particles and oligosaccharide function in LDL-receptor ligand binding. © Oxford University Press 2004
    all rights reserved.

    DOI: 10.1093/glycob/cwi033

    Scopus

    PubMed

    researchmap

  • Kinetic analysis of pepsin digestion of chicken egg white ovomucoid and allergenic potential of pepsin fragments 査読

    Kayoko Takagi, Reiko Teshima, Haruyo Okunuki, Satsuki Itoh, Nana Kawasaki, Toru Kawanishi, Takao Hayakawa, Yoichi Kohno, Atsuo Urisu, Jun-Ichi Sawada

    International Archives of Allergy and Immunology   136 ( 1 )   23 - 32   2005年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Background: The allergenic potential of chicken egg white ovomucoid (OVM) is thought to depend on its stability to heat treatment and digestion. Pepsin-digested fragments have been speculated to continue to exert an allergenic potential. OVM was digested in simulated gastric fluid (SGF) to examine the reactivity of the resulting fragments to IgE in sera from allergic patients. Methods: OVM was digested in SGF and subjected to SDS-PAGE. The detected fragments were then subjected to N-terminal sequencing and liquid chromatography/mass spectrometry/mass spectrometry analysis to confirm the cleavage sites and partial amino acid sequences. The reactivity of the fragments to IgE antibodies in serum samples from patients allergic to egg white was then determined using Western blotting (n = 24). Results: The rate of OVM digestion depended on the pepsin/OVM ratio in the SGF. OVM was first cleaved near the end of the first domain, and the resulting fragments were then further digested into smaller fragments. In the Western blot analysis, 93% of the OVM-reactive sera also bound to the 23.5- to 28.5-kDa fragments, and 21% reacted with the smaller 7- and 4.5-kDa fragments. Conclusion: When the digestion of OVM in SGF was kinetically analyzed, 21% of the examined patients retained their IgE-binding capacity to the small 4.5-kDa fragment. Patients with a positive reaction to this small peptide fragment were thought to be unlikely to outgrow their egg white allergy. The combination of SGF-digestibility studies and human IgE-binding experiments seems to be useful for the elucidation and diagnosis of the allergenic potential of OVM. Copyright © 2005 S. Karger AG, Basel.

    DOI: 10.1159/000082581

    Scopus

    PubMed

    researchmap

  • Profiling analysis of oligosaccharides in antibody pharmaceuticals by capillary electrophoresis 査読

    Satoru Kamoda, Chie Nomura, Mitsuhiro Kinoshita, Saori Nishiura, Rika Ishikawa, Kazuaki Kakehi, Nana Kawasaki, Takao Hayakawa

    Journal of Chromatography A   1050 ( 2 )   211 - 216   2004年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Carbohydrate chains in glycoprotein pharmaceuticals have important roles for the expression of their biological activities. Therefore, development of an assessment method for the carbohydrate chains is an important parameter for quality control of glycoprotein pharmaceuticals such as newly developed therapeutic antibodies. In this report, we applied capillary electrophoresis with laser-induced fluorescence detection to the analysis of carbohydrate chains after releasing with glycoamidase followed by derivatization with 3-aminobenzoic acid. We found that four major oligosaccharides present in antibody pharmaceuticals were successfully separated with good resolution. The present method showed good precision in both migration times and relative peak areas, and gave comparable accuracy with that using a derivatization method with 8-aminopyrene-1,3,6-trisulfonate. © 2004 Elsevier B.V. All rights reserved.

    DOI: 10.1016/j.chroma.2004.08.049

    Scopus

    PubMed

    researchmap

  • Enhancement of hepatocyte growth factor-induced cell scattering in N-acetylglucosaminyltransferase III-transfected HepG2 cells 査読

    Masashi Hyuga, Sumiko Hyuga, Nana Kawasaki, Miyako Ohta, Satsuki Itoh, Shingo Niimi, Toru Kawanishi, Takao Hayakawa

    Biological and Pharmaceutical Bulletin   27 ( 6 )   781 - 785   2004年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    N-Acetylglucosaminyltransferase III (GnT-III), which catalyzes the synthesis of a bisecting GlcNAc residue of N-glycans, is thought to be involved in the function of glycoproteins such as growth factor receptors. We investigated the effects of the overexpression of GnT-III on the hepatocyte growth factor (HGF) receptor c-Met, a glycoprotein, in human hepatocarcinoma HepG2 cells. GnT-III activity was elevated about 250-fold in HepG2 cells stably transfected with the GnT-III gene, whereas no significant change in GnT-III activity was observed in mock transfectants. Cell scattering assay revealed that HGF-induced cell scattering was enhanced depending on the GnT-III activities in the GnT-III transfectants. Western blot analysis and E-PHA lectin blot analysis showed that the level of c-Met protein was the same in both transfectants
    however, the bisecting GlcNAc residue on c-Met was detected only in the GnT-III transfectants. Although the peak level of c-Met phosphorylation was not different in both transfectants, the level of tyrosine phosphorylation of c-Met decreased more rapidly in the GnT-III transfectants than in the mock transfectants. Furthermore, HGF-induced extracellular-regulated kinase (ERK) phosphorylation was slightly higher in the GnT-III transfectants than in the mock transfectants. These results show that overexpression of GnT-III in HepG2 cells enhances HGF-induced cell scattering, which may result from, at least in part, enhancement of HGF-induced ERK phosphorylation. © 2004 Pharmaceutical Society of Japan.

    DOI: 10.1248/bpb.27.781

    Scopus

    PubMed

    researchmap

  • Analysis of site-specific glycosylation in recombinant human follistatin expressed in Chinese hamster ovary cells 査読

    Masashi Hyuga, Satsuki Itoh, Nana Kawasaki, Miyako Ohta, Akiko Ishii, Sumiko Hyuga, Takao Hayakawa

    Biologicals   32 ( 2 )   70 - 77   2004年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Follistatin (FS), a glycoprotein, plays an important role in cell growth and differentiation through the neutralization of the biological activities of activins. In this study, we analyzed the glycosylation of recombinant human FS (rhFS) produced in Chinese hamster ovary cells. The results of SDS-PAGE and MALDI-TOF MS revealed the presence of both non-glycosylated and glycosylated forms. FS contains two potential N-glycosylation sites, Asn95 and Asn259. Using mass spectrometric peptide/glycopeptide mapping and precursor-ion scanning, we found that both N-glycosylation sites were partially glycosylated. Monosaccharide composition analyses suggested the linkages of fucosylated bi- and triantennary complex-type oligosaccharides on rhFS. This finding was supported by mass spectrometric oligosaccharide profiling, in which the m/z values and elution times of some of the oligosaccharides from rhFS were in good agreement with those of standard oligosaccharides. Site-specific glycosylation was deduced on the basis of the mass spectra of the glycopeptides. It was suggested that biantennary oligosaccharides are major oligosaccharides located at both Asn95 and Asn259, whereas the triantennary structures are present mainly at Asn95. © 2004 The International Association for Biologicals. Published by Elsevier Ltd. All rights reserved.

    DOI: 10.1016/j.biologicals.2004.04.001

    Scopus

    PubMed

    researchmap

  • LC/MSを用いた糖鎖プロファイリングによるグライコーム解析 査読

    川崎 ナナ, 橋井 則貴, 伊藤 さつき, 日向 昌司, 川西 徹, 早川 堯夫

    生物物理化学 = Journal of Electrophoresis   48 ( 1 )   5 - 10   2004年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本電気泳動学会  

    CiNii Books

    researchmap

    その他リンク: http://search.jamas.or.jp/link/ui/2005215652

  • Analyses of glycopeptides and glycoproteins by liquid chromatography-mass spectrometry and liquid chromatography-tandem mass spectrometry.

    Nana Kawasaki, Miyako Ohta, Satsuki Itoh, Takao Hayakawa

    Methods in molecular biology (Clifton, N.J.)   251   263 - 274   2004年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Scopus

    PubMed

    researchmap

  • Microanalysis of N-linked oligosaccharides in a glycoprotein by capillary liquid chromatography/mass spectrometry and liquid chromatography/tandem mass spectrometry 査読

    Nana Kawasaki, Satsuki Itoh, Miyako Ohta, Takao Hayakawa

    Analytical Biochemistry   316 ( 1 )   15 - 22   2003年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Academic Press Inc.  

    We have studied rapid and simple sugar mapping using liquid chromatography/electrospray ionization mass spectrometry (LC/MS) equipped with a graphitized carbon column. The oligosaccharide mixture was separated on the basis of the sequence, branching structure, and linkage, and each oligosaccharide was characterized based on its molecular mass. In this study we demonstrated the usefulness of capillary LC/MS (CapLC/MS) and capillary liquid chromatography/tandem mass spectrometry (CapLC/MS/MS) as sensitive means for accomplishing the structural analysis of oligosaccharides in a low-abundance glycoprotein. The carbohydrate heterogeneity and molecular mass information of each oligosaccharide can be readily obtained from CapLC/MS of a small amount of glycoprotein. CapLC/MS/MS provided b-ion series, which is informative with regard to monosaccharide sequence. Exoglycosidase digestion followed by CapLC/MS elucidated a carbohydrate residue linkage. Using this method, we characterized N-linked oligosaccharides in hepatocyte growth factor produced in mouse myeloma NS0 cells as the complex-type bi-, tri-, and tetraantennary terminated with N-glycolylneuraminic acids and α-linked galactose residues. Sugar mapping with CapLC/MS and CapLC/MS/MS is useful for monitoring glycosylation patterns and for structural analysis of carbohydrates in a low-abundance glycoprotein and thus will become a powerful tool in biological, pharmaceutical, and clinical studies. © 2003 Elsevier Science (USA). All rights reserved.

    DOI: 10.1016/S0003-2697(03)00031-9

    Scopus

    PubMed

    researchmap

  • Detection of replication-competent adenoviruses spiked into recombinant adenovirus vector products by infectivity PCR 査読

    Akiko Ishii-Watabe, Eriko Uchida, Akiko Iwata, Ryuji Nagata, Kouei Satoh, Kejun Fan, Mitsuhiro Murata, Hiroyuki Mizuguchi, Nana Kawasaki, Toru Kawanishi, Teruhide Yamaguchi, Takao Hayakawa

    Molecular Therapy   8 ( 6 )   1009 - 1016   2003年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Academic Press Inc.  

    The presence of replication-competent adenovirus (RCA) in clinical lots of adenovirus vectors raises a variety of safety concerns. To detect RCA in adenovirus vector products, the cell culture/cytopathic effect (CPE) method has generally been preferred. However, it is difficult to evaluate the amount of RCA clearly and quantitatively by this method. In addition, the cell culture/CPE method requires large-scale cell culturing and a substantial amount of time. For the purpose of establishing a method to detect RCA more sensitively and rapidly, we developed the infectivity PCR, a hybrid method that combines the infectivity assay and quantitative PCR. This method allows RCA to be quantified by real-time quantitative PCR using primers and a probe designed for E1 DNA. By infectivity PCR, 1 pfu of RCA spiked into 109 particles of adenovirus vectors could be detected. In contrast, CPE was observed in the cells infected with 104 pfu of RCA spiked into 109 particles of adenovirus vectors. The glass-beads method was suitable for extracting DNA rapidly from the RCA-infected cells. These results showed that infectivity PCR combined with the glass-beads-based DNA extraction method was useful for the detection of RCA in adenovirus vector products.

    DOI: 10.1016/j.ymthe.2003.09.001

    Scopus

    PubMed

    researchmap

  • Structural analysis of a glycoprotein by liquid chromatography-mass spectrometry and liquid chromatography with tandem mass spectrometry - Application to recombinant human thrombomodulin 査読

    Satsuki Itoh, Nana Kawasaki, Miyako Ohta, Takao Hayakawa

    Journal of Chromatography A   978 ( 1-2 )   141 - 152   2002年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Using recombinant human thrombomodulin (rhTM) expressed in Chinese hamster ovary (CHO) cells, we studied the structural analysis of a glycoprotein by liquid chromatography-mass spectrometry (LC-MS) and liquid chromatography with tandem mass spectrometry (LC-MS-MS). First, we analyzed the structure of both the O- and N-linked glycans in rhTM by oligosaccharide mapping using LC-MS equipped with a graphitized carbon column (GCC-LC-MS). Major O- and N-linked glycans were determined to be core 1 structure and fucosyl biantennary containing NeuAc0-2, respectively. Next, the post-translational modifications and their heterogeneities, including the site-specific glycosylation, were analyzed by mass spectrometric peptide/glycopeptide mapping of trypsin-digested rhTM and precursor-ion scanning. Precursor-ion scanning was successful in the detection of five glycopeptides. Four N-glycosylation sites and their site-specific carbohydrate heterogeneity were determined by their mass spectra. O-Glycosylation could be estimated on the basis of its mass spectrum. We were able to identify partial β-hydroxylation on Asn324 and Asn439, and O-linked glucose on Ser287 from the peptide/glycopeptide map and their mass spectra. We demonstrated that a sequential analysis of LC-MS and LC-MS-MS are very useful for the structural analysis of O- and N-linked glycans, polypeptides, and post-translational modifications and their heterogeneities, including site-specific glycosylation in a glycoprotein. Our method can be applied to a glycoprotein in biological samples. © 2002 Elsevier Science B.V. All rights reserved.

    DOI: 10.1016/S0021-9673(02)01423-1

    Scopus

    PubMed

    researchmap

  • Simultaneous microanalysis of N-linked oligosaccharides in a glycoprotein using microbore graphitized carbon column liquid chromatography-mass spectrometry 査読

    Satsuki Itoh, Nana Kawasaki, Miyako Ohta, Masashi Hyuga, Sumiko Hyuga, Takao Hayakawa

    Journal of Chromatography A   968 ( 1-2 )   89 - 100   2002年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    We previously reported that graphitized carbon column liquid chromatography-mass spectrometry (GCC-LC-MS) is very useful for the structural analysis of carbohydrates in a glycoprotein. In this study, GCC-LC-MS was adapted for the simultaneous microanalysis of oligosaccharides. A variety of oligosaccharide alditols prepared from fetuin, ribonuclease B, and recombinant human erythropoietin were used as model oligosaccharides. The use of microbore GCC-LC-MS was found to be successful for rapid, sensitive, and simultaneous analysis of high-mannose-type, desialylated fucosyl complex-type, sialylated complex-type, and sialylated fucosyl complex-type oligosaccharide alditols. Furthermore, we demonstrate that this method is applicable to the analysis of carbohydrate heterogeneity in a glycoprotein that possesses diverse oligosaccharides. Microbore GCC-LC-MS was able to characterize high-mannose-type, hybrid-type, and complex-type oligosaccharides in tissue plasminogen activator produced from human melanoma cells in a single analysis. © 2002 Elsevier Science B.V. All rights reserved.

    DOI: 10.1016/S0021-9673(02)00951-2

    Scopus

    PubMed

    researchmap

  • Simultaneous microanaly of N-binked oligosaccharides in a glycoprotein using microbore cardon column LO/MS 査読

    J.Chromatogr. A   2002年

     詳細を見る

  • Usefulness of glycopeptide mapping by liquid chromatography/mass spectrometry in comparability assessment of glycoprotein products 査読

    Miyako Ohta, Nana Kawasaki, Satsuki Itoh, Takao Hayakawa

    Biologicals   30 ( 3 )   235 - 244   2002年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Academic Press  

    We previously reported on glycopeptide mapping of erythropoietin (EPO) by liquid chromatography/mass spectrometry (LC/MS). Using this method, glycopeptides in proteolytic digestion can be eluted before peptides, and are further separated on the basis of the carbohydrate structure. The detailed glycosylation at each glycosylation site can be elucidated based on mass chromatography and mass spectroscopy. In this study, we evaluated glycopeptide mapping with regard to its use in comparability assessment of glycoprotein products possessing multiple glycosylation sites. Models of closely related glycoprotein products used in this study are EPOs produced from three different sources. We previously reported that there are differences in the carbohydrate heterogeneity of these EPOs with regard to sialylation, acetylation, and sulphation patterns, using sugar mapping by LC/MS. In this paper, we demonstrated that glycopeptide mapping can distinguish site-specific glycosylation among these three EPOs and reveal the differences in acetylation, sialylation, and sulphation at each glycosylation site in one analysis. Our method can thus be useful in comparability assessment of therapeutic glycoproteins in terms of glycosylation. © 2002 The International Association for Biologicals. Published by Elsevier Science Ltd. All rights reserved.

    DOI: 10.1006/biol.2002.0339

    Scopus

    PubMed

    researchmap

  • Usefulness of sugar mapping by liquid chromatography/mass spectrometry in comparability assessments of glycoprotein products 査読

    Nana Kawasaki, Miyako Ohta, Satsuki Itoh, Masashi Hyuga, Sumiko Hyuga, Takao Hayakawa

    Biologicals   30 ( 2 )   113 - 123   2002年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Academic Press  

    We have previously reported that sugar-mapping by liquid chromatography/mass spectrometry (LC/MS) equipped with a graphitized carbon column (GCC) can be useful for structural analysis of carbohydrates in a glycoprotein. In this paper, we evaluated sugar-mapping with regard to its use in comparability assessment of glycoprotein products. Erythropoietins (EPO) produced from three different sources were chosen as models of the closely related glycoprotein products. The two-dimensional displays of sugar maps drawn by LC/MS with GCC clearly showed the differences in carbohydrate heterogeneity with regard to sialylation, acetylation, and sulphation patterns among three EPOs. Exoglycosidase digestion followed by sugar-mapping provided information regarding the structure of characteristic carbohydrates in each EPO. These results demonstrate that LC/MS with GCC can reveal the details of carbohydrate heterogeneity in order to distinguish between closely related glycoprotein products. Our method can thus be useful in comparability assessments of therapeutic glycoproteins. © 2002 The International Association for Biologicals. Published by Elsevier Science Ltd. All rights reserved.

    DOI: 10.1006/biol.2002.0324

    Scopus

    PubMed

    researchmap

  • Study on evaluating methods for the quality control of glycoprotein products. (IV) - Erythropoietin products. Part 4 査読

    Miyako Ohta, Nana Kawasaki, Satsuki Itoh, Takao Hayakawa

    Bulletin of National Institute of Health Sciences   ( 120 )   89 - 97   2002年

     詳細を見る

    記述言語:日本語   掲載種別:研究論文(学術雑誌)  

    We have previously reported on peptide mapping of recombinant human erythropoietin (rhEPO) by liquid chromatography/mass spectrometry (LC/MS). Using this method, both peptides and glycosylation at each glycosylation site can be elucidated based on the mass chromatogram and mass spectrum. In this study, we evaluated the mass spectrometric peptide mapping with regard to its use in comparability assessment of both protein parts and carbohydrates parts in glycoprotein products. Models of closely related glycoprotein products used in this study are rhEPOs produced from three different sources. We demonstrated that the mass spectrometric peptide mapping can elucidate the identity of protein part, and differences in site-specific carbohydrates heterogeneity due to acetylation and sulfation among the three rhEPOs. Our method can thus be useful in comparability assessment of therapeutic glycoproteins.

    Scopus

    PubMed

    researchmap

  • Structural analysis of a glycoprotein by LC/MS and LC/MS/MS.Application to recombinant human thrompomodulin 査読

    J.Chromatogr.A   2002年

     詳細を見る

  • Structural analysis of sulfated N-linked oligosaccharides in erythropoietin 査読

    N Kawasaki, Y Haishima, M Ohta, S Itoh, M Hyuga, S Hyuga, T Hayakawa

    GLYCOBIOLOGY   11 ( 12 )   1043 - 1049   2001年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:OXFORD UNIV PRESS INC  

    We previously demonstrated that high-performance liquid chromatography with electrospray ionization mass spectrometry (LC/MS) equipped with a graphitized carbon column (GCC) is useful for the structural analysis of carbohydrates in glycoproteins. Using LC/MS with GCC, sulfated N-linked oligosaccharides were found in erythropoietin (EPO) expressed in baby hamster kidney cells. Sulfation occurs in a part of the N-linked oligosaccharides in the EPO. Sulfated monosaccharide residue in the sulfated N-linked oligosaccharide was determined by exoglycosidase digestion followed by sugar mapping by LC/MS. The linkage position and branch-location of the sulfate group in the tetraantennary oligosaccharide were analyzed by H-1-nuclear magnetic resonance. It was suggested that sulfation occurs on the C-6 position of GlcNAc located in the GlcNAcbeta1-4Manalpha1-3 branch.

    DOI: 10.1093/glycob/11.12.1043

    Web of Science

    researchmap

  • Ganglioside GD1a inhibits HGF-induced motility and scattering of cancer cells through suppression of tyrosine phosphorylation of c-Met 査読

    Sumiko Hyuga, Nana Kawasaki, Masashi Hyuga, Miyako Ohta, Rie Shibayama, Toru Kawanishi, Sadako Yamagata, Tatsuya Yamagata, Takao Hayakawa

    International Journal of Cancer   94 ( 3 )   328 - 334   2001年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    We previously reported that ganglioside GD1a, which is highly expressed in poorly metastatic FBJ-S1 cells, inhibits the serum-induced motility of FBJ-LL cells and that the metastatic potential of FBJ-LL cells is completely suppressed by enforced GD1a expression (Hyuga et al., Int J Cancer 1999
    83:685-91). We recently discovered that hepatocyte growth factor (HGF) induces FBJ-LL cell motility. In the present study, the HGF-induced motility of FBJ-S1 cells was found to be one-thirtieth that of FBJ-LL cells. This motility of GD1a-expressing transfectants, which were produced by transfection of FBJ-LL cells with GM2/GD2 synthase cDNA, decreased with increases in their GD1a expression and HGF induced almost no motility in GD1a-pretreated FBJ-LL cells, indicating that GD1a inhibits the HGF-induced motility of FBJ-LL cells. The expression of the HGF receptor c-Met on FBJ-S1 cells, FBJ-LL cells, transfectants and a mock-transfectant was almost the same. The level of tyrosine phosphorylation of c-Met after HGF stimulation in FBJ-S1 cells, GD1a-pretreated FBJ-LL cells and a GD1a-expressing transfectant was significantly lower than in FBJ-LL cells and a mock-transfectant. These findings suggested that GD1a inhibits the HGF-induced motility of FBJ-LL cells through suppression of tyrosine phosphorylation of c-Met. HepG2 cells, a human hepatoma cell line, were used to investigate whether GD1a interferes with other cancer cells expressing c-Met. HepG2 cells did not express GD1a. HGF induced cell scattering of HepG2 cells and the scattering was inhibited by pretreating the cells with GD1a. The c-Met in the cells was autophosphorylated by stimulation with HGF, but after treating the cells with GD1a, the HGF-induced autophosphorylation of c-Met was suppressed. These results suggest that GD1a acts as a negative regulator of c-Met in cancer cells. © 2001 Wiley-Liss, Inc.

    DOI: 10.1002/ijc.1481

    Scopus

    PubMed

    researchmap

  • Selective glycopeptide mapping of erythropoietin by on-line high-performance liquid chromatography-electrospray ionization mass spectrometry 査読

    Miyako Ohta, Nana Kawasaki, Sumiko Hyuga, Masashi Hyuga, Takao Hayakawa

    Journal of Chromatography A   910 ( 1 )   1 - 11   2001年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Selective glycopeptide mapping of recombinant human erythropoietin (rhEPO) used as a model glycoprotein was successfully carried out by on-line high-performance liquid chromatography-electrospray ionization mass spectrometry (LC-ESI-MS) using a Vydac C18 column eluted in acetonitrile-1 mM ammonium acetate, pH 6.8. rhEPO expressed in a Chinese hamster ovary clone was exhaustively digested into four glycopeptides and nine peptides with endoproteinase Glu-C. Both glycopeptides and peptides were eluted with trifluoroacetic acid as the eluent, whereas only glycopeptides were eluted selectively with ammonium acetate in the following order: N38, N24, O126, and N83. Furthermore, many glycoforms included in each glycopeptide were found to be separated by differences in the numbers of sialic acid and N-acetyllactosaminyl repeats. Twenty, 16 and 22 different N-linked oligosaccharides were determined at Asn24, 38, and 83, respectively, and two different O-linked oligosaccharides were observed at Ser126. Our method is simple, rapid, and useful for determining the carbohydrate structures at each glycosylation site and for elucidating the site-specific carbohydrate heterogeneity. © 2001 Elsevier Science B.V.

    DOI: 10.1016/S0021-9673(00)01116-X

    Scopus

    PubMed

    researchmap

  • Application of liquid chromatography/mass spectrometry and liquid chromatography with tandem mass spectrometry to the analysis of the site-specific carbohydrate heterogeneity in erythropoietin 査読

    Nana Kawasaki, Miyako Ohta, Sumiko Hyuga, Masashi Hyuga, Takao Hayakawa

    Analytical Biochemistry   285 ( 1 )   82 - 91   2000年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Academic Press Inc.  

    High-performance liquid chromatography with electrospray ionization mass spectrometry (LC/MS) and liquid chromatography with tandem mass spectrometry (LC/MS/MS) were applied to the analysis of the site-specific carbohydrate heterogeneity in erythropoietin (EPO) used as a model of the sialylated glycoprotein. N-linked oligosaccharides were released from recombinant human EPO expressed in Chinese hamster ovary cells enzymatically and reduced with NaBH4. Many different sialylated oligosaccharides of EPO were separated and characterized by LC/MS equipped with a graphitized carbon column (GCC). Glycosylation sites and the preliminary glycosylation pattern at each glycosylation site were determined by LC/MS of endoproteinase Glu-C-digested EPO. The detailed site-specific carbohydrate heterogeneity caused by the differences in the molecular weight, branch, linkage, and sequence was elucidated by GCC-LC/MS of the N-linked oligosaccharides released from the isolated glycopeptides. Structural details of the isomers were analyzed by LC/MS/MS, and it was indicated that di- and trisialylated tetraantennary oligosaccharides are attached to Asn24, 38, and 83, whereas their isomers, di- and trisialylated triantennary oligosaccharides containing N-acetyllactosamines, are combined with Asn24. Our method is useful for the determination of glycosylation sites, the site-specific carbohydrate heterogeneity of glycoproteins, and the carbohydrate structure. (C) 2000 Academic Press.

    DOI: 10.1006/abio.2000.4739

    Scopus

    PubMed

    researchmap

  • Crocus sativus lectin recognizes Man3GlcNAc in the N-glycan core structure 査読

    Yasuo Oda, Katsuyoshi Nakayama, Badarulhisam Abdul-Rahman, Mitsuhiro Kinoshita, Osamu Hashimoto, Nana Kawasaki, Takao Hayakawa, Kazuaki Kakehi, Noboru Tomiya, Yuan C. Lee

    Journal of Biological Chemistry   275 ( 35 )   26772 - 26779   2000年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Crocus sativus lectin (CSL) is one of the truly mannose-specific plant lectins that has a unique binding specificity that sets it apart from others. We studied sugar-binding specificity of CSL in detail by a solution phase method (fluorescence polarization) and three solid phase methods (flow injection, surface plasmon resonance, and microtiter plate), using a number of different glycopeptides and oligosaccharides. CSL binds the branched mannotriose structure in the N-glycan core. Substitution of the terminal Man in the Manα(1-3)Man branch with GlcNAc drastically decreases binding affinity much more than masking of the terminal Man in the Manα(1-6)Man branch. Most interestingly, the β-Man-linked GlcNAc in N-glycan core structure contributes greatly to the binding. The effect of this GlcNAc is so strong that it can substantially offset the negative effect of substitution on the nonreducing terminal Man residues. On the other hand, the GlcNAc that is usually attached to Asn in N-glycans and the L-Fuc linked at the 6-position of the GlcNAc are irrelevant to the binding. A bisecting GlcNAc neither contributes to nor interferes with the binding. This unique binding specificity of CSL offers many possibilities of its use in analytical and preparative applications.

    DOI: 10.1074/jbc.M003765200

    Scopus

    PubMed

    researchmap

  • Difference between follistatin isoforms in the inhibition of activin signalling: Activin neutralizing activity of follistatin isoforms is dependent on their affinity for activin 査読

    Osamu Hashimoto, Nana Kawasaki, Kunihiro Tsuchida, Shunichi Shimasaki, Takao Hayakawa, Hiromu Sugino

    Cellular Signalling   12 ( 8 )   565 - 571   2000年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    We demonstrate the difference between the follistatin isoforms (FS-288 and FS-315), two activin-binding proteins, in the neutralizing activity for activin signalling. Transcriptional reporter assay using 3TP-Lux, an activin- responsive reporter construct, showed that the inhibitory effect of FS-288 on activin-induced transcriptional response is more potent than that of FS-315. The potency was not influenced by the presence of heparan sulfates, by which FS, in particular FS-288, associates with cell surfaces at a high affinity. Furthermore, FS-288 inhibited the binding of activin to its type II receptor more markedly than did FS-315, as evidenced by surface plasmon resonance and affinity cross-linking experiments. Moreover, the Kd of FS-288 and FS-315 for activin A was estimated to be 46.5 ± 0.37 pM and 432 ± 26 pM, respectively, by surface plasmon resonance experiments. These results indicate that the different potency between the two FS isoforms in the inhibition of activin activities depends on their affinity for activin A. (C) 2000 Elsevier Science Inc.

    DOI: 10.1016/S0898-6568(00)00099-1

    Scopus

    PubMed

    researchmap

  • Possible role of hepatocyte growth factor/scatter factor and activin A produced by the target organ in liver metastasis 査読

    Sumiko Hyuga, Nana Kawasaki, Osamu Hashimoto, Masashi Hyuga, Miyako Ohta, Sadako Yamagata, Tatsuya Yamagata, Takao Hayakawa

    Cancer Letters   153 ( 1-2 )   137 - 143   2000年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    The molecular mechanism of organ-specific metastasis to the liver remains largely unknown. However, it is conceivable that paracrine growth factors produced by a target organ induce migration and proliferation of malignant cells to that organ, and this is the cause of organ-specific metastasis. In this study, we investigated the effect of hepatocyte growth factor/scatter factor (HGF/SF) and activin A, which are known to be produced by the liver, on the motility and growth of liver-metastatic cell line FBJ-LL. HGF/SF and activin A induced motility synergistically, but they did not affect the proliferation of FBJ-LL cells. Expression of the HGF/SF receptor, the c-met gene, and the activin-receptor type IA, type IB, and type IIA genes in FBJ-LL cells was detected by reverse transcription polymerase chain reaction. These findings suggest that both HGF/SF and activin A promote organ-specific metastasis to the liver by induction of migration through their specific receptors on liver-metastatic cells. Copyright (C) 2000 Elsevier Science Ireland Ltd.

    DOI: 10.1016/S0304-3835(00)00360-8

    Scopus

    PubMed

    researchmap

  • Comparative studies on the analysis of glycosylation heterogeneity of sialic acid-containing glycoproteins using capillary electrophoresis 査読

    Mitsuhiro Kinoshita, Etsuko Murakami, Yasuo Oda, Tadashi Funakubo, Daisuke Kawakami, Kazuaki Kakehi, Nana Kawasaki, Kazushige Morimoto, Takao Hayakawa

    Journal of Chromatography A   866 ( 2 )   261 - 271   2000年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Comparative studies concerning glycoform analysis of sialoglycoproteins by capillary electrophoresis were performed using a few separation modes hitherto reported. Glycoprotein samples examined in the present study were successfully separated to their respective glycoforms using surface-modified capillaries commercially available for capillary gas chromatography in the running buffer near their isoelectric points. The analysis times were less than 50 min and reproducibilities in migration times were excellent (less than 2.0% RSD for both run-to-run and day-to-day analyses). We present a method for the glycoform analysis of α1-acid glycoprotein in sera by simple pre-treatment as an application. The present technique will become one of the general methods for the evaluation of glycosylation heterogeneity of commercially available glycoprotein drugs. Copyright (C) 2000 Elsevier Science B.V.

    DOI: 10.1016/S0021-9673(99)01080-8

    Scopus

    PubMed

    researchmap

  • Application of LC/MS and LC/MS/MS to the analysis of the site-specific carbohydrate heterogeneity in erythropoietin 査読

    Anal. Biochem.   2000年

     詳細を見る

  • Fluorometric determination of aminopolycarboxylates using fluo-3

    N Kawasaki, YC Lee, O Hashimoto, M Yamamoto, T Kawanishi, T Hayakawa

    ANALYTICAL BIOCHEMISTRY   270 ( 2 )   329 - 331   1999年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ACADEMIC PRESS INC  

    DOI: 10.1006/abio.1999.4077

    Web of Science

    PubMed

    researchmap

  • Analysis of carbohydrate heterogeneity in a glycoprotein using liquid chromatography/mass spectrometry and liquid chromatography with tandem mass spectrometry 査読

    Nana Kawasaki, Miyako Ohta, Sumiko Hyuga, Osamu Hashimoto, Takao Hayakawa

    Analytical Biochemistry   269 ( 2 )   297 - 303   1999年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Academic Press Inc.  

    High-performance liquid chromatography with online electrospray ionization mass spectrometry (ESI-LC/MS) was investigated for the analysis of carbohydrate heterogeneity using RNase B as a model glycoprotein. Oligosaccharides released from RNase B with endoglycosidase H were reduced and separated on a graphitized carbon column (GCC). GCC-HPLC/MS in the positive-ion mode was successful in the identification of one Man5GlcNAc, three Man6GlcNAc, three Man7GlcNAc, three Man8GlcNAc, one Man9GlcNAc, and an oligosaccharide having six hexose units (Hex) and two N-acetylhexosamine units (HexNAc). The branch structures of the three Man7GlcNAc isomers were determined by liquid chromatography with tandem mass spectrometry (LC/MS/MS). LC/MS/MS analysis was shown to be useful for the detection and identification of a trace amount of Hex6HexNAc2 alditol as a hybrid-type oligosaceharide. Its structure was confirmed by the combination of LC/MS with enzymatic digestion using β-galactosidase and N-acetyl-β-glucosaminidase. The relative quantities of high-mannose-type oligosaccharides in RNase B detected by ESI-LC/MS are in reasonable agreement with those by UV, high-pH anion- exchange chromatography with pulsed amperometric detection, fluorophore- assisted carbohydrate electrophoresis. Our results indicate that LC/MS and LC/MS/MS can be utilized to elucidate the distribution of oligosaccharides and their structures, which differ in molecular weight, sugar sequence, and branch structure.

    DOI: 10.1006/abio.1999.4026

    Scopus

    PubMed

    researchmap

  • Analysis of carbohydrate heterogeneity in a glycoprotein using LC/MS and LC/MS/MS 査読

    Anal. Biochem.   1999年

     詳細を見る

  • ヘルパーT細胞(Th1,Th2)表面のN-結合型糖鎖のFACE法による解析

    前田 希, 小菅 崇, 豊島 聡, 田村 敏生, 成内 秀雄, 川崎 ナナ, 森本 和滋, 早川 尭夫

    日本薬学会年会要旨集   118年会 ( 3 )   57 - 57   1998年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本薬学会  

    researchmap

  • Control of hemoglobin synthesis in erythroid differentiating K562 cells. II. Studies of iron mobilization in erythroid cells by high-performance liquid chromatography-electrochemical detection 査読

    Nana Kawasaki, Kazushige Morimoto, Takao Hayakawa

    Journal of Chromatography B: Biomedical Applications   705 ( 2 )   193 - 201   1998年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Elsevier  

    We have demonstrated that iron controls hemoglobin (Hb) synthesis in erythroid differentiating K562 cells by enhancing the activity of a key enzyme of the Hb synthesis, δ-aminolevulinate synthase (ALAS). In the present study, we studied iron mobilization and the role of iron in erythroid differentiating cells by measuring the level of iron by means of high-performance liquid chromatography using electrochemical detection (HPLC-ED). After treatment of K562 cells with sodium butyrate, the expression of transferrin receptor (TfR) increased initially, followed by an increase in the levels of both total iron and Hb as well as the ALAS activity. However, no increase could be found in the levels of non-heme iron, low-molecular-mass iron (LMMFe) and ferritin. Addition of diferric transferrin (FeTf) enhanced both δ-aminolevulinic acid (ALA) and Hb synthesis. In contrast, addition of hemin elevated the levels of all iron species as well as the Hb synthesis but reduced the TfR expression and ALA contents in both butyrate treated and untreated cells. These results suggest that Hb synthesis is controlled by TfR expression, and that the ALA synthesis is suppressed by iron released from heme and/or Hb due to lowered expression of TfR.

    DOI: 10.1016/S0378-4347(97)00511-2

    Scopus

    PubMed

    researchmap

  • Quantum-dye labeled proteins for glycobiology: A viable nonradioactive alternative tracer 査読

    Yuan C. Lee, Nana Kawasaki, Reiko T. Lee, Noriko Suzuki

    Glycobiology   8 ( 9 )   849 - 856   1998年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Oxford University Press  

    Quantum dye (QD), a macrocyclic europium-chelate, developed as a cytological marker, has never been used for quantitative applications. It would be ideal, however, if the same tracer can be used for both qualitative and quantitative purposes. We have labeled some lectins and neoglycoproteins with QD for the purpose of quantitative analyses in glycobiology: and tested its suitability in three different areas in glycobiology: (1) glycosyltransferase, (2) an animal lectin mannose-binding protein, and (3) the Gal/GalNAc receptor of rat liver membrane. Usefulness of QD-labeled lectins was amply demonstrated by the quantification of galactosyltransferase activity using QD-soybean agglutinin and QD-RCA120 (Ricinus communis agglutinin). We also showed that QD-labeled neoglycoproteins, QD-Man-BSA and QD-Gal-BSA, BSA, can replace radioiodinated counterparts in the binding assays of animal lectins (serum mannose binding protein and hepatic Gal/GalNAc receptor.) The advantage of QD and other europium labels is that it does not decay as radioiodides do. The long shelf-life results in more consistent results from repeated experiments.

    DOI: 10.1093/glycob/8.9.849

    Scopus

    PubMed

    researchmap

  • Europium labeling of natural and synthetic glycopeptides 査読

    Nana Kawasaki, Yuan C. Lee

    Analytical Biochemistry   250 ( 2 )   260 - 262   1997年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Academic Press Inc.  

    DOI: 10.1006/abio.1997.2233

    Scopus

    PubMed

    researchmap

  • Effect of active oxygen radicals on protein and carbohydrate moieties of recombinant human erythropoietin 査読

    Eriko Uchida, Kazushige Morimoto, Nana Kawasaki, Yoko Izaki, Ahmed Abdu Said, Takao Hayakawa

    Free Radical Research   27 ( 3 )   311 - 323   1997年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Informa Healthcare  

    DOI: 10.3109/10715769709065769

    Scopus

    PubMed

    researchmap

  • Control of hemoglobin synthesis in erythroid differentiating K562 cells I. Role of iron in erythroid cell heme synthesis 査読

    Nana Kawasaki, Kazushige Morimoto, Tsuyoshi Tanimoto, Takao Hayakawa

    Archives of Biochemistry and Biophysics   328 ( 2 )   289 - 294   1996年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Academic Press Inc.  

    K562 cells were used to investigate the factors that control hemoglobin (Hb) synthesis. Treatment with sodium butyrate enhanced Hb synthesis and glycophorin A expression. δ-Aminolevulinate synthase (ALAS) activity and Hb levels simultaneously increased to a similar extent and with a similar time course, and the increases were dependent on the concentration of diferric transferrin (FeTf) in the culture medium. Addition of exogenous δ-aminolevulinic acid (ALA) resulted in a dose-dependent increase in Hb content. Hb synthesis was inhibited 50% after addition of succinylacetone (SA), a potent inhibitor of δ-aminolevulinate dehydratase. These findings suggest that ALAS is a key enzyme in the eight steps of de novo heme synthesis and that iron, including FeTf, plays a central role in Hb synthesis through control of ALAS activity in erythroid differentiating cells. On the other hand, erythropoietin (EPO) treatment had no effect on Hb synthesis and slightly suppressed glycophorin A expression. Hemin enhanced Hb synthesis in the K562 cells but not glycophorin A expression. The addition of ALA, SA, or FeTf to hemin-treated cells caused no significant changes in Hb synthesis. Butyrate, EPO, and hemin acted on the K562 cells in different ways and caused different biochemical changes in the Hb synthesis process. © 1996 Academic Press, Inc.

    DOI: 10.1006/abbi.1996.0175

    Scopus

    PubMed

    researchmap

  • Effects of acetaminophen on the ultrastructure of isolated rat hepatocytes 査読

    Hisako Fujimura, Nana Kawasaki, Tsuyoshi Tanimoto, Hiroyuki Sasaki, Teruo Suzuki

    Experimental and Toxicologic Pathology   47 ( 5 )   345 - 351   1995年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    The effects of acetaminophen (AA) on the ultrastructure of isolated hepatocytes (IHC) of rat following incubation of IHC suspensions with AA were examined by electron microscopy. The effect of N-acetyl-p-benzoquinone imine (NAPQI), a putative toxic metabolite of AA, were also observed. IHC were prepared from livers obtained from phenobarbital-treated rats by collagenase perfusion method. With 5 and 20 mM AA, surface blebs mainly containing smooth endoplasmic reticulum (ER) occurred in IHC. Dilatation of Golgi apparatus, partial degranulation of rough ER and enlargement of mitochondria were also observed. The altered mitochondria showed a low electron-dense matrix with loss of mitochondrial granules. With 500 μM NAPQI, surface blebs containing various organelles occurred in IHC. Disorderly distributions of cytoplasmic organelles, mild dilatation of rough and smooth ER and cytoplasmic myeloid bodies were observed. The characteristic myeloid bodies were seemingly derived from degranulated rough ER. © 1995, All rights reserved.

    DOI: 10.1016/S0940-2993(11)80345-3

    Scopus

    PubMed

    researchmap

  • The loss of in vivo activity of recombinant human erythropoietin by active oxygen species 査読

    Ahmed Abdu Said, Kazushige Morimoto, Eriko Uchida, Nana Kawasaki, Kyoko Hibi, Yoko Izaki, Takao Hayakawa

    Free Radical Research   22 ( 3 )   229 - 238   1995年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Informa Healthcare  

    The effects of active oxygen species on the in vivo activity of recombinant human erythropoietin (EPO) treated by Fenton system, xanthine (X) plus xanthine oxidase (XO) system and hydrogen peroxide (H2O2) has been studied by means of counting the increase in number of hemolyser-resistant cells (HRCs) in EPO-injected mice. The results showed that both Fenton and X plus XO systems caused a significant reduction of the activity in proportion to the concentration of generated active oxygen species. Meanwhile, the treatment of EPO with H2O2 alone resulted in a relatively slight reduction of the activity. Electrophoretic studies on the structure of EPO revealed that its main protein band on sodium dodecyl sulfate-polyacrylamide gel (SDS-PAGE) disappeared in proportion with the extent of exposure to active oxygen generating systems. Both Fenton and X plus XO systems caused a significant loss of fluorescence in the pyridylamino (PA-) sugar chain in proportion to the concentration of generated active oxygen species, and no degradation products in the sugar chain part of the PA-sugar chain were detected. This showed that aromatic groups in EPO were sensitive to attack by active oxygen species. These results provide evidence that hydroxyl radical and other active oxygen species have a potential to react with EPO, leading to a reduction of its in vivo activity. © 1995 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted.

    DOI: 10.3109/10715769509147542

    Scopus

    PubMed

    researchmap

  • Determination of non-protein-bound iron in human synovial fluid by high-performance liquid chromatography with electrochemical detection 査読

    Nana Kawasaki, Tsuyoshi Tanimoto, Akira Tanaka, Takao Hayakawa, Nobuyuki Miyasaka

    Journal of Chromatography B: Biomedical Sciences and Applications   656 ( 2 )   436 - 440   1994年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Non-protein-bound iron in human synovial fluid was determined using high-performance liquid chromatography with electrochemical detection. The procedure was based on the separation of the iron-diethylenetriaminepentaacetic acid (DPTA) complex formed directly on a chromatographic column containing an anion-exchange resin followed by electrochemical detection. The method enabled more than 0.1 μM Fe(III) to be determined with an injection volume of 10 μl. A mixture of synovial fluid, 20 μM DTPA and acetate buffer was incubated in the presence and absence of superoxide (O-2) generated by a xanthine-xanthine oxidase system and was ultrafiltered through a 30 000 molecular mass cut-off filter. No iron was detected in the ultrafiltrate at physiological pH. However, the presence of iron was observed in the ultrafiltrate at low pH, and O-2 and decreased pH, iron may be released into the synovial fluid. © 1994.

    DOI: 10.1016/0378-4347(94)00135-9

    Scopus

    PubMed

    researchmap

  • Determination of non-protein-bound iron in rat tissue by ion chromatoraphy with electrochemical detection 査読

    Nana Kawasaki, Tsuyoshi Tanimoto, Akira Tanaka

    Analytical Biochemistry   192 ( 1 )   104 - 108   1991年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    A new, rapid, sensitive, and specific method combining ion chromatography with electrochemical detection was developed for measuring non-protein-bound Fe(II) and Fe(III) in biological samples. The procedure was based on the separation of the iron-diethylenetri-aminepentaacetic acid complex formed directly on the chromatographic column with anion-exchange resin followed by electrochemical detection. The method enabled more than 0.5 μm Fe(II) and Fe(III) to be determined for injection volumes of 10 μl. This method was applicable for the determination of Fe(II) and Fe(III) in ultrafiltrates of the rat liver cytosolic fraction. It was found that release of iron from iron-bound proteins was pH dependent and that non-protein-bound iron in the tissues was determined in a ferrous state at low pH values. © 1991.

    DOI: 10.1016/0003-2697(91)90192-V

    Scopus

    PubMed

    researchmap

  • Determination of iron(III) ion using ion chromatography with electrochemical detection and its application to the assay of the ferroxidase activity of cerulplasmin 査読

    Nana Kawasaki, Akiko Ishigami, Tsuyoshi Tanimoto, Akira Tanaka

    Journal of Chromatography A   503 ( C )   237 - 243   1990年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    A simple, rapid and sensitive method for the determination of iron(III) ion by ion chromatography coupled with electrochemical detection was developed. The method reduced the interferences of iron(III) ions and enabled more than 5 pmol of iron(III) to be determined with an injection volume of 10 μl. The method was applied to the determination of ferroxidase activity of ceruloplasmin with good reproducibility. The production of iron(III) ion by cerulplasmin was found to be linear with respect to reaction time and protein concentration. © 1990.

    DOI: 10.1016/S0021-9673(01)81505-3

    Scopus

    researchmap

  • Characterization of aldose reductase and aldehyde reductase from rat testis 査読

    Nana Kawasaki, Tsuyoshi Tanimoto, Akira Tanaka

    Biochimica et Biophysica Acta (BBA)/Protein Structure and Molecular   996 ( 1-2 )   30 - 36   1989年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Aldose reductase (alditol:NAD(P)+ 1-oxidoreductase, EC 1.1.1.21) and aldehyde reductase (alcohol:NADP+ oxidoreductase, EC 1.1.1.2) were purified to a homogeneity from rat testis. The molecular weights of aldose reductase and aldehyde reductase were estimated to be 38 000 and 41 000 by SDS-polyacrylamide gel electrophoresis, and the pI values of these enzymes were found to be 5.3 and 6.1 by chromatofocusing, respectively. Aldose reductase had activity for aldo-sugars such as xylose, glucose and galactose, whereas aldehyde reductase was virtually inactive for these aldo-sugars. The Km values of aldose reductase for aldo-sugars were relatively high. When a correction was made for the fraction of aldo-sugar present as the aldehyde form, which is the real substrate of the enzyme, the Km values were much lower. Aldose reductase utilized both NADPH and NADH as coenzyme, whereas aldehyde reductase utilized only NADPH. Aldose reductase was activated significantly by sulfate ion, while aldehyde reductase was little affected. Both enzymes were inhibited strongly by the known aldose reductase inhibitors. However, aldehyde reductase was in general less susceptible to these inhibitors when compared to aldose reductase. Both aldose reductase and aldehyde reductase treated with pyridoxal 5-phosphate have lost the susceptibility to aldose reductase inhibitor, suggesting that in these two enzymes aldose reductase inhibitor interacts with a lysine residue. © 1989.

    DOI: 10.1016/0167-4838(89)90090-3

    Scopus

    PubMed

    researchmap

  • Mechanism of testicular atrophy induced by Di‐n‐butyl phthalate in rats. Part 1 査読

    Masamichi Fukuoka, Tsuyoshi Tanimoto, Yu Zhou, Nana Kawasaki, Akira Tanaka, Isao Ikemoto, Toyohei Machida

    Journal of Applied Toxicology   9 ( 4 )   277 - 283   1989年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Repeated oral doses of di‐n‐butyl phthalate (DBP) to male rats caused a decrease in testicular fructose and glucose and a sloughing of the germ cells on the first day of treatment. On day 2, more severe sloughing was seen and was accompanied by decreases in testicular iron and zinc levels and increases in the level of inositol and cholesterols. The sloughing was followed by atrophy, accompanied by dissociation of the germ cells from the Sertoli cells and reduction of triglycerides, cholesterols and phospholipids containing choline and ethanolamine residues in the testis. Copyright © 1989 John Wiley &amp
    Sons, Ltd.

    DOI: 10.1002/jat.2550090413

    Scopus

    PubMed

    researchmap

▼全件表示

書籍等出版物

  • 有効性・安全性確保のためのバイオ医薬品の品質管理戦略第2版 : クオリティ・バイ・デザインを取り入れた製造・品質管理

    川崎, ナナ, 石井, 明子( 担当: 編集)

    じほう  2020年11月  ( ISBN:9784840752329

     詳細を見る

    総ページ数:xii, 274p   記述言語:日本語  

    CiNii Books

    researchmap

  • 薬事ハンドブック

    川崎 ナナ( 担当: 分担執筆 範囲: 抗体医薬品の国際一般名(INN)命名ルールの変更)

    じほう  2018年3月 

     詳細を見る

  • バイオ医薬品のCTD-Q作成

    川崎 ナナ( 担当: 分担執筆 範囲: バイオ医薬品における特異事項と同等性/同質性)

    サイエンス&テクノロジー  2018年1月 

     詳細を見る

  • 糖鎖の新機能開発・応用ハンドブック

    川崎ナナ, 原園 景, 石井明子( 担当: 分担執筆 範囲: 糖タンパク質バイオ医薬品の開発と品質・安全性評価)

    NTS  2015年8月 

     詳細を見る

  • 有効性・安全性確保のためのバイオ医薬品の品質管理戦略 : クオリティ・バイ・デザインを取り入れた製造・品質管理

    川崎 ナナ, 川西 徹( 担当: 編集)

    じほう  2015年  ( ISBN:9784840747257

     詳細を見る

    記述言語:日本語  

    CiNii Books

    researchmap

  • 医薬品の名前 ステムを知ればクスリがわかる

    川崎 ナナ( 担当: 分担執筆 範囲: 生物薬品)

    じほう  2013年2月 

     詳細を見る

  • バイオ医薬品 : 開発の基礎から次世代医薬品まで

    西島 正弘, 川崎 ナナ( 担当: 編集)

    化学同人  2013年  ( ISBN:9784759815092

     詳細を見る

    記述言語:日本語  

    CiNii Books

    researchmap

▼全件表示

MISC

  • ガラクトース転移酵素欠損マウスは高免疫原性腫瘍の増殖を抑制する(Galactosyltransferase-deficiency suppresses the growth of immunogenic tumors in mice)

    魏 恒, 成瀬 智恵, 川崎 ナナ, 浅野 雅秀

    日本癌学会総会記事   81回   P - 3009   2022年9月

     詳細を見る

    記述言語:英語   出版者・発行元:(一社)日本癌学会  

    researchmap

  • 血清グライコプロテオミクス LC/MS/MSを用いる血清糖タンパク質の網羅的解析

    高倉 大輔, 川崎 ナナ

    ぶんせき   ( 570 )   210 - 216   2022年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本分析化学会  

    researchmap

  • 糖鎖生物学と腎臓 腎機能に関連した非硫酸化HNK-1糖鎖の発現解析および腎機能障害マーカーへの展開

    森瀬 譲二, 高倉 大輔, 川崎 ナナ, 野中 元裕, 岡 昌吾

    日本腎臓学会誌   64 ( 3 )   179 - 179   2022年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本腎臓学会  

    researchmap

  • 薬の名前 ステムを知れば薬がわかる(追補-11) 神経系作用薬を定義する新しいステム「-fenacin」、「-fensine」、「-isant」、「-laner」

    宮田 直樹, 田辺 光男, 内田 恵理子, 川崎 ナナ

    PHARM TECH JAPAN   38 ( 8 )   1311 - 1316   2022年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)じほう  

    researchmap

  • 薬の名前 ステムを知れば薬がわかる(追補-10) モノクローナル抗体命名ルール大改正 抗体を表すステム「-mab」の命名が停止に

    川崎 ナナ, 中川 秀彦, 宮田 直樹

    PHARM TECH JAPAN   38 ( 2 )   271 - 274   2022年2月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)じほう  

    researchmap

  • 薬の名前 ステムを知れば薬がわかる(追補-9) 酵素阻害薬を定義するステム「-stat(-)」、「-costat」、「-daxistat」、「-folastat」、「-glenastat」

    宮田 直樹, 田辺 光男, 内田 恵理子, 川崎 ナナ

    PHARM TECH JAPAN   37 ( 15 )   2677 - 2685   2021年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)じほう  

    researchmap

  • 次世代を担う若手研究者が集う疾患糖鎖研究のフロンティア 腎障害に伴う非硫酸化HNK-1糖鎖の発現変化解析

    森瀬 譲二, 飯倉 七奈子, 阿部 沙也佳, 北野 仁望, 高倉 大輔, 川崎 ナナ, 野中 元裕, 岡 昌吾

    日本生化学会大会プログラム・講演要旨集   94回   [1S01a - 03]   2021年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本生化学会  

    researchmap

  • 【COVID-19治療薬-3 バイオ医薬品および予防用ワクチン】薬の名前 ステムを知れば薬がわかる(追補-8)

    内田 恵理子, 川崎 ナナ, 田辺 光男, 宮田 直樹

    PHARM TECH JAPAN   37 ( 12 )   2133 - 2140   2021年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)じほう  

    researchmap

  • 【COVID-19治療薬-2】薬の名前 ステムを知れば薬がわかる(追補-7)

    宮田 直樹, 田辺 光男, 内田 恵理子, 川崎 ナナ

    PHARM TECH JAPAN   37 ( 9 )   1569 - 1574   2021年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)じほう  

    researchmap

  • 【COVID-19治療薬-1】薬の名前 ステムを知れば薬がわかる(追補6)

    宮田 直樹, 頭金 正博, 田辺 光男, 内田 恵理子, 川崎 ナナ

    PHARM TECH JAPAN   37 ( 8 )   1371 - 1376   2021年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)じほう  

    researchmap

  • 薬の名前 ステムを知れば薬がわかる(追補-5) 酵素阻害薬を定義する共通のステム「-stat(-)」

    宮田 直樹, 田辺 光男, 内田 恵理子, 川崎 ナナ

    PHARM TECH JAPAN   37 ( 5 )   787 - 793   2021年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)じほう  

    researchmap

  • 薬の名前 ステムを知れば薬がわかる(追補-4) 特定の酵素阻害薬を定義する新しいステム 「-parstat」、「-polstat」、「-telstat」、「-tristat」、「-xestat」など

    宮田 直樹, 田辺 光男, 内田 恵理子, 川崎 ナナ

    PHARM TECH JAPAN   37 ( 1 )   109 - 116   2021年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)じほう  

    researchmap

  • 薬の名前 ステムを知れば薬がわかる(追補-3) 特定の酵素阻害薬を定義する新しいステム「-becestat」、「-castat」、「-dustat」、「-elestat」、「-gacestat」など

    宮田 直樹, 田辺 光男, 内田 恵理子, 川崎 ナナ

    PHARM TECH JAPAN   36 ( 15 )   2427 - 2440   2020年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)じほう  

    researchmap

  • 薬の名前 ステムを知れば薬がわかる(追補-3) 特定の酵素阻害薬を定義する新しいステム「-becestat」、「-castat」、「-dustat」、「-elestat」、「-gacestat」など

    宮田 直樹, 田辺 光男, 内田 恵理子, 川崎 ナナ

    PHARM TECH JAPAN   36 ( 15 )   2427 - 2440   2020年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)じほう  

    researchmap

  • 神経幹細胞分化過程におけるiPS細胞のプロテオームの定量解析

    浦澤 貴哉, 小泉 匠, 木村 一雅, 太田 悠葵, 川崎 ナナ

    日本生化学会大会プログラム・講演要旨集   93回   [1Z12 - 619)]   2020年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本生化学会  

    researchmap

  • 親水性相互作用濃縮法及びLC-MS/MSを用いたiPS細胞由来神経細胞膜糖タンパク質の同定

    木村 一雅, 小泉 匠, 太田 悠葵, 川崎 ナナ

    日本生化学会大会プログラム・講演要旨集   93回   [1Z01 - 002)]   2020年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本生化学会  

    researchmap

  • 【躍進する質量分析の薬学への展開】質量分析とグライコプロテオミクス 大腸がん診断マーカー開発への応用

    川崎 ナナ

    ファルマシア   56 ( 7 )   657 - 661   2020年7月

  • 薬の名前 ステムを知れば薬がわかる(追補-2) 特定のチロシンキナーゼ阻害薬を定義する新しいステム「-ertinib」、「-trectinib」、「-metinib」、「-xertinib」など

    宮田 直樹, 田辺 光男, 内田 恵理子, 川崎 ナナ

    PHARM TECH JAPAN   36 ( 9 )   1581 - 1591   2020年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)じほう  

    researchmap

  • N型糖鎖修飾を介したAMPA受容体のチャンネル機能制御

    緑川 良介, 若園 佳彦, 高倉 大輔, 森瀬 譲二, 川崎 ナナ, 岡 昌吾, 高宮 考悟

    日本生理学雑誌   82 ( 2 )   35 - 35   2020年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本生理学会  

    researchmap

  • 薬の名前 ステムを知れば薬がわかる(追補-1) インターネットで閲覧可能なステム情報

    宮田 直樹, 中川 秀彦, 川崎 ナナ

    PHARM TECH JAPAN   36 ( 1 )   137 - 143   2020年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)じほう  

    researchmap

  • ガラクトース転移酵素及びシアル酸転移酵素共発現カイコによるシアル酸修飾抗体の作製

    高倉大輔, 立松謙一郎, 三崎亮, 大橋貴生, 藤山和仁, 瀬筒秀樹, 川崎ナナ

    日本糖質学会年会要旨集   39th   2020年

     詳細を見る

  • トランスジェニックカイコを用いて製造されるバイオ医薬品の品質管理戦略構築に関する考え方

    石井明子, 多田稔, 立松謙一郎, 冨田正浩, 市原隆光, 山口秀人, 田中貴, 田中剛, 原園景, 木吉真人, 柴田寛子, 遊佐敬介, 佐藤陽治, 武田茂樹, 伊藤孝司, 川崎ナナ, 瀬筒秀樹

    医薬品医療機器レギュラトリーサイエンス   50 ( 10 )   615‐627 - 627   2019年10月

     詳細を見る

  • 薬の名前 続:ステムを知れば薬がわかる(第18回)[最終回]

    宮田 直樹, 田辺 光男, 内田 恵理子, 川崎 ナナ

    PHARM TECH JAPAN   35 ( 13 )   2645 - 2652   2019年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)じほう  

    researchmap

  • 薬の名前 続:ステムを知れば薬がわかる(第17回)

    川崎 ナナ, 内田 恵理子, 田辺 光男, 宮田 直樹

    PHARM TECH JAPAN   35 ( 11 )   2351 - 2359   2019年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)じほう  

    researchmap

  • 薬の名前 続:ステムを知れば薬がわかる(第16回)

    宮田 直樹, 田辺 光男, 内田 恵理子, 川崎 ナナ

    PHARM TECH JAPAN   35 ( 10 )   2105 - 2115   2019年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)じほう  

    researchmap

  • 薬の名前 続:ステムを知れば薬がわかる(第15回)

    宮田 直樹, 田辺 光男, 内田 恵理子, 川崎 ナナ

    PHARM TECH JAPAN   35 ( 9 )   1771 - 1778   2019年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)じほう  

    researchmap

  • 薬の名前 続:ステムを知れば薬がわかる(第14回)

    川崎 ナナ, 内田 恵理子, 佐藤 陽治, 田辺 光男, 宮田 直樹

    PHARM TECH JAPAN   35 ( 8 )   1559 - 1567   2019年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)じほう  

    researchmap

  • 薬の名前 続:ステムを知れば薬がわかる(第13回)

    宮田 直樹, 田辺 光男, 内田 恵理子, 川崎 ナナ

    PHARM TECH JAPAN   35 ( 6 )   1147 - 1156   2019年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)じほう  

    researchmap

  • 薬の名前 続:ステムを知れば薬がわかる(第12回)

    内田 恵理子, 川崎 ナナ, 田辺 光男, 宮田 直樹

    PHARM TECH JAPAN   35 ( 5 )   955 - 964   2019年4月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)じほう  

    researchmap

  • 薬の名前 続:ステムを知れば薬がわかる(第11回)

    宮田 直樹, 田辺 光男, 内田 恵理子, 川崎 ナナ

    PHARM TECH JAPAN   35 ( 3 )   653 - 658   2019年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)じほう  

    researchmap

  • 薬の名前 続:ステムを知れば薬がわかる(第10回)

    内田 恵理子, 川崎 ナナ, 田辺 光男, 宮田 直樹

    PHARM TECH JAPAN   35 ( 2 )   385 - 392   2019年2月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)じほう  

    researchmap

  • 薬の名前 続:ステムを知れば薬がわかる(第9回)

    宮田 直樹, 田辺 光男, 内田 恵理子, 川崎 ナナ

    PHARM TECH JAPAN   35 ( 1 )   151 - 159   2019年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)じほう  

    researchmap

  • 日本薬局方糖鎖試験法の国際調和に関する研究 : 日局参考情報「単糖分析及びオリゴ糖分析/糖鎖プロファイル法」への標準的な糖鎖試験の手順の追加に関する考察

    原園 景, 木吉 真人, 川崎 ナナ, 石井 明子

    医薬品医療機器レギュラトリーサイエンス = Pharmaceutical and medical device regulatory science   50 ( 11 )   704 - 718   2019年

     詳細を見る

    記述言語:日本語   出版者・発行元:日本公定書協会  

    CiNii Books

    researchmap

    その他リンク: http://search.jamas.or.jp/link/ui/2020045619

  • トランスジェニックカイコを用いて製造されるバイオ医薬品の品質管理戦略構築に関する考え方—Points to Consider on Quality Risk Management of Biopharmaceuticals Produced by Transgenic Silkworms

    石井 明子, 多田 稔, 立松 謙一郎, 冨田 正浩, 市原 隆光, 山口 秀人, 田中 貴, 田中 剛, 原園 景, 木吉 真人, 柴田 寛子, 遊佐 敬介, 佐藤 陽治, 武田 茂樹, 伊藤 孝司, 川崎 ナナ, 瀬筒 秀樹

    医薬品医療機器レギュラトリーサイエンス = Pharmaceutical and medical device regulatory science   50 ( 10 )   615 - 627   2019年

     詳細を見る

    記述言語:日本語   出版者・発行元:日本公定書協会  

    CiNii Books

    CiNii Research

    researchmap

    その他リンク: https://search.jamas.or.jp/link/ui/2020011765

  • 薬の名前 続:ステムを知れば薬がわかる(第8回)

    川崎 ナナ, 内田 恵理子, 田辺 光男, 宮田 直樹

    PHARM TECH JAPAN   34 ( 15 )   3227 - 3235   2018年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)じほう  

    researchmap

  • 薬の名前 続:ステムを知れば薬がわかる(第7回)

    田辺 光男, 川崎 ナナ, 内田 恵理子, 宮田 直樹

    PHARM TECH JAPAN   34 ( 14 )   3031 - 3039   2018年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)じほう  

    researchmap

  • 薬の名前 続:ステムを知れば薬がわかる(第6回)

    川崎 ナナ, 内田 恵理子, 田辺 光男, 宮田 直樹

    PHARM TECH JAPAN   34 ( 13 )   2797 - 2804   2018年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)じほう  

    researchmap

  • 薬の名前 続:ステムを知れば薬がわかる(第5回)

    宮田 直樹, 田辺 光男, 内田 恵理子, 川崎 ナナ

    PHARM TECH JAPAN   34 ( 11 )   2473 - 2478   2018年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)じほう  

    researchmap

  • 遺伝子組換えカイコによる抗体医薬品の開発と課題

    太田 悠葵, 立松 謙一郎, 亀田 康太郎, 小泉 匠, 川崎 ナナ, 瀬筒 秀樹

    質量分析   66 ( 4 )   164 - 169   2018年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:一般社団法人 日本質量分析学会  

    DOI: 10.5702/massspec.S18-33

    CiNii Books

    researchmap

  • 薬の名前 続:ステムを知れば薬がわかる(第4回)

    宮田 直樹, 田辺 光男, 川崎 ナナ, 内田 恵理子

    PHARM TECH JAPAN   34 ( 10 )   2211 - 2217   2018年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)じほう  

    researchmap

  • 糖鎖と疾患 糖鎖と自己免疫疾患

    大海 雄介, 伊勢 渉, 高倉 大輔, 高橋 伸典, 川崎 ナナ, 高橋 宜聖, 古川 鋼一

    日本口腔科学会雑誌   67 ( 2 )   83 - 83   2018年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:(NPO)日本口腔科学会  

    researchmap

  • 薬の名前 続:ステムを知れば薬がわかる(第3回)

    宮田 直樹, 田辺 光男, 川崎 ナナ

    PHARM TECH JAPAN   34 ( 9 )   1831 - 1840   2018年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)じほう  

    researchmap

  • 薬の名前 続:ステムを知れば薬がわかる(第2回)

    川崎 ナナ, 田辺 光男, 宮田 直樹

    PHARM TECH JAPAN   34 ( 8 )   1487 - 1493   2018年6月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)じほう  

    researchmap

  • 薬の名前 続:ステムを知れば薬がわかる(第1回)

    宮田 直樹, 田辺 光男, 川崎 ナナ

    PHARM TECH JAPAN   34 ( 7 )   1273 - 1278   2018年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)じほう  

    researchmap

  • 液体クロマトグラフィーを用いたバイオ医薬品の試験における分析条件変更管理等に関する研究

    原園 景, 小笠原 勝, 川崎 ナナ, 太田 悠葵, 鈴木 茂生, 石井 明子

    医薬品医療機器レギュラトリーサイエンス = Pharmaceutical and medical device regulatory science   49 ( 9 )   642 - 652   2018年

     詳細を見る

    記述言語:日本語   出版者・発行元:日本公定書協会  

    CiNii Books

    researchmap

    その他リンク: http://search.jamas.or.jp/link/ui/2019002271

  • シングルユースシステムを用いて製造されるバイオ医薬品の品質確保に関する提言

    石井 明子, 橋井 則貴, 松本 真理子, 香取 典子, 新井 進, 粟津 洋寿, 磯野 哲也, 井上 友美, 永座 明, 大山 幸仁, 奥村 剛宏, 梶原 大介, 田熊 晋也, 丹下 浩一, 塚原 正義, 筒井 麻衣子, 寺島 伊予, 中川 泰志郎, 服部 秀志, 林 慎介, 原 芳明, 松田 博行, 村上 聖, 矢野 高広, 巌倉 正寛, 大政 健史, 川崎 ナナ, 広瀬 明彦

    日本PDA学術誌GMPとバリデーション   19 ( 2 )   15 - 29   2017年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本PDA製薬学会  

    これまでに蓄積された科学的知見とリスクマネジメントの考えに基づき、シングルユースシステムを用いて製造されるバイオ医薬品の品質確保に関して考慮すべき要件を提言した。本稿では主に以下の項目で述べた。1)適用範囲、2)基本的要件、3)バイオ医薬品の品質確保及び安定供給のためのリスクアセスメント、4)バイオ医薬品の品質確保及び安定供給のためのリスク対応(管理戦略)、5)ライフサイクルマネジメント。シングルユース製品を用いたバイオ医薬品の製造工程の開発では、シングルユース製品によって生じるバイオ医薬品の品質、有効性、安全性確保及び安定供給に対するリスクとその対応策を明確にし、関係者で共有することが基本的要件となる。

    researchmap

    その他リンク: https://search.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2017&ichushi_jid=J05545&link_issn=&doc_id=20180115530001&doc_link_id=10.11347%2Fpda.19.15&url=https%3A%2F%2Fdoi.org%2F10.11347%2Fpda.19.15&type=J-STAGE&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00007_3.gif

  • 【社会生活に密接にかかわる生体高分子・機能性高分子と分析化学】抗体医薬品の品質評価・管理と分析化学

    太田 悠葵, 川崎 ナナ

    ぶんせき   ( 514 )   483 - 488   2017年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本分析化学会  

    researchmap

  • 関節リウマチを主な適用疾患とするバイオ医薬品における有害事象プロファイルの比較

    小林 哲, 村山 一茂, 太田 悠葵, 川崎 ナナ, 豊島 聰, 石井 明子

    薬剤疫学   21 ( 2 )   63 - 76   2017年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本薬剤疫学会  

    日本で承認されている免疫調節作用を有する抗体医薬品12品目について、報告数の多い有害事象の基本語(Preferred Term;PT)を特定するため、2015年時点で医薬品医療機器総合機構が公開していた医薬品副作用データベースに集積されていた症例を解析した。その結果、報告数の多いPTとして、肺炎、間質性肺疾患、ニューモシスチス・イロベチイ肺炎(Pneumocystiis jiroveci pneumonia;ニューモシスチス肺炎)、蜂巣炎、敗血症、および帯状疱疹等を特定した。これらのPTについて、特に日本で5種類の製品が承認されている抗TNF薬(infliximab、adalimumab、golimumab、certolizumab pegolおよびetanercept)をはじめとした関節リウマチ治療薬に着目し、医薬品ごとに各PTの発現頻度と初回発現時期を解析・比較した。ここでは、シグナル検出指標の報告オッズ比(reporting odds ratio;ROR)を発現頻度の指標として用いた。また、初回発現時期の対照薬としては、抗TNF薬とは標的が異なる関節リウマチ治療薬で、症例の報告数も比較的多い抗インターロイキン-6受容体抗体のtocilizumabを選択した。その結果、肺炎と間質性肺疾患、および敗血症については、RORと初回発現時期の解析からは特定の関節リウマチ治療薬との関連を示唆する結果は得られなかった。一方、ニューモシスチス肺炎については、特にinfliximabで高いRORが得られた。Infliximabではニューモシスチス肺炎の初回発現時期も他の医薬品より早い傾向にあり(0.19yr)、tocilizumab(0.32yr)を対照としてMann-Whitney検定を行うと、有意水準1%で有意差が認められた。Infliximabはニューモシスチス肺炎のRORが高いだけでなく、初回発現時期も特徴的であることから、ニューモシスチス肺炎との間に他よりも強い関連が示唆された。同様なことが、蜂巣炎とtocilizumab、帯状疱疹とcertolizumab pegolについても観察され、感染症に関する一部のPTは、特定のバイオ医薬品に強く関連する可能性が示唆された。肺疾患や皮膚疾患を持つ患者等については、抗TNF薬を使用する際に、これらの感染症が生じやすい可能性に配慮する必要があると考えられた。(著者抄録)

    researchmap

    その他リンク: https://search.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2017&ichushi_jid=J03595&link_issn=&doc_id=20170428180002&doc_link_id=10.3820%2Fjjpe.21.63&url=https%3A%2F%2Fdoi.org%2F10.3820%2Fjjpe.21.63&type=J-STAGE&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00007_3.gif

  • 関節リウマチ抗原特異的抗体上のシアル酸はII型コラーゲン誘導型関節炎を抑制する

    大海 雄介, 伊勢 渉, 原園 景, 高倉 大輔, 福山 英啓, 川崎 ナナ, 河原 敏男, 黒崎 知博, 高橋 宜聖, 古川 鋼一

    日本生化学会大会プログラム・講演要旨集   89回   [3T08 - 063)]   2016年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本生化学会  

    J-GLOBAL

    researchmap

  • TGカイコ由来ヒトリソソーム酵素をアクセプターとした人工合成N型糖鎖付加とリソソーム病治療への応用

    西岡宗一郎, 西岡宗一郎, 小林功, 小林功, 原園景, 原園景, 久保勇樹, 松崎祐二, 真板宣夫, 日高朋, 辻大輔, 辻大輔, 瀬筒秀樹, 瀬筒秀樹, 瀬筒秀樹, 町井博明, 町井博明, 石井明子, 石井明子, 川崎ナナ, 川崎ナナ, 伊藤孝司, 伊藤孝司, 伊藤孝司

    日本生化学会大会(Web)   89th   ROMBUNNO.1T08‐03(1P‐047) (WEB ONLY) - 03(1P   2016年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本生化学会  

    J-GLOBAL

    researchmap

  • 下垂体性性腺刺激ホルモン製剤の品質特性に関する研究

    原園 景, 川崎 ナナ, 小林 哲, 石井 明子

    医薬品医療機器レギュラトリーサイエンス = Pharmaceutical and medical device regulatory science   47 ( 5 )   388 - 392   2016年

     詳細を見る

    記述言語:日本語   出版者・発行元:日本公定書協会  

    CiNii Books

    researchmap

    その他リンク: http://search.jamas.or.jp/link/ui/2016318424

  • 平成25年度「日本薬局方の試験法等に関する研究」研究報告 クオリティ・バイ・デザインにより製造・管理される抗体医薬品等の医薬品各条記載に関する研究

    川崎 ナナ, 多田 稔, 石井 明子

    医薬品医療機器レギュラトリーサイエンス = Pharmaceutical and medical device regulatory science   47 ( 1 )   60 - 63   2016年

     詳細を見る

    記述言語:日本語   出版者・発行元:日本公定書協会  

    CiNii Books

    researchmap

    その他リンク: http://search.jamas.or.jp/link/ui/2016109422

  • 抗原特異的IgGへのシアル酸付加は関節リウマチを抑制する

    大海 雄介, 伊勢 渉, 原園 景, 福山 英啓, 川崎 ナナ, 黒崎 知博, 高橋 宜聖, 古川 鋼一

    日本生化学会大会・日本分子生物学会年会合同大会講演要旨集   88回・38回   [3P1137] - [3P1137]   2015年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本生化学会  

    J-GLOBAL

    researchmap

  • Nonclinical Evaluation of Next-generation Therapeutic Monoclonal Antibodies

    Akiko Ishii-Watabe, Minoru Tada, Takuo Suzuki, Nana Kawasaki

    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN   135 ( 7 )   857 - 866   2015年7月

     詳細を見る

    記述言語:日本語   掲載種別:書評論文,書評,文献紹介等   出版者・発行元:PHARMACEUTICAL SOC JAPAN  

    Therapeutic monoclonal antibodies (mAbs) exert their effects via binding to specific target molecules, which is expected to show rare off-target adverse reactions. However, nonclinical evaluation of mAbs is difficult because they often lack reactivity toward orthologous targets in animals. During the nonclinical evaluation of mAbs, not only the target molecules but fragment crystallizable (Fc) receptors, which regulate the immune effector functions and pharmacokinetic properties of mAbs, should be considered. In this review, factors for extrapolating nonclinical study results to clinical settings are discussed by focusing on Fc receptors. The human Fe gamma receptor family consists of Fc gamma RI, IIa, IIb, IIIa, and IIIb; Fey receptors in laboratory animals are structurally and functionally different from those in humans. In addition, interactions between human IgG-Fc, a component of therapeutic mAbs, and animal Fc gamma receptors are still not fully understood. With regard to neonatal Pc receptor (FcRn), related molecules comprising the FcRn family are not known; however, critical amino acid residues involved in IgG binding are different between human and mouse. In case of next-generation mAbs with a novel structure or mode of action, knowledge from related drugs is limited. To ensure safety of next-generation mAbs, a thorough understanding of the differences in Fc receptors among species and the interactions between mAbs and Fc receptors is required, and the appropriateness of the nonclinical study design should be carefully examined prior to conducting clinical studies.

    Web of Science

    researchmap

  • Japanese bioanalytical method validation guideline: The world's first regulatory guideline dedicated to ligand-binding assays

    Mami Imazato-Hirano, Yoshitaka Taniguchi, Masaaki Kakehi, Yoji Kuze, Takahiro Nakamura, Yoshiyuki Minamide, Kazuhiro Miya, Jun Hosogi, Masataka Katashima, Kotaro Maekawa, Haruhiro Okuda, Shingo Niimi, Nana Kawasaki, Akiko Ishii-Watabe, Noriko Katori

    Bioanalysis   7 ( 9 )   1151 - 1156   2015年5月

     詳細を見る

    記述言語:英語   掲載種別:書評論文,書評,文献紹介等   出版者・発行元:Future Science Ltd  

    DOI: 10.4155/bio.15.43

    Scopus

    PubMed

    researchmap

  • カイコを利用する創薬イノベーションと未来 カイコが創る次世代抗体医薬品

    石井 明子, 原園 景, 多田 稔, 立松 謙一郎, 瀬筒 秀樹, 川崎 ナナ

    日本薬学会年会要旨集   135年会 ( 1 )   149 - 149   2015年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本薬学会  

    researchmap

  • カイコを利用する創薬イノベーションと未来 組換えカイコを用いるネオグライコバイオロジクスの創製

    伊藤 孝司, 西岡 宗一郎, 小林 功, 久保 勇樹, 原園 景, 石井 明子, 川崎 ナナ, 瀬筒 秀樹

    日本薬学会年会要旨集   135年会 ( 1 )   150 - 150   2015年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本薬学会  

    researchmap

  • 関節リウマチにおける抗原特異的IgGシアル酸の機能解析

    大海 雄介, 伊勢 渉, 高橋 聖宜, 原園 景, 福山 英啓, 川崎 ナナ, 黒崎 知博, 古川 鋼一

    日本生化学会大会プログラム・講演要旨集   87回   [3P - 037]   2014年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本生化学会  

    researchmap

  • トランスジェニックカイコ由来ヒトリソソーム酵素の分子特性解析とグライコシンターゼによる糖鎖修飾

    西岡宗一郎, 小林功, 原園景, 久保勇樹, 真板宣夫, 池戸駿介, 東哲也, 辻大輔, 瀬筒秀樹, 町井博明, 石井明子, 川崎ナナ, 伊藤孝司

    日本生化学会大会(Web)   87th   3P-061 (WEB ONLY) - 061]   2014年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本生化学会  

    J-GLOBAL

    researchmap

  • 酸性糖鎖の糖鎖試験法に関する研究

    原園 景, 橋井 則貴, 栗林 亮佑, 柳原 繁弘, 西 基宏, 岡本 寿美子, 寺島 勇, 森 啓太郎, 山口 秀人, 佐藤 貴之, 村上 弘次, 岩田 美紀, 前田 由貴子, 前田 瑛起, 山田 英丙, 水野 保子, 岡野 清, 大庭 澄明, 川崎 ナナ

    日本薬学会年会要旨集   134年会 ( 2 )   281 - 281   2014年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本薬学会  

    researchmap

  • 平成24年度「日本薬局方の試験法等に関する研究」研究報告 抗体医薬品の医薬品各条における試験方法の設定に関する研究

    川崎 ナナ, 原園 景, 石井 明子

    医薬品医療機器レギュラトリーサイエンス   45 ( 10 )   866 - 873   2014年

     詳細を見る

    記述言語:日本語   出版者・発行元:日本公定書協会  

    CiNii Books

    researchmap

    その他リンク: http://search.jamas.or.jp/link/ui/2015015000

  • Ba-4 膵α-アミラーゼの糖鎖認識による腸内での糖質消化と糖吸収の調節活性(その他の糖質関連酵素,一般講演,日本応用糖質科学会平成26年度大会(第63回))

    豊田 陽子, 伊達 公恵, 川崎 ナナ, 橋井 則貴, 小川 温子

    応用糖質科学:日本応用糖質科学会誌   4 ( 3 )   B39   2014年

     詳細を見る

    記述言語:日本語   出版者・発行元:一般社団法人 日本応用糖質科学会  

    DOI: 10.5458/bag.4.3_B39-4

    CiNii Books

    researchmap

  • 抗体医薬品及び免疫抑制作用を有する各種薬剤の投与症例におけるウイルス感染プロファイルの比較とこれを利用したウイルス感染のリスク分析

    小林 哲, 遊佐 敬介, 川崎 ナナ

    医薬品医療機器レギュラトリーサイエンス   45 ( 5 )   436 - 441   2014年

     詳細を見る

    記述言語:日本語   出版者・発行元:日本公定書協会  

    CiNii Books

    researchmap

    その他リンク: http://search.jamas.or.jp/link/ui/2014242643

  • MDR-1を介してパクリタキセル耐性を示すHuH-7/PTX細胞に対する漢方薬の抗癌剤感受性回復作用(Recovery effect of Kampo Medicines on MDR-1-Mediated Multidrug Resistance in Hepatocellular Carcinoma HuH-7/PTX Cells)

    日向 昌司, 日向 須美子, 川崎 ナナ, 花輪 壽彦

    日本癌学会総会記事   72回   466 - 466   2013年10月

     詳細を見る

    記述言語:英語   出版者・発行元:日本癌学会  

    researchmap

  • トランスジェニックカイコを用いて生産された抗CD20抗体の特性解析

    多田稔, 立松謙一郎, 原園景, 石井明子, 瀬筒秀樹, 町井博明, 川崎ナナ

    日本生化学会大会(Web)   86th   2P-373 (WEB ONLY) - 373   2013年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本生化学会  

    J-GLOBAL

    researchmap

  • トランスジェニックカイコ絹糸腺由来組換えヒトカテプシンAの分子修飾と機能解析

    西岡宗一郎, 小林功, 辻大輔, 池戸駿介, 東哲也, MOTIUR Rahman Md, 真板宣夫, 瀬筒秀樹, 町井博明, 原園景, 石井明子, 川崎ナナ, 伊藤孝司

    日本生化学会大会(Web)   86th   1P-010 (WEB ONLY) - 010   2013年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本生化学会  

    J-GLOBAL

    researchmap

  • ガラクトシアリドーシス治療薬候補としてのトランスジェニックカイコ由来ヒトカテプシンAの解析

    西岡宗一郎, 小林功, 辻大輔, 池戸駿介, 東哲也, MOTIUR Md. Rahman, 真板宣夫, 瀬筒秀樹, 町井博明, 原園景, 石井明子, 川崎ナナ, 伊藤孝司

    生化学   85 ( 7 )   599 - 599   2013年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本生化学会  

    J-GLOBAL

    researchmap

  • 麻黄の活性成分・Herbacetinのマルチキナーゼ阻害作用

    日向 昌司, 日向 須美子, 天倉 吉章, 川崎 ナナ, 合田 幸広, 花輪 壽彦

    Journal of Traditional Medicines   30 ( Suppl. )   87 - 87   2013年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)和漢医薬学会  

    researchmap

  • セミナー 一般名がわかるステムの知識(2)生物薬品

    川崎 ナナ, 宮田 直樹

    日本薬剤師会雑誌 = Journal of the Japan Pharmaceutical Association   65 ( 2 )   133 - 136   2013年2月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本薬剤師会  

    CiNii Books

    researchmap

    その他リンク: http://search.jamas.or.jp/link/ui/2013121965

  • ウイルス等感染性因子安全性評価に関する研究

    小林 哲, 遊佐 敬介, 川崎 ナナ

    国立医薬品食品衛生研究所報告   ( 131 )   7 - 15   2013年

     詳細を見る

    記述言語:日本語   出版者・発行元:国立医薬品食品衛生研究所安全情報部  

    CiNii Books

    researchmap

    その他リンク: http://search.jamas.or.jp/link/ui/2014103908

  • GPIアンカー合成は線虫Caenorhabditis elegansの配偶子幹細胞ニッチの維持と生殖系列細胞発生に必須である

    村田 大輔, 野村 和子, 出嶋 克史, 水口 惣平, 川崎 ナナ, 中島 紫, 伊藤 さつき, 安藤 恵子, 中台 枝里子, 三谷 昌平, 松田 采子, 野村 一也

    日本生化学会大会プログラム・講演要旨集   85回   3T25 - 07   2012年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本生化学会  

    researchmap

  • リソソーム病治療への応用を目指したTGカイコ由来組換えヒトカテプシンAの分子特性評価

    西岡宗一郎, 小林功, 辻大輔, MOTIUR Rahman Md, 池戸駿介, 真板宣夫, 原園景, 石井明子, 川崎ナナ, 瀬筒秀樹, 町井博明, 伊藤孝司

    日本生化学会大会(Web)   85th   3P-060 (WEB ONLY) - 060   2012年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本生化学会  

    J-GLOBAL

    researchmap

  • GPIアンカー型蛋白質の生合成は線虫C.elegansの生殖細胞発生に必須である

    村田 大輔, 野村 和子, 出嶋 克史, 水口 惣平, 川崎 ナナ, 中島 紫, 伊東 さつき, 安藤 恵子, 中台 枝理子, 三谷 昌平, 野村 一也

    脂質生化学研究   54   133 - 134   2012年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本脂質生化学会  

    researchmap

  • 座談会 わが国における今後のバイオ医薬品の開発について

    川崎 ナナ, 武田 伸一, 渡部 一人

    医薬品医療機器レギュラトリーサイエンス   43 ( 10 )   884 - 896   2012年

     詳細を見る

    記述言語:日本語   出版者・発行元:日本公定書協会  

    CiNii Books

    researchmap

    その他リンク: http://search.jamas.or.jp/link/ui/2012373603

  • 抗体医薬品の糖鎖試験法の検討

    原園景, 橋井則貴, 栗林亮佑, 高久明美, 柳原繁弘, 西基宏, 岡本寿美子, 津田祐理子, 中島和幸, 森啓太郎, 筑紫周子, 佐藤貴之, 四方靖, 村上弘次, 掛樋一晃, 木下充弘, 神末和哉, 阿部碧, 川崎ナナ

    日本薬学会年会要旨集   132nd ( 4 )   2012年

     詳細を見る

  • 液体クロマトグラフィー/質量分析及び主成分分析によるエリスロポエチン製剤先行品及び後続品の糖鎖プロファイル類似性評価

    橋井則貴, 原園景, 栗林亮佑, 中澤志織, 川崎ナナ, 川崎ナナ

    日本薬学会年会要旨集   132nd ( 4 )   2012年

     詳細を見る

  • カラムスイッチング法を用いた液体クロマトグラフィー/質量分析法による抗体医薬品の糖鎖不均一性解析:プロセス解析工学への応用

    栗林亮佑, 橋井則貴, 原園景, 川崎ナナ

    日本薬学会年会要旨集   132nd ( 4 )   2012年

     詳細を見る

  • 医薬品規制の国際調和の推進による医薬品審査の迅速化のための基盤的研究 生物薬品の特性・品質解析,品質試験法の開発に関する研究

    川崎ナナ, 橋井則貴, 日向昌司, 栗林亮佑

    医薬品規制の国際調和の推進による医薬品審査の迅速化のための基盤的研究 平成23年度 総括・分担研究報告書   2012年

     詳細を見る

  • バイオ医薬製造技術シリーズ 液体クロマトグラフィー/質量分析による糖タンパク質医薬品の糖鎖解析

    橋井則貴, 原園景, 栗林亮佑, 川崎ナナ

    Pharm Tech Japan   28 ( 14 )   2012年

     詳細を見る

  • 治療用タンパク質の免疫原性(その4)

    新見 伸吾, 原島 瑞, 日向 昌司, 川崎 ナナ

    医薬品医療機器レギュラトリーサイエンス   42 ( 9 )   818 - 826   2011年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)医薬品医療機器レギュラトリーサイエンス財団  

    蛋白質医薬品の免疫原性を適切に評価することは、後期の段階における開発中止のリスクを軽減し、有効性および安全性に優れた蛋白質医薬品を医療の場に提供する上で重要である。蛋白質医薬品の免疫原性に関連した危険因子、非臨床試験における免疫原性試験の留意点と意義、非臨床試験および臨床試験における蛋白質医薬品の免疫原性の評価戦略、抗体の検出試験と中和活性試験、などについて概説した。

    researchmap

  • ヒトに感染が疑われているレトロウイルスとウイルス安全性

    遊佐 敬介, 山口 照英, 川崎 ナナ

    医薬品医療機器レギュラトリーサイエンス   42 ( 5 )   444 - 447   2011年

     詳細を見る

    記述言語:日本語   出版者・発行元:日本公定書協会  

    CiNii Books

    researchmap

  • 医薬品規制の国際調和の推進による医薬品審査の迅速化のための基盤的研究 生物薬品の特性・品質解析,品質試験法の開発に関する研究

    川崎ナナ, 橋井則貴, 日向昌司, 栗林亮佑

    医薬品規制の国際調和の推進による医薬品審査の迅速化のための基盤的研究 平成22年度 総括・分担研究報告書   2011年

     詳細を見る

  • 液体クロマトグラフィー/質量分析及び主成分分析による糖鎖プロファイルのデータマイニング法の評価

    橋井則貴, 原園景, 栗林亮佑, 中澤志織, 中澤志織, 川崎ナナ, 川崎ナナ

    質量分析総合討論会講演要旨集   59th   2011年

     詳細を見る

  • カラムスイッチング法を用いたLC/MSによるバイオ医薬品の糖鎖不均一性解析技術の開発

    栗林亮佑, 橋井則貴, 原園景, 川崎ナナ

    レギュラトリーサイエンス学会誌   1 ( Supplement )   2011年

     詳細を見る

  • 質量分析によるエポエチン先行品と後続品のグライコフォームプロファイルの比較

    原園景, 橋井則貴, 栗林亮佑, 川崎ナナ

    レギュラトリーサイエンス学会誌   1 ( Supplement )   2011年

     詳細を見る

  • カラムスイッチング法を用いた液体クロマトグラフィー/質量分析による抗体医薬品の糖鎖不均一性解析法の開発

    栗林亮佑, 橋井則貴, 原園景, 川崎ナナ

    生化学   2011年

     詳細を見る

  • ヘパリン純度試験に関する研究(第6報)日局医薬品各条ヘパリンナトリウム確認試験及び純度試験の改正に伴うヘパリンナトリウム標準品の品質確保に関する研究

    橋井 則貴, 川崎 ナナ, 秦 艶

    医薬品医療機器レギュラトリーサイエンス   42 ( 9 )   827 - 835   2011年

     詳細を見る

    記述言語:日本語   出版者・発行元:医薬品医療機器レギュラトリーサイエンス財団  

    CiNii Books

    researchmap

    その他リンク: http://search.jamas.or.jp/link/ui/2011350971

  • 抗体医薬品の体内動態制御に関わる受容体 : FcRn

    石井 明子, 鈴木 琢雄, 多田 稔, 川西 徹, 山口 照英, 川崎 ナナ

    日本薬理學雜誌 = Folia pharmacologica Japonica   136 ( 5 )   280 - 284   2010年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:公益社団法人 日本薬理学会  

    腫瘍や自己免疫疾患等の治療を目的とした分子標的薬として,抗体医薬品の研究開発が国内外で活発に行われている.抗体医薬品の特徴は標的分子に高い親和性をもって極めて特異的に結合することであるが,他のバイオ医薬品と比較して血中半減期が長いことも特筆すべき点である.ペプチドあるいはタンパク質を医薬品として応用する場合には血中半減期が実用化のためのハードルとなることが少なくない.しかし,多くの抗体医薬品は,生体内IgGの分解抑制に関わるneonatal Fc receptor(FcRn)を介したリサイクリング機構を利用することができるため,数日~数週間という長い血中半減期を有している.FcRnは齧歯類の新生児小腸に高発現し,乳汁に含まれる母親由来IgGの吸収に関与する受容体として同定された.その後の研究により,FcRnが成体においても種々の組織に発現し,IgGのリサイクリングやトランスサイトーシス等に関与していることが報告され,母子免疫以外にも様々な側面でIgGの体内動態制御に関わっていることが明らかにされている.我々は,既承認抗体医薬品のFcRn結合親和性を解析し,ヒトでの血中半減期とFcRn結合親和性の相関,および抗体医薬品のFcRn結合親和性を規定する構造特性の一端を明らかにした.近年の創薬研究では,FcRn結合親和性を改変した抗体医薬品等の開発が進んでいる他,FcRnのもう1つのリガンドであるアルブミンを利用することにより体内動態特性を改変したタンパク質医薬品の開発も進んでいる.FcRnは,抗体医薬品をはじめとするバイオ医薬品の体内動態制御に関わる鍵分子の1つと言えるであろう.

    DOI: 10.1254/fpj.136.280

    CiNii Books

    researchmap

    その他リンク: http://search.jamas.or.jp/link/ui/2011049115

  • 治療用タンパク質の免疫原性(その3)

    新見 伸吾, 原島 瑞, 日向 昌司, 川崎 ナナ

    医薬品医療機器レギュラトリーサイエンス   41 ( 9 )   726 - 735   2010年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一財)医薬品医療機器レギュラトリーサイエンス財団  

    医療現場で使用される治療用蛋白質の75%はヒト型組換え蛋白質で、その殆どはヒト体内で産生される蛋白質と同じアミノ酸配列を有するが、患者で抗体の産生が誘導されたことが報告されている。治療用蛋白質に対する抗体価の測定方法の原理および特徴、抗体活性の測定系構築における留意点、インターフェロン-β、エリスロポエチンおよびパニツムマブに対し患者で産生が誘導された抗体の測定の現状と問題点について概説した。

    researchmap

  • 糖鎖関連医薬品の開発と分析化学

    川崎 ナナ

    ぶんせき   ( 421 )   17 - 22   2010年1月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本分析化学会  

    CiNii Books

    researchmap

    その他リンク: http://search.jamas.or.jp/link/ui/2010093272

  • The Expression and Function of HNK-1 Glyco-Epitope on a Glutamate Receptor Subunit Glur2

    Ippei Morita, Shinako Kakuda, Yusuke Takeuchi, Itoh Satsuki, Nana Kawasaki, Shogo Oka

    GLYCOBIOLOGY   19 ( 11 )   1363 - 1363   2009年11月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:OXFORD UNIV PRESS INC  

    Web of Science

    researchmap

  • 抗体医薬品の品質・安全性確保(セミナー,<特集>抗体医薬品の開発)

    山口 照英, 川崎 ナナ

    ファルマシア   45 ( 7 )   677 - 682   2009年

     詳細を見る

    記述言語:日本語   出版者・発行元:公益社団法人 日本薬学会  

    DOI: 10.14894/faruawpsj.45.7_677

    CiNii Books

    researchmap

  • Mass spectrometric analysis of carbohydrate heterogeneity for the characterization of glycoprotein-based products

    Kawasaki Nana, Itoh Satsuki, Hashii Noritaka, Harazono Akira, Takakura Daisuke, Yamaguchi Teruhide

    TRENDS IN GLYCOSCIENCE AND GLYCOTECHNOLOGY   20 ( 112 )   97 - 116   2008年5月

     詳細を見る

    記述言語:英語   掲載種別:書評論文,書評,文献紹介等   出版者・発行元:GAKUSHIN PUBL CO  

    Analysis of the carbohydrate heterogeneity of glycoprotein-based substances is crucial for establishing the nomenclature and definition of biological substances, ensuring consistency in the quality of these products, comparatively assessing the products obtained after the implementation of changes in the manufacturing process, and developing biosimilar or follow-on biological products. Liquid chromatography/mass spectrometry is recognized as one of the most useful techniques for analyzing the carbohydrate heterogeneity of glycoprotein substances. Here, we demonstrate the utility of LC/MS for analyzing the carbohydrate heterogeneity by using some representative glycoproteins such as tissue-plasminogen activator, a monoclonal antibody, the follicle-stimulating hormone, and human chorionic gonadotropin. Further, we demonstrate that MS-based glycoprotein analysis has potential applications in glycomics.

    Web of Science

    researchmap

  • ヘパリン不純物問題とその対応(話題)

    川崎 ナナ

    ファルマシア   44 ( 12 )   1167 - 1171   2008年

     詳細を見る

    記述言語:日本語   出版者・発行元:公益社団法人 日本薬学会  

    DOI: 10.14894/faruawpsj.44.12_1167

    CiNii Books

    researchmap

  • 糖鎖と医薬品

    川崎 ナナ, 伊藤 さつき, 山口 照英

    Journal of applied glycoscience   54   52 - 52   2007年7月

     詳細を見る

    記述言語:日本語  

    CiNii Books

    researchmap

  • LC/MS<sup>n</sup>を用いた糖鎖抗原付加タンパク質の同定

    川崎ナナ, 川崎ナナ, 高倉大輔, 中島紫, 橋井則貴, 橋井則貴, 伊藤さつき, 原園景, 山口照英

    日本プロテオーム学会大会プログラム・抄録集   2007 (Web)   2007年

     詳細を見る

  • ヒトミエロペルオキシダーゼの部位特異的糖鎖構造解析

    伊藤さつき, 川崎ナナ, 川崎ナナ, 橋井則貴, 橋井則貴, 原園景, 中島紫, 高倉大輔, 内田恵理子, 押澤正, 山口照英

    生化学   2007年

     詳細を見る

  • N-acetylglucosaminyltransferase III antagonizes N-acetylglucosaminyltransferase V on alpha3beta1 integrin-mediated cell migration

    Yanyang Zhao, Jianguo Gu, Takatoshi Nakagawa, Akihiro Kondo, Nana Kawasaki, Eiji Miyoshi, Naoyuki Taniguchi

    GLYCOBIOLOGY   16 ( 11 )   1106 - 1106   2006年11月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:OXFORD UNIV PRESS INC  

    Web of Science

    researchmap

  • LC/MS/MSを用いたヒト血清グライコプロテオームの解析

    原園景, 川崎ナナ, 川崎ナナ, 伊藤さつき, 橋井則貴, 中島紫, 中島紫, 川西徹, 山口照英

    日本プロテオーム学会大会プログラム・抄録集   2006 (Web)   2006年

     詳細を見る

  • Mass spectrometry of glycoproteins

    Nana Kawasaki, Satsuki Itoh, Akira Harazono, Noritaka Hashii, Yukari Matsuishi, Takao Hayakawa, Toru Kawanishi

    Trends in Glycoscience and Glycotechnology   17 ( 97 )   193 - 203   2005年

     詳細を見る

    記述言語:英語   掲載種別:書評論文,書評,文献紹介等   出版者・発行元:Gakushin Publishing Company  

    This review presents mass spectrometric methods for glycoprotein identification, determination of glycosylation sites, structural elucidation of carbohydrates, and their applications to glycomics and proteomics. ©2005 FCCA (Forum: Carbohydrates Coming of Age).

    DOI: 10.4052/tigg.17.193

    Scopus

    researchmap

  • SUGAR CHAIN STRUCTURE OF SPERM RECEPTOR HrVC70 ON THE VITELLINE COAT IN THE ASCIDIAN HALOCYNTHIA RORETZI(Developmental Biology,Abstracts of papers presented at the 76^<th> Annual Meeting of the Zoological Society of Japan) :

    Sawada Hitoshi, Sawa Saeko, Itoh Satsuki, Kawasaki Nana

    Zoological science   22 ( 12 )   1455 - 1455   2005年

     詳細を見る

    記述言語:英語   出版者・発行元:Zoological Society of Japan  

    CiNii Books

    researchmap

    その他リンク: http://id.nii.ac.jp/1141/00039830/

  • LC/MS<sup>n</sup>による糖鎖の構造特異的検出

    川崎ナナ, 川崎ナナ, 橋井則貴, 橋井則貴, 松石紫, 伊藤さつき, 原園景, 川西徹

    日本プロテオーム学会大会プログラム・抄録集   2005 (Web)   2005年

     詳細を見る

  • LC/MS/MSを用いた糖タンパク質の糖鎖解析 : 糖鎖結合位置及び結合糖鎖の解析

    伊藤 さつき, 原園 景, 川崎 ナナ, 橋井 則貴, 松石 紫, 川西 徹, 早川 堯夫

    生物物理化学 = Journal of Electrophoresis   48 ( 4 )   163 - 168   2004年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本電気泳動学会  

    CiNii Books

    researchmap

  • Mechanism of inhibition of the metalloprotease meprin alpha and beta by mannan-binding protein

    M Hirano, BY Ma, M Baba, R Murai, N Kawasaki, S Oka, N Kawasaki, T Kawasaki

    GLYCOBIOLOGY   14 ( 11 )   1098 - 1098   2004年11月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:OXFORD UNIV PRESS INC  

    Web of Science

    researchmap

  • HGFにより誘導される細胞分散とc-Metのチロシンリン酸化に対する各種ガングリオシドの効果及びc-Metへの結合解析

    日向 須美子, 川崎 ナナ, 日向 昌司, 花輪 壽彦, 早川 尭夫

    日本癌学会総会記事   61回   308 - 308   2002年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本癌学会  

    researchmap

  • LC/MSを用いた糖ペプチドマッピング法による甲状腺刺激ホルモンの部位特異的な糖鎖の不均一性の解析

    太田 美矢子, 川崎 ナナ, 伊藤 さつき, 日向 昌司, 日向 須美子, 早川 堯夫

    日本薬学会年会要旨集   122年会 ( 3 )   80 - 80   2002年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本薬学会  

    researchmap

  • キャピラリーLC/MS及びLC/MS/MSによる微量糖タンパク質糖鎖の構造解析

    川崎 ナナ, 伊藤 さつき, 太田 美矢子, 日向 昌司, 日向 須美子, 早川 堯夫

    日本薬学会年会要旨集   122年会 ( 3 )   79 - 79   2002年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本薬学会  

    researchmap

  • LC/MSを用いたタイプの異なるN-結合型糖鎖の一斉分析

    伊藤 さつき, 川崎 ナナ, 太田 美矢子, 日向 昌司, 日向 須美子, 早川 堯夫

    日本薬学会年会要旨集   122年会 ( 3 )   79 - 79   2002年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本薬学会  

    researchmap

  • GlcNAc転移酵素IIIはHGFシグナルを亢進する

    日向 昌司, 川崎 ナナ, 日向 須美子, 太田 美矢子, 伊藤 さつき, 早川 堯夫

    日本薬学会年会要旨集   122年会 ( 3 )   79 - 79   2002年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本薬学会  

    researchmap

  • HGFで誘導されるc-Metのチロシンリン酸化に対するガングリオシドの効果

    日向 須美子, 川崎 ナナ, 日向 昌司, 太田 美矢子, 伊藤 さつき, 早川 堯夫

    日本薬学会年会要旨集   122年会 ( 3 )   79 - 79   2002年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本薬学会  

    researchmap

  • 糖鎖含有タンパク製剤の評価試験法に関する研究(4)エリスロポエチン製剤(その4)

    太田 美矢子, 川崎 ナナ, 伊藤 さつき

    国立医薬品食品衛生研究所報告   ( 120 )   89 - 97   2002年

     詳細を見る

    記述言語:日本語   出版者・発行元:国立医薬品食品衛生研究所化学物質情報部  

    CiNii Books

    researchmap

    その他リンク: http://search.jamas.or.jp/link/ui/2003246017

  • BIACOREを用いたガングリオシドGD1aによるHGFシグナル抑制機構の解析

    日向 須美子, 川崎 ナナ, 日向 昌司, 太田 美矢子, 伊藤 さつき, 早川 尭夫

    生化学   73 ( 8 )   1054 - 1054   2001年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本生化学会  

    researchmap

  • GlcNAc転移酵素III遺伝子導入HepG2細胞のHGF誘導細胞分散運動の亢進

    日向 昌司, 川崎 ナナ, 日向 須美子, 太田 美矢子, 伊藤 さつき, 早川 尭夫

    生化学   73 ( 8 )   698 - 698   2001年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本生化学会  

    researchmap

  • LC/MS及びNMRを用いたエリスロポエチンの硫酸化糖鎖の構造解析

    川崎 ナナ, 配島 由二, 太田 美矢子, 伊藤 さつき, 日向 昌司, 日向 須美子, 早川 尭夫

    生化学   73 ( 8 )   692 - 692   2001年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本生化学会  

    researchmap

  • LC/MS及びLC/MS/MSを用いた組換え型ヒトフォリスタチンの糖鎖構造解析

    伊藤 さつき, 川崎 ナナ, 日向 昌司, 太田 美矢子, 日向 須美子, 早川 尭夫

    生化学   73 ( 8 )   692 - 692   2001年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本生化学会  

    researchmap

  • 糖タンパク質性医薬品の同等性・同質性評価法としてのLC/MSの有用性

    太田 美矢子, 川崎 ナナ, 伊藤 さつき, 日向 昌司, 日向 須美子, 早川 尭夫

    日本薬学会年会要旨集   121年会 ( 4 )   137 - 137   2001年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本薬学会  

    researchmap

  • GlcNAc転移酵素III遺伝子導入による組換えフォリスタチンの糖鎖構造の改変

    日向 昌司, 川崎 ナナ, 太田 美矢子, 伊藤 さつき, 日向 須美子, 早川 尭夫

    日本薬学会年会要旨集   121年会 ( 4 )   8 - 8   2001年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本薬学会  

    researchmap

  • LC/MSを用いた組換え型ヒトトロンボモジュリンの糖鎖解析

    伊藤 さつき, 川崎 ナナ, 太田 美矢子, 日向 昌司, 日向 須美子, 早川 尭夫

    日本薬学会年会要旨集   121年会 ( 4 )   5 - 5   2001年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本薬学会  

    researchmap

  • 研究に関する資料 糖鎖含有タンパク製剤の品質評価試験法に関する研究(3)エリスロポエチン製剤 その3

    伊藤 さつき, 川崎 ナナ, 太田 美矢子

    国立医薬品食品衛生研究所報告   ( 119 )   65 - 69   2001年

     詳細を見る

    記述言語:日本語   出版者・発行元:国立医薬品食品衛生研究所化学物質情報部  

    CiNii Books

    researchmap

    その他リンク: http://search.jamas.or.jp/link/ui/2002188613

  • 表面プラズモン共鳴(SPR)イムノアッセイによるフォリスタチンの迅速定量

    日向 昌司, 川崎 ナナ, 日向 須美子

    国立医薬品食品衛生研究所報告   ( 119 )   57 - 60   2001年

     詳細を見る

    記述言語:日本語   出版者・発行元:国立医薬品食品衛生研究所化学物質情報部  

    CiNii Books

    researchmap

    その他リンク: http://search.jamas.or.jp/link/ui/2002190543

  • HGFで誘導される高転移性癌細胞の運動能のガングリオシドGD1aによる抑制機構

    日向 須美子, 川崎 ナナ, 日向 昌司, 太田 美矢子, 柴山 理恵, 川西 徹, 山形 貞子, 山形 達也, 早川 堯夫

    日本癌学会総会記事   59回   43 - 43   2000年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本癌学会  

    researchmap

  • ガングリオシドGD1aによるVEGF発現の抑制

    日向 須美子, 川崎 ナナ, 日向 昌司, 太田 美矢子, 山形 貞子, 山形 達也, 早川 尭夫

    日本薬学会年会要旨集   120年会 ( 3 )   72 - 72   2000年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本薬学会  

    researchmap

  • 糖鎖含有タンパク製剤の品質評価試験法に関する研究(2)エリスロポエチン製剤(2)

    川崎 ナナ, 太田 美矢子, 日向 須美子

    国立医薬品食品衛生研究所報告   ( 116 )   117 - 121   1998年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:国立医薬品食品衛生研究所化学物質情報部  

    CiNii Books

    researchmap

    その他リンク: http://search.jamas.or.jp/link/ui/1999087992

  • Control of hemoglobin synthesis in erythroid differentiating K562 cells : II. Studies of iron mobilization in erythroid cells by high-performance liquid chromatography-electrochemical detection

    KAWASAKI Nana, MORIMOTO Kazushige, HAYAKAWA Takao

    Journal of chromatography. B, Biomedical sciences and applications   705 ( 2 )   193 - 201   1998年2月

     詳細を見る

    記述言語:英語  

    CiNii Books

    researchmap

  • K562細胞の赤芽球分化過程における細胞内鉄動態とヘモグロビン(Hb)合成調節機構について

    川崎 ナナ, 森本 和滋, 早川 尭夫

    日本薬学会年会要旨集   116年会 ( 3 )   90 - 90   1996年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本薬学会  

    researchmap

  • 蛍光体支援糖質電気泳動法(FACE)による糖鎖含有タンパク質の糖鎖解析への応用

    森本 和滋, Alim A.F.A., 川崎 ナナ, 早川 尭夫

    日本薬学会年会要旨集   116年会 ( 3 )   80 - 80   1996年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本薬学会  

    researchmap

▼全件表示

講演・口頭発表等

▼全件表示

産業財産権

  • 癌の判定用マーカー

    川崎ナナ, 太田悠葵, 市川靖史, 寺内康夫, 芝田渉

     詳細を見る

    出願番号:特願2018-120945  出願日:2018年6月

    researchmap

  • 多機能型プローブペプチド

    太田悠葵, 川崎ナナ

     詳細を見る

    出願番号:特願2017-043134  出願日:2017年3月

    researchmap

  • 疾患特異的な組織因子経路インヒビター2の糖鎖構造の利用

    荒川憲昭, 高倉大輔, 川崎ナナ, 大竹則久

     詳細を見る

    出願番号:特願2017-22398  出願日:2017年2月

    researchmap

  • 糖ペプチド濃縮カラム及び糖ペプチド濃縮方法

    太田悠葵, 川崎ナナ, 高倉大輔

     詳細を見る

    出願番号:特願2016-169200  出願日:2016年8月

    公開番号:特開2016-169200 

    researchmap

  • 糖タンパク質または糖ペプチドの定性及び定量法

    太田悠葵, 川崎ナナ, 高倉大輔

     詳細を見る

    出願番号:特願2016-161118  出願日:2016年8月

    researchmap

共同研究・競争的資金等の研究課題

  • 膵癌早期診断のための血液バイオマーカーの同定

    研究課題/領域番号:24K10386  2024年4月 - 2027年3月

    日本学術振興会  科学研究費助成事業  基盤研究(C)

    栗田 裕介, 小林 規俊, 長谷川 翔, 川崎 ナナ, 市川 靖史, 窪田 賢輔

      詳細を見る

    配分額:4550000円 ( 直接経費:3500000円 、 間接経費:1050000円 )

    researchmap

  • 神経内分泌腫瘍(NENs)の早期発見、治療効果予測のための血液バイオマーカーの探索

    研究課題/領域番号:23K06719  2023年4月 - 2026年3月

    日本学術振興会  科学研究費助成事業  基盤研究(C)

    小林 規俊, 川崎 ナナ, 市川 靖史

      詳細を見る

    配分額:4680000円 ( 直接経費:3600000円 、 間接経費:1080000円 )

    researchmap

  • グライコプロテオミクスによる神経分化の分子基盤の解明と神経変性疾患マーカーの探索

    研究課題/領域番号:21H02617  2021年4月 - 2024年3月

    日本学術振興会  科学研究費助成事業  基盤研究(B)

    川崎 ナナ, 大橋 祥子, 高倉 大輔

      詳細を見る

    配分額:17420000円 ( 直接経費:13400000円 、 間接経費:4020000円 )

    本研究の目的は、神経変性疾患などの診断法や治療法の開発に資する研究として、神経変性疾患モデル細胞を用いて、神経分化に伴う糖タンパク質の糖鎖修飾とその機能を解析し、神経変性疾患に係わる糖鎖の構造や糖鎖生合成酵素を明らかにすることである。
    令和3年度は、iPS細胞 (iPSC) 由来アルツハイマー疾患 (AD)モデル神経前駆細胞を入手し、神経分化のための条件検討を行った。また、ADとの関係が示唆されているタウタンパク質のO型糖鎖修飾を解析する方法を開発する目的で、データ非依存的(DIA)-MSによるムチン型糖鎖の解析について検討した。すなわち、iPSCを用いてムチン型糖タンパク質のライブラリを構築し、このライブラリがDIA-MSによる定量に利用できることを確認した。
    また、我々が既に見出している神経特異的N型糖鎖BA2の機能解析を行った。BA2はN-アセチルグルコサミン (GlcNAc) 5個、マンノース3個、フコース1個からなるバイセクトフコシル2本鎖であり、我々は、ヒトiPSCが神経系細胞に分化する過程で、BA2が成長円錐に存在する軸索反発作用分子とその受容体や神経接着分子に選択的に結合していることを見出している。令和3年度は、軸索伸長におけるBA2の役割を明らかにすることを目的に、神経分化過程にあるiPSCにsiRNAを作用されることで、バイセクト構造形成に不可欠なBeta-1,4-Mannosyl-Glycoprotein 4-Beta-N-Acetylglucosaminyltransferase(タンパク質名:GnT3;遺伝子名:MGAT3)をノックダウンし、その影響を調べた。siRNAを作用させた細胞では、コントロールと比較して、軸索がまっすぐに伸長せず、ネットワークが適切に形成されていない様子が観察され、BA2は神経ネットワーク形成に関与していることが示唆された。

    researchmap

  • iPS創薬・再生医療のための糖鎖分化マーカー探索と分化評価法の開発

    2018年4月 - 2021年3月

    文科省  基盤研究B 

    川崎 ナナ

      詳細を見る

    担当区分:研究代表者  資金種別:競争的資金

    researchmap

  • 糖タンパク質バイオ医薬品の糖鎖の高機能化のための解析・制御・管理システムの開発

    2015年9月 - 2019年3月

    AMED  革新的バイオ医薬品創出基盤技術開発事業 

    川崎 ナナ

      詳細を見る

    担当区分:研究代表者  資金種別:競争的資金

    researchmap

  • 個別化医療に向けた抗体医薬品の標的分子の糖鎖構造と薬効・体内動態の関係の解明

    研究課題/領域番号:26293037  2014年4月 - 2017年3月

    日本学術振興会  科学研究費助成事業  基盤研究(B)

    川崎 ナナ, 小川 久美子, 多田 稔, 石井 明子

      詳細を見る

    配分額:16900000円 ( 直接経費:13000000円 、 間接経費:3900000円 )

    抗体医薬品の個別化医療の実現に向けて,標的分子の多様性と抗体との反応性の関係を明らかにする必要がある.本研究では,抗体医薬品標的タンパク質の糖鎖の多様性を明らかにすることを目的として,抗体医薬品を用いた免疫沈降,トリプシン消化,アセトン沈殿による糖ペプチドの濃縮,及びLC/MSにより部位特異的に糖鎖構造を解析する方法を開発した.この方法により,ヒト上皮様細胞癌由来A431細胞株のEGFRの5結合部位の糖鎖を明らかにし,Asn528に7-9個のGlcNAcと2-6個のFucからなる多様な糖鎖が結合していることを確認した.また,ヒト及びBHK細胞由来FcγRの部位特異的糖鎖構造も明らかにした.

    researchmap

  • 統合的神経機能の制御を標的とした糖鎖の作動原理解明

    研究課題/領域番号:23110001  2011年4月 - 2016年3月

    日本学術振興会  科学研究費助成事業  新学術領域研究(研究領域提案型)

    門松 健治, 川崎 ナナ, 田村 純一, 北川 裕之, 柚崎 通介, 鈴木 健一, 岡 昌吾, 小松 由紀夫, 戸島 拓郎, 吉田 秀郎, 古川 鋼一, 高宮 考悟, 木全 弘治, 山下 俊英

      詳細を見る

    配分額:59020000円 ( 直接経費:45400000円 、 間接経費:13620000円 )

    本新学術領域の研究目的は、神経機能を制御する「糖鎖機能ドメイン」から受容体、下流の分子動態、統合的な神経機能に至る制御機能の解明である。さらに、糖鎖研究と神経研究の融合・連携により、「神経糖鎖生物学」という新たな学問領域の創生を目指すことを目的とした。
    我々は、糖鎖研究・神経科学両分野から参集した多彩な研究者間で有機的・相互補完的な連携が進むように活動を行ってきた。1.融合研究進展の状況、2.国際化の推進、3.若手研究者育成の評価、4.アウトリーチ活動などの観点から総合的に評価すると、この我々の活動は、新しい学術の創生を大きく前進させたといえる。

    researchmap

  • 神経活動制御におけるHNK-1を中心としたN型糖鎖機能の解析

    研究課題/領域番号:23110006  2011年4月 - 2016年3月

    日本学術振興会  科学研究費助成事業  新学術領域研究(研究領域提案型)

    岡 昌吾, 川崎 ナナ, 竹松 弘, 森瀬 譲二

      詳細を見る

    配分額:127010000円 ( 直接経費:97700000円 、 間接経費:29310000円 )

    近年、脳の高次機能に糖鎖が深く関わることが次々に示され、神経系における糖鎖研究の重要性が増している。本研究では神経可塑性の調節に重要な役割を持つHNK-1糖鎖、およびシナプス可塑性調節に中心的な役割を担うAMPA受容体に発現するN型糖鎖を中心に解析を行った。その結果、AMPA受容体上のN型糖鎖が、その細胞表面発現量、細胞表面上での側方拡散の調節などに関わることを明らかにした。また、ペリニューロナルネット上に存在する新規HNK-1糖鎖を同定し、神経可塑性調節に重要なコンドロイチン硫酸鎖の合成を制御していることを明らかにした。

    researchmap

  • 先天性筋ジストロフィーに関わる機能性糖鎖の発現制御機構に関する研究

    研究課題/領域番号:23659153  2011年 - 2012年

    日本学術振興会  科学研究費助成事業  挑戦的萌芽研究

    岡 昌吾, 川崎 ナナ

      詳細を見る

    配分額:3770000円 ( 直接経費:2900000円 、 間接経費:870000円 )

    α-ジストログリカン上の糖鎖はラミニンなどの細胞外基質との結合に重要であり、その付加不全は先天性筋ジストロフィーの発症に関連する。本研究においてHNK-1糖鎖合成に関連する硫酸基転移酵素(HNK-1ST)が、α-ジストログリカン上の糖鎖の発現調節に関与していることを見出した。さらにメラノーマ細胞を用いてHNK-1ST によるα-ジストログリカン上の糖鎖の硫酸化が細胞の移動性を制御することを明らかにした。

    researchmap

  • 膵臓酵素に見出した糖鎖認識による消化・吸収と外分泌調節機構の解明

    研究課題/領域番号:22570111  2010年 - 2012年

    日本学術振興会  科学研究費助成事業  基盤研究(C)

    小川 温子, 川崎 ナナ

      詳細を見る

    配分額:4810000円 ( 直接経費:3700000円 、 間接経費:1110000円 )

    デンプン分解酵素α-アミラーゼ、トリプシノーゲンならびに膵リパーゼに見出した糖鎖結合部位とその生物機能について解明した。1.ウシトリプシノーゲンとMe-GalNAcとの共結晶化とX線結晶解析により2か所の糖結合部位を決定した。2.ヒト膵リパーゼの大腸菌での発現、精製、リフォールディング方法を検討し、大量精製法を確立した(特許出願済)。ブタ膵リパーゼとレコンビナントヒト膵リパーゼの糖鎖認識には類似性があることが示された。3.ブタ膵α-アミラーゼ(PPA)と腸管刷子縁の糖鎖リガンドとの結合によりデンプン消化が2.5倍に活性化する一方、膵液分泌時のPPA高濃度下では糖吸収が阻害される事を見出した。PPAの糖タンパク質糖鎖結合性は、急激な高血糖を抑制し恒常性に寄与する。

    researchmap

  • 神経特異的な糖鎖による神経可塑性の調節機構の解明

    研究課題/領域番号:21370053  2009年 - 2011年

    日本学術振興会  科学研究費助成事業  基盤研究(B)

    岡 昌吾, 川崎 ナナ

      詳細を見る

    配分額:18720000円 ( 直接経費:14400000円 、 間接経費:4320000円 )

    HNK-1糖鎖は学習記憶などの脳の高次機能の調節に重要な糖鎖である。本研究ではHNK-1糖鎖がどのような分子機構で脳の高次機能を調節しているのかを明らかにする目的として研究を行い、HNK-1糖鎖がスパインと呼ばれる神経細胞上の重要な構造の形成に関与することや新たなキャリアー分子としてグルタミン酸受容体のサブユニットの一つであるGluR2上に発現せいていることを明らかにした。

    researchmap

  • グライコミクス技術による腫瘍関連糖タンパク質の探索と腫瘍マーカーへの応用

    研究課題/領域番号:21590056  2009年 - 2011年

    日本学術振興会  科学研究費助成事業  基盤研究(C)

    川崎 ナナ

      詳細を見る

    配分額:4680000円 ( 直接経費:3600000円 、 間接経費:1080000円 )

    先に報告者らは,ヘテロ核リボ核酸タンパク質(hnRNP)が腫瘍マーカーとして知られるシアリルルイスx(sLe^x)の付加タンパク質であることを示唆する結果を得ている.本研究では, hnRNPファミリーの一部はsLe^xとゴルジ体で共局在しており,それらの発現レベルはDNA合成期から分裂準備期にかけて亢進していることを見出した.また, sLe^xの生合成は主にフコース転移酵素VIが関与しており,この酵素の発現を抑制することにより,大腸癌細胞の増殖が抑制されることを見出した.これらの結果より, sLe^xとhnRNPは,大腸癌の増殖に関係している可能性があり, hnRNPは新しい腫瘍マーカーとして利用できる可能性があることが示唆された.

    researchmap

  • グライコミクス技術を用いた腫瘍関連糖タンパク質の特異的検出と同定

    研究課題/領域番号:18590045  2006年 - 2008年

    日本学術振興会  科学研究費助成事業  基盤研究(C)

    川崎 ナナ, 高倉 大輔

      詳細を見る

    配分額:4100000円 ( 直接経費:3500000円 、 間接経費:600000円 )

    大腸癌等に特異的に発現しているシアリルルイスx付加タンパク質として,ヘテロ核リボ核酸タンパク質A3が示唆された.

    researchmap

  • 糖鎖生物学と神経科学の融合による神経糖鎖生物学領域の創成

    研究課題/領域番号:16GS0313  2004年 - 2008年

    日本学術振興会  科学研究費助成事業  学術創成研究費

    岡 昌吾, YONG Ma, 小堤 保則, 木下 政人, 川崎 ナナ, 石 龍徳, 伊藤 信行, 伊藤 信行

      詳細を見る

    配分額:515970000円 ( 直接経費:396900000円 、 間接経費:119070000円 )

    生物はタンパク質だけでなく糖鎖にもその生体情報を書き込み、同一タンパク質に多様な機能を付加していると考えられる。神経発生、神経回路形成は細胞の分化、移動、軸索の伸長、標的細胞の認識、シナプス形成など多くの過程を経て行われる。これらの過程において特徴的な発現を示す糖鎖について研究を行い、糖鎖が神経発生、神経可塑性において重要な役割を担っていること示す知見を得た。

    researchmap

  • ナノフローLC/MSを用いたGPIアンカー型タンパク質の糖鎖の構造と機能解析

    研究課題/領域番号:15590052  2003年 - 2005年

    日本学術振興会  科学研究費助成事業  基盤研究(C)

    川崎 ナナ, 蜂須賀 暁子

      詳細を見る

    配分額:3100000円 ( 直接経費:3100000円 )

    GPIアンカー型タンパク質は,リン酸エタノールアミンを介してトリマンノース,グルコサミン,及びホスファチジルイノシトールが結合した膜タンパク質で,脳・神経系では,神経網形成などにおいて重要な役割を担っていると考えられている.GPIアンカー型タンパク質には複数のN結合型糖鎖が付加し,発生や成長に伴って変化することが示唆されているが,膜タンパク質のため精製が難しいことや,分子構造が複雑であることなどから,糖鎖構造が明らかにされているタンパク質は少ない.そこで,本研究では,ラット脳より脂質部分を切り離した可溶性GPI結合タンパク質をSDS-PAGEで分離し,LC/MS^nを用いてThy-1,LAMP,OBCAM,NTM,kilonの部位特異的糖鎖構造を解析した.
    生後3週間のラットの脳からGPI結合タンパク質を分画してSDS-PAGEを行い,20-25kDaのバンドにThy-1,また,45-85kDaのバンドにLAMP,OBCAM,NTM,及びkilonが泳動されていることを確認した.はじめに,20-25kDaのバンドから1%SDSを用いてThy-1を抽出し,トリプシンで消化した後,LC/MS^nを行い,Asn23及び98には高マンノース型糖鎖,混成型,及び2本鎖を中心とした複合型糖鎖,またAsn74にはフコシル複合型糖鎖が主に結合していることを明らかにした.つぎに,45-85kDaのバンドからLAMP,OBCAM,NTM,及びkilonをまとめて抽出し,混合物のままトリプシン消化した。タンパク質混合物消化物のLC/MS^nを行い,各タンパク質の糖鎖付加部位ごとの糖鎖の特徴を明らかにすることができた.その結果,この4つのタンパク質はペプチド部分だけでなく,糖鎖付加も類似していることが明らかになった.例えば,N末側には共通して高マンノース型糖鎖,また,C末にはルイス型糖鎖が集中して結合していた.
    今後は,病態マウス,または成長段階の異なるマウスのLAMP,OBCAM,NTM,及びkilonの糖鎖を解析し,疾患や神経網形成と糖鎖の関係の解明につなげたいと考えている.また,今回確立したSDS-PAGEとLC/MS^nを用いた部位特的糖鎖解析法を,他のGPI結合タンパク質を含む様々な糖タンパク質の糖鎖構造解析に利用していきたい.

    researchmap

  • 二次元電気泳動及びLC/MS/MSによる糖タンパク質糖鎖の構造と機能解析法の開発

    研究課題/領域番号:12672102  2000年 - 2002年

    日本学術振興会  科学研究費助成事業  基盤研究(C)

    川崎 ナナ

      詳細を見る

    配分額:3200000円 ( 直接経費:3200000円 )

    細胞・組織発現糖タンパク質の機能と構造を解析するために,2次元電気泳動法を用いた糖タンパク質のプロファイリング,及びLC/MSによる糖鎖プロファイリングと糖ペプチドマッピングからなるゲル内糖タンパク質の構造解析法の開発を行った.
    はじめに,モデル糖タンパク質として肝細胞増殖因子,トロンボモジュリン及び組織プラスミノーゲンアクチベータを用い,微量糖タンパク質構造解析法の開発を行った.まず,結合糖鎖の構造と分布を解析するために,グラファイトカーボンカラムを用いたキャピラリーLC/MS(CapLC/MS)による遊離糖鎖のプロファイリング法を開発した.タンパク質部分はトリプシン消化し,LC/MS/MSによるタンパク質同定に利用できることを確認した.また,同定された糖タンパク質を適当な酵素で断片化し,CapLC/MSを用いてペプチド・糖ペプチド混合物の中から糖ペプチドだけを描き出す糖ペプチドマッピング法を開発し,各糖鎖の結合位置を明らかにすることが可能となった.
    つぎに,2次元電気泳動法による細胞・組織発現糖タンパク質のプロファイリングと,糖鎖プロファイリングのゲル内糖タンパク質の糖鎖構造解析への応用を検討した.ラット脳からTritonX114による分画とPIPLC消化によりGPIアンカー型糖タンパク質画分を調製し,2次元電気泳動により,脳内GPIアンカー型糖タンパク質のプロファイルを作成した.泳動ゲル上のスポットを切り出し,ゲル内PNGaseF及びトリプシン消化を行い,N結合糖鎖とペプチド断片をそれぞれ回収した.ペプチド断片を用いてLC/MS/MSを行い,NCAM, LAMP, NTM, OBCAM, kilon,及びprionが同定された.このうち糖鎖構造未知のLAMP, NTM, OBCAM, kilonを含むスポットから抽出された糖鎖部分をCapGCC-LC/MSで分析し,脳特異的糖鎖BA-2,高マンノース型糖鎖,及びフコースやシアル酸を複数含む複合型糖鎖等であることが示唆された.本分析法は,今後,異なる細胞・組織(正常と病態等)間のプロファイルの比較による糖タンパク質の役割や機能の解明,及び差異の見られた糖タンパク質の構造の解析に役立つものと期待される.

    researchmap

▼全件表示

社会貢献活動

  • 講演会「バイオ医薬品製造と分析技術」

    役割:企画

    日本質量分析学会関東談話会  第149回関東談話会・男女共同参画推進委員会  2018年9月

     詳細を見る

    種別:講演会

    researchmap

  • セミナー「香り、食品への質量分析の活用」

    役割:企画

    日本質量分析学会関東談話会  第148回関東談話会  2018年3月

     詳細を見る

    種別:セミナー・ワークショップ

    researchmap

  • ラボツアー「横浜MSメーカーラボツアー」

    役割:企画

    日本質量分析学会関東談話会・男女共同参画推進委員会  第147回関東談話会  2018年1月

     詳細を見る

    種別:セミナー・ワークショップ

    researchmap

  • 市民講座「バイオテクノロジー応用医薬品の効果と可能性」

    役割:講師

    横浜市立大学  2016年8月

     詳細を見る

    種別:セミナー・ワークショップ

    researchmap

  • バイオテクノロジーで病気を治す

    役割:講師

    理化学研究所・横浜市立大学  理化学研究所横浜市立大学一般公開 講演会  2015年8月

     詳細を見る

    種別:セミナー・ワークショップ

    researchmap